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SUMMARY
The major part of this thesis describes studies on the 
biosynthesis of the benzoylated drimane sesquiterpene pebrolide 
and on mycophenolic acid.
The location of tritium in pebrolide biosynthesised from
_ *1 £l ■»
12-T, 2- Cj mevalonate was established by degradation and in 
particular the A-cx-oxymethylene group was shown to be derived from 
the methylene group of mevalonate, in agreement with the specificity 
of cyclisation found in di- and tri- terpene biosynthesis.
A number of degradative sequences for the determining of the 
level of tritium incorporation into different parts of mycophenolic 
acid were studied. Application of one of these to material 
biosynthesised from I2-T, 2- C| sodium acetate showed that the 
incorporation of acetate into the phthalide methylene group was 
in accord with the intermediacy of a tetraketide precursor. A 
farnesyl analogue of mycophenolic acid, its methyl ether (which 
were isolated from cultures of P . stoloniferum) and desmethylmycophenolic 
acid were tested (by radiotracer methods) as precursors, and the 
final steps in the biosynthesis of mycophenolic acid elucidated.
The stereochemistry of a dibydrobenzofuran metabolite of 
P. brevicomoactum, related to mycophenolic acid, has been established 
by synthesis from mycophenolic acid.
A minor metabolite (brevigellin) of P. brevicompactum was
isolated and shown by chemical and spectroscopic means to be a 
cyclodepsipeptiae containing a previously unreported amino acid 
residue•
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1Fungi, together with algae and bacteria, are traditionally 
classified as members of the plant Sub-kingdom Thallophyta which 
comprises "plants” that are without functional roots, stems, leaves 
or flowers, do not form embryos (as in seeds) and may consist of 
only one cell or of an aggregation of cells. In view of the dissimilar­
ities to the rest of the plant kingdom the classification of the 
non-photosynthetic members of this group as plants is somewhat dubious, 
and some authorities have considered the fungi as neither plant nor 
animal but belonging to a separate kingdom.
The classification of the fungi rests upon the sexual reproductive
mechanism exhibited by the organism and on the nature of the mycelium 
1 2
(or thallus) ’ • The most primitive class is the Phycomycetes, the 
simplest of which are unicellular and often aquatic. Some species 
do form extensive mycelia, such as the water moulds of the order 
Saprolegniales and the common black bread mould Mucor. Phizophus 
nigricans. The Ascomycetes derive thevir name from the sac-like vessel 
(asci) in which sexual spores are formed. This class includes the 
the yeasts and the filamentous fungi typified by the genera Aspergillus 
and Penicillia. The Basidiomycetes are the highest form of fungi 
and are familiar to the layman as mushrooms, toadstools and the smuts 
and rusts of cereals. In contrast to the previous classes 
Basidiomycetes rarely form asexual spores.
A fourth class, the Fungi Imperfecti, is artificial and comprises 
those species in which a sexual (or perfect) stage has not been
2observed. Many of these fungi are known to be the conidial stages
of perfect fungi (generally the Ascomycetes). For example, Fusarium
moliforme is the conidial stage of the gibberellin producing Ascomycete
Gibberella fujikuroi. This class contains the carniverous fungi
3
such as the nematode predator Dactylaria gracilis and several
pathogenic species such as Candida albicans which is responsible
for pulmonary candidiasis in man and animals, and Epidermophyton
floccosum which causes both tinea (ring worm) and athlete's foot.
The lichens are symbiotic associations of fungi (Ascomycetes
or Basidiomycetes) with unicellular algae. The alga, being
photosynthetic, provides organic nutrients for the fungus (mycobiot)
which, in turn, provides mechanical support and minerals for the
alga (phycobiot). In a number of cases the component organisms have
been cultivated separately under laboratory conditions.
In general the chemical processes essential to the support of
life are common to all organisms, these processes provide the synthetic
intermediates and the key macromolecules such as the proteins and
DNA and also the energy necessary to support metabolism. In contrast
to these primary metabolic processes the fungi, in common with the
higher plants and bacteria, possess a secondary synthetic form of
metabolism the products of which are species and sometimes strain
dependent, but play no obvious role in the natural economy of the
organism. The diversity of chemical structure displayed by the
if
secondary metabolites of fungi led Raistrick to term the phenomena 
'polychemism1. Although in a number of cases specific function has
353been tentatively ascribed to a number of these metabolites , in 
general they have generated interest not through their function in 
the producing organism but rather by the effect which some of these 
metabolites have on alien systems. The discovery of the effectiveness 
of penicillin, produced by the mould Penicillium chrysogenum, in 
treating bacterial infections in man gave tremendous impetus to the 
study of fungal secondary metabolites, leading to the isolation of 
many other antibiotics of economic importance.
While a number of secondary metabolites are structurally similar, 
to primary metabolites, and are presumably formed by modification 
of the processes producing these, most of these compounds possess 
structural features unknown in primary metabolites and consequently 
the biosynthetic steps leading to their formation are of intrinsic 
interest. The main body of this thesis describes an attempt to 
elucidate the sequences involved in the biosynthesis of two such 
metabolites of the mould Penicillium brevicompactum (Fungi Imperfecti).
CHAPTER 1
Pig. 1:1 - The biosynthesis of mevalonic acid.
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The plant terpenes are probably the largest known class of
naturally occurring compounds. Despite their structural and functional
diversity, a certain regularity of structural features was noted
by early workers and this was explained as resulting from a common
derivation involving polymerisation of a 'C^ . nucleus1. These ideas
5were rationalised by Ruzicka in his "Biogenetic Isoprene Rule" which
postulated that terpene structures could be derived from 'head-to-
tail1 linkage of 'active isoprene1.
Although Bloch had demonstrated that the carbon skeleton of
cholesterol was totally derived from acetate, the origin of the
7
unit was largely a matter of speculation until Folker e_t al. showed
that mevalonic acid was a better precursor of cholesterol. The stages
of mevalonic acid (MVA) biosynthesis from acetate have been demonstrated
9
with purified enzyme systems , and are outlined m  Fig. 1:1.
Alternative pathways for the formation of mevalonic acid have been 
10
demonstrated . Certain plants and microorganisms are capable of
11utilising leucine as a precursor (Fig. 1:1).
The phosphorylation of L-raevalonic acid to 5-phosphomevalonic
acid is irreversible and is virtually the only specific enzymatic
reaction of mevalonic acid. A second phosphorylation gives
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5-pyrophosphomevalonic acid , which reacts with a molecule of ATP 
to give ADP, inorganic phosphate and isopentenyl pyrophosphate (ipPP) 
(Fig. 1:2). Experiments with [3-^0] mevalonic acid^ have shown 
that the labelled oxygen is located in the inorganic phosphate formed, 
which suggests the intermediacy of (1 ). It has. been shown^ that
Fig. 1:2 - Formation of isopentenylpyrophosphate.
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Fig. 1:4 - Biosynthesis of polyisoprenoids.
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5the elimination of inorganic phosphate from this molecule proceeds
with trans stereochemistry. Isopentenyl pyrophosphate, which can
be regarded as the formal 'isoprene unit' required by Ruzicka's
hypothesis is converted enzymatically^’ ^  by a prototropic shift^
to dimethylallyl pyrophosphate (DmPP) (Fig. 1:3>)»
The coupling of dimethylallyl pyrophosphate with one molecule
of isopentenyl pyrophosphate to yield geranyl pyrophosphate and the
successive addition of further molecules of isopentenyl pyrophosphate
to give farnesyl and geranylgeranyl pyrophosphates (Fig. 1:^) have
been demonstrated with enzyme systems isolated from both plant and
15animal sources. Popjak has isolated a single enzyme capable of
synthesising farnesyl pyrophosphate.
The stereochemistry of the coupling process has been the subject
16
of extensive studies by Cornforth and Popjak using substrates 
asymmetrically labelled with hydrogen isotopes. They have proposed 
that the reaction proceeds in two distinct steps (Fig. 1:5). The 
first stage is the trans addition of the allylic group and of a 
nucleophilic group X to the double bond of isopentenyl pyrophosphate;
and the second a trans elimination of X and a proton (H„) from the
  .. K
intermediate. The identity of the group X is in some doubt.
17Johnson has suggested that it may be regarded as an oxygen atom 
of the pyrophosphate leaving group.
As a consequence of the stereospecificity of the isomerisation 
of isopentenyl pyrophsophate the of mevalonic acid becomes the 
trans methyl of the isopropylidene group of geranyl pyrophosphate.
■Me
0
(2)
(3)
rabbit
(4)
■* CH3CHO
OMe OMe
Me COOH
> C O 2
6This retention of stereochemical individuality has been demonstrated
by Birch in the case of mycelianamide ( 2) labelled with [2- CJ
mevalonate. Cleavage with sodium in liquid ammonia gave the
hydrocarbon ( 3) which was fed to a rabbit, and recovered from its
urine as the acid ( • Ozonolysis of the acid gave essentially
unlabelled acetaldehyde.
The cyclic terpenes can be considered to arise from cyclisation
of appropriate acyclic terpenoid species; thus cyclisation of farnesyl
pyrophosphate (three C<_ units), geranylgeranyl pyrophosphate (four
19units) and squalene (two farnesyl units linked head-to-head) 
give rise to the sesqui-, di- and tri- terpenes respectively. The
3 20mechanisms which have been proposed for the cyclisation processes ’
demand the retention of stereochemical individuality of the angular
methyl groups of the cyclised terpenes. Proof of this has been
presented in a number of cases including that of the fungal diterpene
21
rosenonolactone ( 5) • Wolf-Kishner reduction of the keto. group of
r 1 1
rosenonolactone labelled with [2- CJ mevalonate, was accompanied
with opening of the lactone ring. The resulting unsaturated acid
1 kwas decarboxylated to give CO^ which contained no C.
21In the triterpene series, Arigoni has shown that there is
also retention of stereochemical identity. The plant triterpene
1soyasapogenol-D ( 6) was labelled with [2- C] mevalonate and oxidised 
to the corresponding keto acid ( 7), decarboxylation of which gave 
inactive CO^.
In contrast, labelling studies on the biosynthesis of the
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monoterpene plant glucosides verbenalin ( 8) , pluraieride ( 9)
2.b
and loganic acid (10) have shown that in these cases the identity 
of the gem methyl groups is lost, suggesting the intermediacy of 
a species (11) in which the isopropylidene carbons are indistinguishable. 
Randomisation has also been reported in the biosynthesis of
2 p 2 ^ ^ c
the sesquiterpenes tutin (12) 1 and coriamyrtin (13) •
r  ^^  iexperiments with [2- CJ mevalonate the methyl and methylene of the 
isopropylidene group are equally labelled. If the methyl groups 
in an intermediate were part of an isopropyl group, they would almost 
certainly be diasteriotopic (chemically and biologically non-equivalent). 
Loss of biosynthetic identity must therefore reflect the occurrence 
of at least one non-specific process in the formation of these 
compounds, e.g. the elimination of water from an intermediate type 
(1*0 .
r
Fig. 1:6 Fungal sesqiterpenes.
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Fungal sesquiterpenes
In contrast to the large number of sesquiterpenes isolated from
higher plants, the fungal sesquiterpenes form a relatively small
class, few of which have skeletons similar to those found in plants.
The majority of fungal sesquiterpenes can be classified on biogenetic
grounds into five distinct groups; the tricothecanes, the
"protoilludanes", the helminthosporal group, the fungallin group
and the azulenes. (Fig. 1-6). The isoprenoid origin of each of the
first four groups has been demonstrated and possible biosynthetic
27 28
routes from farnesyl pyrophosphate have been proposed 1 . The
azulenes appear to be derived from farnesyl pyrophosphate without
rearrangement of the intermediates.
The sesquiterpene benzoates pebrolide (15), desacetylpebrolide
29(16) and deoxypebrolide (17) are the only drirnane sesquiterpenes
to have been isolated from a fungus. The Acrostalogmus sp. antibiotics 
30(18) and (19) are probably degraded diterpenes but could be formed 
by introduction of a one carbon unit into a drirnane skeleton.
A quite separate group of sesquiterpenes are those derived by 
alkylation of a polyketide derived nucleus with a farnesyl unit.
The occurrence of cyclic and acyclic metabolites in the same organisms 
suggests that cyclisations occur after introduction of the side chain. 
For example, the acyclic antibiotics (20) and (21), and the cyclised
metabolites (22) and (23) are produced by the same strain of Fusarium
3*1 32 33sp. . Siccanochromene E (2*fy and its co-metabolite siccanin (25)
3/4.
exhibit an unusual cis ring fusion. Tauranin (26) has a drirnane
(26)
skeleton which has the trans configuration analogous to that 
pebrolide (15).
DISCUSSION
Tx
( 15a )
10
Radiotracer studies in the biosynthesis of pebrolide
Pebrolide (15) and the closely related metabolites 
desacetylpebrolide (16) and 1-deoxypebrolide (17) were isolated 
from the fungus Penicillium brevicompactum and their structures 
determined by a combination of degradative chemistry and X-ray analysis. 
The terpenoid origin of pebrolide was demonstrated by the incorporation 
of [ 2-^c] mevalonate^.
The principal aim of the following experiments was to establish 
whether the biosynthetic individuality of the gem dimethyl of the 
precursor are preserved in the same way in the biosynthesis of this 
sesquiterpene, as in the formation of di- and tri- terpenes. The 
structure of pebrolide offers unique advantage in that the 4k - and 
4f>- carbon atoms are chemically distinct.
Pebrolide derived from [2-T] mevalonate might be expected to 
have the labelling pattern shown in (15a) - If the 4p-methyl group 
is derived from the of mevalonate then 2 Tritium atoms will be 
incorporated in this group, but if the 4k-acetoxymethyl group is 
derived from C^ then only 1-j tritium atoms (the statistical residue 
after oxidation of a doubly tritiated methyl) will be present. Complete 
randomisation of label due to a symmetrical intermediate would lead to 
1 tritium atom being located in the 4p-methyl group, and f of a tritium 
atom in the 4<<-acetoxymethyl group.
A degradative sequence suitable for determining the distribution 
of tritium in pebrolide biosynthesised from [2—T ] mevalonate had 
previously been investigated using inactive material by C. H.
Fig. 1:7 - Degradation of pedtrolide (15).
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11
2 Q
Cadzadilla , in this laboratory as summarised in Fig. 1:7. The
r 14- ilabelled compounds derived from pebrolide biosynthesised from [ 2 CJ 
mevalonate were identified by comparison by thin layer chromatography 
and mixed melting point with authentic samples.
A preliminary study of sesquiterpene production by P. brevicompactum 
in surface culture, by analytical t.l.c. of the culture filtrate 
extracts, had shown that pebrolide was produced from the fourth day 
onwards, whilst significant quantities of desacetylpebrolide were 
not produced until after the eighth day. However another metabolite, 
the depsipeptide, brevigellin (208) , traces of which prevent the 
crystallisation of pebrolide and which is not easily separated from 
pebrolide by preparative t.l.c., is produced from the seventh day 
onwards. For this reason the best time for feeding was thought to 
be between the fourth and sixth day of growth.
The first of the two feeding experiments described was carried
29out by C. H. Cadzilla , whose results are reproduced in Table 1:1.
1An aqueous solution of DL-[2- c] and [2-T ] mevalonic acid 
lactone (0.05 and 2.0 mCi. respectively) was fed to a four day old 
surface culture of P. brevicompactum which was then harvested after 
a further two days growth. The metabolites present in the culture 
filtrate were isolated using the charcoal/acetone method. Inactive 
pebrolide was added to the extract, reisolated by crystallisation 
and purified by repeated crystallisation. However, t.l.c. radioscan 
of the labelled pebrolide showed that even after several
crystallisations traces of a slightly less polar metabolite of much
r i/f i
Table 1:1 Degradation of L G,TJ pebrolide from experiment I
Compound
rel. molar activity (dpm./mM.)
1 kC T
%T based 
on pebrolide
T/lZfC
atomic
pebrolide
(15a)
(27a)
(29a)
3.2 x 10^ 8.7 x 105 
3.18 x 10 7.15 x 10^
100
82
^.35/3
( ^ 7/3)*
3.36/3
(3.78/3)*
(1.76/3)*
( )* denotes results obtained by C. Hernandez Cadzadilla*^
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higher specific activity were present. On oxidation with Jones'
reagent the contaminant was converted to a product (or products)
slightly less polar than pebrolide ketone (27)*
Samples of pebrolide and the ketone were purified by repeated
crystallisation until the contaminants could no longer be detected
by t.l.c. radioscan. The total activity of the reisolated pebrolide
14
was 0.001 pCi. with respect to C, which represents an incorporation
r 1 Zj. i
of 0.014% based on L-L 2- CJ mevalonate. .
The polarity of the contaminant mentioned above and that of
its oxidation product, coupled with the high specific activity
observed suggested that it may have been a sterol or a closely related
mixture of sterols. Analytical t.l.c. examination of the mycelial
extracts of P. brevicompactum showed that ergosterol (the only sterol
produced in significant quantities by this fungus) is produced from
the fifth day of growth onwards. In order to reduce contamination
from this source it was thought that the cultures should be harvested
at an earlier stage of growth. Consequently, in a second experiment
cultures of P. brevicompactum were fed with DL-[ 2-^c] and [2-t]
mevalonic acid lactone (0.1 and 4 mCi. respectively) on the third
day of growth and harvested on the fourth day. Inactive pebrolide
and desacetylpebrolide were added to the extract of the culture filtrate
and were reisolated by a combination of column and preparative layer
chromatography. Samples of both were crystallised until constant
r 1 A" iactivity was achieved. The incorporation of [ 2 - CJ mevalonate into
r 1 4 lpebrolide was 0.002% (based on L-j.2- Cj mevalonate) and that into 
desacetylpebrolide was 0.0004%.
AcCH
t  (!5a )
(28a)
HOOC
(30a)
(32a)
tvfefOO c
(328)
r1 4 1
Table 1:2 Degradation of L C,TJ pebrolide from experiment II
Compound rel. molar activity (dpm./mM.)1 4C T
%T based 
on pebrolide
T/lZfC
(atomic)
pebrolide
(15a)
(29a)
(32a)
(32b)
4 1 s
2.50 x 10 3.87 x 10^
4 5
1.51 x 10 1.75 x 10^
4 S 
1.50 x 10 1.62 x 10^
1 4 4 1.49 x 10 1.0 x 10
100
^5
41.6
2.6
^.36/3
1.98/3
1.87/3
0.12/3
Table 1:3
Position %T
exptl. calc •
1 18 23
4a-methylene and 
CH,C0- 37 31
2,6,8 3.^ 0
7 39 46
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Pebrolide from each of the feeding experiments was degraded 
by the scheme outlined in Fig. 1:.7; the results are summarised in
Tables 1:1, 1:2, and 1:3-
1 4The atomic (T/ C) ratio of pebrolide from both feedings is 
in accord with the predicted ratio (4.33/3) in the case where the 
4©(-methylene is stereoselectively derived from the C^ of mevalonate.
Oxidation of pebrolide to pebrolide ketone with Jones' reagent 
results in the loss of 18% of the tritium activity, which confirms 
the incorporation of one tritium atom at C^. The atomic ratio of 
the ketone (3 *36/3) is in good agreement with a predicted ratio of
3*33/3.
Selective hydrolysis of pebrolide ketone (270 with dilute acid 
and oxidation of the alcohol (28a) with Jones' reagent gave the keto 
acid (29a), which retained only 45% of the tritium activity of pebrolide. 
The difference in the atomic ratios found for the keto acid (1.98/3) 
and the ketone (27a) is almost exactly that predicted.
Basic hydrolysis of the benzoate, which was accompanied by 
epimerisation of the lactone, gave the keto hydroxy acid (30s) which 
was oxidised to the diketo acid (51a) with Jones' reagent, and this 
was esterified with diazomethane to give the methyl ester (52a). 
Comparison of the activity of tritium in the keto acid (£9e) and the 
methyl ester (32a) shows that only a small fraction of'the total tritium 
has been lost (3.4% of the total in pebrolide). This activity 
corresponds to incorporation in the positions 2 , 6 and 8 of the 
pebrolide skeleton.
Fig. 1:8 — Proposed biogenesis of pebrolide.
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Exchange of the tritium at positions 7 and 5 with refluxing 
dilute aqueous sodium hydroxide was accompanied by hydrolysis of 
the ester (32& to the corresponding acid (31b), which was re-esterified 
with ethereal diazomethane prior to counting. The tritium content 
of the product was only 2.3% of that of the ester prior to treatment 
with base, indicating that the remaining two tritium atoms had been 
incorporated at the 7 position as predicted.
The results indicate that in the biosynthesis of pebrolide the 
o-carbon atom at is directly derived from the of mevalonate, 
and that the stereoselectivity of ring closure is identical to that 
observed in the di- and tri- terpenoids.
A possible biosynthetic route from farnesyl pyrophosphate is
outlined in Fig. 1:8. By analogy with the pyrophosphate (33) which
35has been shown to be an intermediate in the biosynthesis of 
rosenonolactone ( 5) by Trichothecium roseum, the drimenyl pyrophosphate 
(3*f) could be an intermediate in the biosynthesis of pebrolide.
However, the intermediacy of either of the isomeric pyrophosphates 
(35) and (36) is also possible. The location of 2 tritium atoms 
at Cj of pebrolide derived from[2-T] mevalonate (Table 1:3) would 
be impossible if the intermediate (35) were involved. Experiments 
with^-T] mevalonate would be required to show whether (36) is a 
possible intermediate.
CHAPTER 2
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Introduction
The implication of acetate in biosynthesis was originally 
proposed by Collie"^ (1907), whose synthesis of orsellinic acid (38) 
from the dehydracetic acid (37) which he obtained from condensation 
of two molecules of ethyl acetoacetate prompted him to suggest that 
polymers of acetate (or rather ketene (CH^C^O)) might be involved 
in the biosynthesis of this and other naturally occurring aromatic
37compounds. This concept lay dormant until re-examined by Birch 
(1953) who used it to rationalize the oxygenation patterns observed 
in a large number of fungal metabolites, by postulating the 
intermediacy of a poly-p-keto-methylenic acid, CH-^CO.CH^^CO^H, '
38
m  their biosynthesis. The first experimental verification of
this was given by the specific incorporation of [l-^c} acetate into
6-methylsalicylic acid (39) by cultures of Penicillium griseofulvum.
Griseofulvin (*fl), also produced by P. griseofulvum, can also be
37derived 'on paper1 from a polyketide precursor (*f0) and the labelling
r 1^ 1 39pattern of this compound derived from [1- CJ acetate has been
shown to be consistent with an intermediate of this type.
As will be discussed later, there is a close relationship between
polyketide biosynthesis and the biosynthesis of fatty acids, the
mechanism of which has been studied in detail and is outlined in 
AO
Fig. 2:1 . An acetyl residue is transferred from coenzyme A, first
to acyl carrier protein (ACP) and then to an enzyme (ESH). The 
malonate moeity of malonyl coenzyme A, formed by the carboxylation 
of acetyl coenzyme A, is similarly transferred to ACP and condensation
Fig. 2:1 - Fatty acid biosynthesis.
CH3 COSCCA + C02 ------------- » H02 CCH2 C0SCoA
CH3COSC0A + HSACP  » CH3COSACP + HSCoA
CH3COSACP + USE  > CK3COSE + HSCoA
H02 CCH2 C02 SCoA + HSACP —» HOjCC^COSACP + HSCoA 
CH3 COSE + CH2 (C02 H)C0SACP -»  CH3 C0CH2 C0SACP+C02  + HSE
CH3COCH2COSACP  > CH3CH(OH)CH2COSACP
CH3CH(OH)CH2COSACP -----------» CH3CH=CHC0SACP
ch 3 c h = c h c o s a c p  ---------- > ch3 ch 2 ch2cosacp
CH3CH2CH2C0SE+C (^C02H)C0SACP > CH3CH2CH2COCH2COSACP
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occurs with the enzyme bound acetyl unit giving acetoacetyl ACP with 
the elimination of CC^* Successive reduction, dehydration and 
reduction give butyryl ACP which is transferred to an enzyme and 
condensed with a further malonyl ACP unit to give a C^ intermediate 
bound to ACP. The process is continued until the desired length 
of chain is formed when the free acid or its coenzyme A derivative 
is liberated from the enzyme complex.
The process of polyketide biosynthesis has not been the subject 
of such an extensive study, but the body of evidence which has been
accumulated points to a close similarity. Firstly, experiments with
Zf 1 if2 k3 bb
whole cells and partially purified enzyme systems ’ have
shown that the precursors of the polyketide chain are malonyl and
acetyl coenzyme A derivatives. Secondly, the physical properties
b8of the "polyketide synthetase" enzymes ’ are similar to those of
the fatty acid synthetase enzyme complexes, and thirdly, the
distribution of radioactivity in fatty acids and 6-methylsalicylic
1acid derived from 1- C and 2-T acetate in cultures of
b6 b7
P. griseofulvum and P. urticae have been shown to be consistent
with their formation by a similar condensation process. A further
similarity is the absence of free intermediates between acetate and
the fully assembled and stabilised polyketides.
The biosynthetic steps involved in polyketide formation can
be envisaged as follows; the initial condensation between protein
bound acetate and malonate units give rise to a protein bound
P-keto acyl unit. The further extensions of this unit include
rcov
M e ^  r C °
^co  cox
CO CO
(42)
OH
R . C H ^ O ^ 0
R = H 
R = Ac
(43)
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poly-(3-keto intermediates which are bound to the enzyme surface,
possibly b«j hydrogen bonding, and release from the enzyme surface
occurs after aromatisation. Evidence for the intermediacy of protein
bound poly-(3-keto compounds has been presented by Gatenbeck who
has shown that the alternariol (k2) synthesising enzyme' system is
more strongly inhibited by the (3-keto compounds, acetylacetone and
ethyl acetoacetate than by the -diketo compound acetonylacetone.
In the absence of NADPH, purified fatty acid synthetase produces
the tri- and tetra- acetic acid lactones (^3) which can be considered
as stabilized polyketide chains. Such pyrones do not themselves
30 51
serve as intermediates 1 in the biosynthesis of other polyketides
in vivo (although their conversion in. vitro to a number of naturally
occurring structural types of polyketides has been demonstrated )
indicating that "polyketide synthetase complex" in contrast to fatty
acid synthetase, must be able to stabilize the reactive poly-p-ketone
intermediates. It has been suggested that metal chelation may play
a part in the stabilization of these intermediates and the control
53of their specific cyclisations
The fact that only the first two carbon atoms of a polyketide 
chain are directly derived from acetate suggests that acetate should 
be incorporated into this position more efficiently than malonate.
This starter effect has been demonstrated in a number of experiments
1+2 ^3 1+7
both with enzyme systems 1 and whole cells ’ .
Acyl groups other than acetyl are also known to initiate polyketide
chain formation. Addition of three malonyl units to a cinnamoyl
(44)
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18
starter group could produce a polyketide (kk), which would give
chalcone (^5) and compounds of the flavanoid series such as
flavanone (^6) by Claisen-type condensation, or compounds of the
stilbene series such as pinosylvic acid (^7) by aldol-type cyclisation.
Labelling experiments support these schemes ; although the cinnamoyl
group (ring A) is derived from shikimic acid, ring B is derived from
acetate. In the biosynthesis of the tetracyclines (^ -8) by
actinomycetes of Streptomyces spp. the 'starter unit1 is probably
55malonamoyl coenzyme A . In actinomycetes propionate can function 
both as a 'starter' and (through methylmalonyl coenzyme A) as av chain 
extender unit, as in the biosynthesis of the macrolide antibiotic 
erythronolide ( 9^)» which is wholly derived from propionate"^. In 
fungi, however, intervention of units other than acetyl is rare although 
an ambiguity arises in the case of compounds which possess saturated 
straight chain residues, such as flavoglaucin (50) and curvularin (51)» 
in which the incorporation of a preformed fatty acid as 'starter' 
can be envisaged. It has been shown, however, that hexanocrte was 
not specifically incorporated into pulvilloricacid (52).
Reduction of carbonyl groups and dehydration without a final 
reduction step (cf. fatty acid biosynthesis) would account for the 
unsaturated side chains of auroglaucin (55) and sclerotiorin (5^0 
and also for the 'missing oxygen atoms' of a large number of polyketides, 
e.g. 6-methylsalicylic acid (39) and 3-hydroxyphthalic acid (55) 
which can be formally derived from a reduced orsellinic acid-type 
precursor•
OH Me
Me Me
AcO
(54)
0^ XOX
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A small class of metabolites are known to be derived from the
condensation of separate polyketide chains. Mollisin (57) a metabolite
58 59of Mollisia caesia has been shown to arise wholly from acetate
which is consistent with formation from two tetraketide chains (56)
with subsequent decarboxylation.
Decarboxylation is a common feature of polyketide biosynthesis;
6 0
fumigatin (58) has been shown to be derived from orsellinic acid
61
and terreic acid (59) from 6-methylsalicylic acid , indicating that 
decarboxylation occurs after aromatisation of a polyketide precursor.
In certain cases the enzymes which catalyse the decarboxylation of 
polyketide substrates have been isolated and characterised, e.g. 
orsellinic acid^, 6-methylsalicylic acid^, and stipitatonic acid (60)^ 
decarboxylases have been reported.
The biosyntheses of fumigatin (58) and terreic acid (59) also 
involve the introduction of ’extra’ oxygen atoms, a process which 
occurs late in a biosynthetic sequence, often after stabilization 
of the polyketide, and is catalysed by relatively non-specific enzymes. 
The biosynthesis of many of the anthraquinones, e.g. emodin (61) 
and islandicin (62), involve both decarboxylation and the introduction 
of oxygen, although it is not known in which order these occur.
In general O-alkylation involves methionine (as its S-adenosyl
65
derivative) as a methyl donor or the prenylpyrophosphates as donors 
of terpenyl units'3*3, and is a terminal step in biosynthesis. Asperugin 
(63) , a metabolite of Aspergillus rugulosus*3^ , contains both types 
of O-alkyl substituent.
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Methyl transfer from S-adenosyl methionine is also responsible
65 68
for the ’extra1 C-methyl groups of many polyketides *
C-methylation was thought earlier to occur at a post-aromatic stage,
but the body of evidence now available; vis. the fact that orsellinic
acid is not incorporated into gliorbseinCS^)^^, and atranorin (65)^,
71
that the ketones (66, 6?) are not incorporated into clavatol (68) ,
and that although methylphloroacetophenone (69) is a precursor of
72usnic acid (71) the desmethyl compound (70) is not ; suggests that
it occurs at some pre-aromatic stage. The isolation of methyl
triacetic acid lactone (72) as a by-product of stipitatic acid (73)
73biosynthesis in P. stipitatum has been interpreted as evidence
that C-methylation precedes the introduction of the final malonyl
unit to the growing polyketide chain, but the reported catalysis
of the methylation of a protein bound substrate, believed to be
74
tetraacetic acid, by extracts of Aspergillus flavipes (which produces
flavipin (6*fA)), indicates that methylation in this case occurs after 
chain formation. The mechanism and timing of C-methylation requires 
detailed study with pure enzymes before any conclusions can be reached.
On the other hand C-alkylation by prenyl units p'robably does 
occur at a post aromatic stage. The prenylation of p-hydroxybenzoic
7*5acid (derived from shikirnate) in bacterial systems has been demonstrated 
and the formation of the ergoline base agroclavine (7lf-) by Claviceps 
purpurea shown to involve alkylation of tryptophan with a mevalonate 
derived C,_ unit^ . The recent isolation of the prenylanthraquinones (76) 
and (77) from a physcion (75) producing strain of Aspergillus
OH o OH
^76) R = 
(77) R =
HO OH
OH Me Q OH
(78) (79) Me
Pig. 2:2 'ihe biosynthesis of .penioillic acid, and patulin.
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Pig. 2s3 - Proposed biosynthesis of the bisfurans.85.
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77flashentraegeri suggests that the same order applies in polyketide
78prenylation. Auroglaucin (53) an<i flavoglaucin (50) from Aspergillus 
79glaucus are derived by introduction of an isopentenyl unit derived
nO SO
from mevalonate, in fuscin (78) and atrovenetin (79) cyclisation 
of the terpenyl side chain has occurred. Metabolites formally derived 
by alkylation of a tetraketide nucleus with a farnesyl unit have been 
described previously (p. 8).
The biosynthesis of a number of acetate derived fungal metabolites 
involves rearrangement of the carbon skeletons of the initial polyketide 
precursors. The sequences involved in the formation of penicillic
81
acid (80) from orsellinic acid , and patulin (81) from 6-methylsalicylic
.,82,83 v, • T?- o oacid are shown m  Fig. 2:2.
The origin of the bisfurano-metabolites of Aspergillus versicolor
8k
and A. flavus (e.g. the versicolorins (82) and aflatoxins (85))
is not immediately obvious from inspection of their structures. The
r 1 ^ f i  r 1 A- l  r l ^ f  1
specific incorporations of [1- Cj and [2- CJ acetate and [ CH^J
methionine into aflatoxin (83a) have been determined by Buchi and
85co-workers , who proposed the biosynthetic sequence (Fig. 2:3) as
86a possible route from a nonaketide precursor. Tanabe e_t al. have
13
examined the incorporation of C labelled precursors into the related
metabolite sterigmatocystin (8^, Fig. 2:3) aa<i shown that these are
consistent with derivation from a nonaketide, rather than from two
87acetate-derived chains as previously proposed
The co-occurrence of the ergochromes (85) and the anthraquinones 
(86) and (87) in cultures of Claviceps purpurea suggested that the
COOMf
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m  0
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former might be formed by oxidative cleavage of an anthraquinone
88
precursor. This has been verified by Franck ert al. who have shown 
that emodin (89) is a precursor of these compounds. ( 1.
The dimeric nature of the ergochromes introduces a further common
89
feature of fungal metabolism, phenol-oxidative coupling , a biosynthetic
process exhibited by a large number of plant systems. Both inter-
and intra- molecular couplings are known. The coupling of orsellinic
90
acid residues in the biosynthesis of oosporein (89) and of
91
methylphloroacetophenone (69) in the formation of usnic acid (71 )
have been demonstrated, and the formation of an ether linkage by
this process in the biosynthesis of griseofulvin (41) has been suggested . 
93Duclauxin (90) is presumably formed by coupling of the corresponding
monomer. Although the dimeric anthraquinones of Penicillium
islandicum^ \  e.g. skyrin (91) and iridoskyrin (92), and their
monomers occur as co-metabolites, the monomers are not incorporated
95into the dimeric compounds , suggesting that coupling occurs at
a stage prior to quinone formation possibly at the level of the
intermediate anthrones. Intramolecular repetition of the coupling
process could lead to the novel structures of luteoskyrin (93)
95and the elsinochromes (9^) •
DISCUSSION
PART 1
OH
Me 0
(95.)
OMe
MeO
(96)
OMe
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MeO
(97)
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Mycophenolic acid (95) holds a position unique in the history 
of the study of fungal metabolites. It was named by Alsberg and
97Black (1915) who isolated it from cultures of Penicillium stoloniferunT ,
98
although Gosio (1896) had described the isolation of a crystalline
antibiotic substance from cultures of MPenicillium glaucum" which
was probably identical. Raistrick and co-workers isolated mycophenolic
acid, together with other phenolic compounds, from twelve different
99 /strains of the Penicillium brevicompactum series (to which P .
stoloniferum belongs) and advanced the structure (95) on the basis
of extensive chemical degradation"'^1 "*^ . This structure has been
103
confirmed by the synthesis of the ozonolysis product (97) of the
methyl ether (96) and more recently by total synthesis of mycophenolic
.,10^,105acid *
Early investigations into the antifungal and antibacterial 
properties of mycophenolic acid showed that the metabolite suppressed 
the growth of certain pathogenic fungi and Gram positive bacteria, 
but the activity/toxicity ratio was considered too low to permit its 
use as a therapeutic agent*^’" * Recently, however, interest in 
mycophenolic acid and its derivatives has been revived with the
discovery that the free acid has marked anti viral"* 07i108, ^mmuno_
* 109 , ... 1 0 7 ,110 ,111 .. . , .suppressive and antitumor activity in vivo. The anti­
mitotic and anti-cancer properties of mycophenolic acid have been 
ascribed to its inhibitory action on inosinic acid dehydrogenase
which results in a suppression of quanine and xanthine nucleotide 
110 113biosynthesis 1 . In contrast to earlier reports, it has also
been shown to inhibit the growth of certain pathogenic fungi in very
(96a)
HO?C
(98a)
• 1
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MeO
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2k
112low concentration
The polyketide origin of the aromatic nucleus of mycophenolic
112+
acid was first suggested by Birch and co-workers who showed that 
r 1^-t
label from [1“ Cj acetate was incorporated into both the side chain
and the nucleus (95a)- Ozonolysis of the labelled O-methylmycophenolic 
acid (96a) afforded the aldehyde (97a) and laevulinic acid (98a). 
Extensive degradation of the laevulinic acid, which possessed 2 /7  
of the activity of the mycophenolic acid, showed a labelling pattern
consistent with terpenoid origin of the side chain. This was confirmed
r 1 k 1 r 1 1by the incorporation of [2- CJ and [k- Cj mevalonate into mycophenolic
"'I  ^1 *1 * 1 5  .
acid (95b) * • Feeding experiments with [ CH^ ] and [CD^J methionine
have shown that the methoxyl and aromatic methyl groups are derived
from the pool^*"1^ .
Although the above experiments had given an indication of the
primary precursors involved, nothing was known of the biosynthetic
115
sequence of their assembly. Birch has claimed* the incorporation 
of [ 5- C ] orsellinic acid (38a) but the location of label in the 
mycophenolic acid formed is consistent with breakdown' of the orsellinic 
acid to acetate prior to incorporation rather than incorporation
115
of the acid as an intact unit. It has been suggested , in view
of the co-occurrence of the pentaketides (99)» (100), (101) and (102)
qq  ' \ ' \ n  29
ln P. brevicornpactum * ’ , that a compound of this type could
*It has recently been reported that |l - C J orsellinic acid is not 
incorporated into mycophenolic acid^
R =H orCO.CH3 
(103)
(950)
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be a precursor, a unit being removed at some later stage in
biosynthesis. Another possibility, by analogy with the sequence .
found in the biosynthesis of other C-methylated polyketides (p.20)
is that introduction of the C-methyl group precedes aromatisation
of the nucleus, and that the first free intermediate is of the type
118
(103)» It has been claimed , without experimental details however, 
that a "starter effect" has been detected in feeding experiments 
with malonyl CoA which would imply that the aromatic precursor is 
a tetraketide. It was proposed to investigate whether or not a 
starter effect is observed using a double labelling technique.
r 1 k ]
[2- C, 2-TJ Acetate should be incorporated both into the side
chain and the nucleus of mycophenolic acid (95c). Having established 
1Afrom the C activities of suitable fragments the relative 
incorporations into the nucleus and side chain, the tritium content 
of the phthalide methylene group could be predicted, assuming uniform 
incorporation of acetate into the nucleus. A substantially higher 
value than predicted would indicate a starter effect, and hence a 
tetraketide precursor, while a lower value would indicate the 
intermediacy of a precursor more highly oxygenated at this position.
r 1 i
In an analogous experiment with L2- C, 2-Tj malonate a certain 
proportion of the total tritium content would again be predicted 
to lie in the phthalide methylene group, assuming uniform incorporation 
of malonate into the.nucleus, as would be expected for a pentaketide 
precursor. A lower proportion again would indicate a starter effect.
In order to assess the incorporations involved, a degradative
26
scheme was required which enabled the incorporation of tritium in
the phthalide methylene group, the incorporation of C in the nucleus
1and the incorporation of tritium and C in the side chain to be 
determined independently. The following section describes the 
investigation of degradative sequences which were carried out using 
inactive material.
ho2c
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Degradations of Mycophenolic acid
(i) The specific oxidation of the phthalide methylene group
The oxidation of O-methylmycophenolic acid (96) with re fluxing
101alkaline potassium permanganate was reported by Raistrick to give
the anhydride (10^ -) in high yield, and this structure was later
116
confirmed spectroscopically by Birch . Oxidation of (96) under 
the conditions described by these authors afforded a mixture of 
compounds, preparative t.l.c. of which gave one major crystalline 
product m. 150-151°C» (14%). Although the melting point of this 
compound was similar to that reported for the anhydride (10^) (153°C)^\ 
elemental analysis and mass spectrometry were consistent with a 
molecular formula C^gH^Oy rather than that recorded for the anhydride
—  'I
(C^gH^QOg). Absorption bands at 3^80 and 1733 cm. in the i.r.
confirmed the presence of hydroxyl and Y-lactone functions but the
bands characteristic of a phthalic anhydride were absent. The presence
of a 2H singlet at -^.85 2" in the n.m.r. shov/ed that the phthalide
methylene group was intact. The n.m.r. spectrum was in accord with
the hydroxylactone structure (105) and comparison with the spectra
119of the available diasteriomeric hydroxylactones (106) and (107) 
showed that the product had the erythro configuration.
The oxidation was repeated using a much larger excess of the 
permanganate reagent, affording a mixture of compounds from which 
the anhydride (I0*f) could be separated by crystallisation from ether 
(13%). The melting point of this compound was depressed on admixture
MeO
(108) R = H
(109) R = Me
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with a sample of (105) hut the compounds could not be distinguished 
by analytical t.l.c. The i.r. (KBr) of the anhydride (10*0 showed 
bands at 35&0, 3^&0, 18*1-0 and 1770 cm.^ in agreement with the values 
reported • Confirmatory evidence for this structure was provided 
by the absence in the n.m.r. of the resonance characteristic of a 
phthalide methylene group and the low value of the aryl methyl group 
resonance (Table 2 :1) which suggests that it is deshielded by an 
ortho carbonyl group.
Subsequent attempts to increase the yield of the anhydride by 
varying the conditions of the reaction afforded mixtures of the 
hydroxylactone (105), the anhydride (lO*f) and several more polar 
products, from which the anhydride could not be readily separated.
In order to avoid possible side reactions involved in oxidation the 
side chain the oxidation was repeated using the methyl ether of the 
lactone (108).
The lactone (108), prepared in almost quantitative yield by
29
treatment of mycophenolic acid with trifluoroacetic acid or boron 
trifluoride etherate, was methylated with diazomethane to give the 
corresponding methyl ether (109, 96%). The failure of this compound 
to give a stain with ferric chloride (t.l.c.) and the presence in 
its n.m.r. spectrum of an additional 3H singlet at 5.90 2' are consistent 
with this structure.
Treatment of the lactone (109) with an excess of alkaline 
permanganate, under the conditions which had been found most effective 
in the oxidation of O-methylmycophenolic acid (9&) » yielded, in 
addition to starting material, a mixture of polar compounds. These
Table 2:1 Chemical shifts (*fr) of protons in the oxidation
products of (96) and (109)
Compound Ar.CH20- Ar.CH(0H)0- ArMe Ar(OMe)2
(105) **.85 — 7.80 5 .92; 6.16
(10*0 — — 7 . **5 5.82; 6.16
(110) — 3 .52 7.68 5 .92; 6.19
(112) ... — 7.66 6.03; 6 .19
OMe 0
(11Q)
0 " ' x r +'
(in)
0 < q COOMe
COOMe
were treated with ethereal diazomethane and the two major products
isolated by preparative t.l.c# The oily major product (20%), the
—  *1psuedo acid (110), showed hydroxyl absorption at 3^00 cm. in the 
i.r. but lacked the bands characteristic of an anhydride. Also,
in place of the resonance characteristic of a phthalide methylene
group, the n.m.r. showed a broad 1H singlet at 3*52"T which sharpened 
on treatment with I^^* The low frequency of this proton can be 
attributed to the deshielding of a benzylic proton by the two oxygen 
functions. The aryl methyl group resonated at a slightly lower value 
than that of the lactone (109) in keeping with lone pair deshielding 
by an ortho carbinol substituent. Evidence that the remainder of 
the molecule was unchanged was provided by the mass spectrum in which 
the base peak (m/e 99) corresponds to the fragment (111), and by 
the upper region of the n.m.r. spectrum which is almost identical
to that of the starting material (109).
The second product, the dimethyl phthalate (112), was isolated
in 5% yield as a colourless oil. In the i.r. (CCl^ ). bands at 1780 
—  1and 17^1 cm. showed the presence of both y-lactone and ester groups, 
while the presence of two carbomethoxyl groups was shown by two 
additional 3H singlets at 6.03^and 6.1lFin the n.m.r. The aryl methyl 
group is apparently deshielded to a smaller extent in this compound 
than'the corresponding group in the anhydride (10 +^) (Table 2 :1) presum­
ably since the ortho carbomethoxyl group is free to rotate out of 
the plane of the aromatic ring. Attempts to improve the yield of 
the phthalate (112) at the expense of the pseudo acid (110) by 
increasing the concentration of the reagent and prolonging the reaction
ch2oh
CH,OH
(113). (114)
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time were unsuccessful.
The difficulty experienced, as above, in converting phthalides
to phthalic acid derivatives can be attributed partly to the difficulty
of opening the phthalide ring and partly to steric limitations imposed
on the approach of an oxidising agent by the bulk of the groups ortho
to the hydroxymethyl group in the ring opened compound. It was thought
that if the phthalide system were reduced to the corresponding 1, ^  diol,
the hydroxymethyl group ortho to the aryl methyl group might be more
accessible to oxidising agents than in the above system.
The oxidation of 1 diols has been reported to yield the
corresponding y-lactones in high yield, except in cases where the
12 3configuration prohibits cyclisation . In the case of a phthalol
no such restriction exists and the product is the corresponding
phthalide. In non-symmetric systems where there is no difference
in the bulk of the substituents ortho to the hydroxymethyl groups,
or in the activation of these groups, a 1:1 mixture of the isomeric
phthalides would be produced. Otherwise it would be expected that
the major product would be that in which oxidation of the least
hindered alcohol has occurred. An extreme example of this has been'
reported in the oxidation of the phthalol (113) with silver carbonate/
celite which yielded helioxanthin (11*0 exclusively, due to the
restriction to the approach of the reagent to the hydroxymethyl group
120ortho to the bulky methylenedioxyphenyl substituent
If mycophenolic acid or a suitable derivative could be efficiently 
reduced to a phthalol, it was thought that subsequent oxidation might 
afford the 3,5 dioxygenated phthalide in workable overall yield.
h o .c h 2
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Preliminary attempts to reduce mycophenolic acid with lithium 
aluminium hydride in ether afforded a mixture of compounds, none 
of which was produced in sufficient yield to merit further investigation. 
However, when the reduction was carried out in tetrahydrofuran, 
analytical t.l.c. showed the presence of one major phenolic product 
(21%) which was more polar than mycophenolic acid. Purification 
of this compound by preparative t.l.c. was complicated by the difficulty 
of recovery from silica gel. The n.m.r. spectrum showed a 4H multiplet 
at and a 2H multiplet at 6.6£ which could be ascribed to the
presence of two aryl and one alkyl hydroxymethyl groups. The phenolic 
nature of the compound was shown by a positive ferric chloride reaction 
(t.l.c.) and the presence of the double bond was suggested by a 1H 
multiplet at k.SZ in the n.m.r. Integration of the upper region 
of the spectrum before and after treatment with indicated the
-1
presence of three hydroxylic protons. Intense absorption at 3300 cm. 
in the i.r. (liquid film) confirmed the polyol nature of the compound, 
absorption corresponding to carbonyl functions being absent. On the 
basis of the above the product can be formulated as the phenolic 
triol (115). In the light of the following work no attempt was made 
to pursue the investigation of this compound.
Although the successful reduction of phenolic phthalides with
121metal hydrides have been reported , most of the examples m  which 
high yields have been obtained, are of mono- or di- substituted 
phthalides. Poor yields can be expected where the phenolate complex 
is sparingly soluble under the reaction conditions. For this reason 
it was thought that improved, yields might be obtained if the reduction
OMe 0
Me 0.0 C
MeO
(117)
MeO
MeO
(108)
+*
(116)
CH2OH
,CH20H 
MeO ^  ^ C H 20H
(U8)
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were carried out on derivatives of mycophenolic acid in which the 
phenolic group was protected. Mycochromanic acid (116) and methyl 
O-methylmycophenolate (117) were chosen as starting materials in 
view of the high yields in which they can be prepared from mycophenolic 
acid.
The conversion of mycophenolic acid to mycochromanic acid in
a refluxing solution of acetic acid and sulphuric acid has been
reported to proceed in high yield, but the exact proportions of the
29acids were not recorded . In order to find the optimum conditions 
a series of small scale reactions was carried out using varying 
proportions of sulphuric acid and acetic acid as solvents, and these 
were monitored by analytical t.l.c. In most cases both mycochromanic 
acid (116) and the lactone (108) were formed, but the optimum yield 
of the former was achieved where 3% sulphuric acid in glacial acetic 
acid was used. On a preparative scale this procedure afforded 
mycochromanic acid (90%) and the lactone (108, 5%) » the yields of 
which were not noticeably affected by prolonged reaction. However 
the lactone (108) could be converted to mycochromanic acid (in 50% 
yield) under the same conditions, perhaps suggesting that there is 
a degree of equilibrium between the two isomers.
Reduction of mycochromanic acid with lithium aluminium hydride 
in refluxing tetrahydrofuran afforded the triol (118), a viscous
-1
oil, as the sole product (98%). This showed a strong peak at 3300 cm* 
in the i.r. (liquid film) suggesting the presence of hydroxyl groups 
and lacked significant absorption in the carbonyl region. In the 
n.m.r. spectrum a multiplet at 5 *39^ and a 2H multiplet between
CBjOH
MeO
(119) (120)
+ *
MeO
(121)
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7.2 and 7-5^ suggested the presence of two aryl and one alkyl
hydroxymethyl groups.
The n.m.r. spectrum of the corresponding triacetate (i.r. bands 
—1
at 17^7 and 12^ -1 cm. ) showed the expected singlets at 7»97^(3H) 
and 7 »98t(6H)} the protons geminal to the acetoxyl groups appearing 
as 2H singlets at A-.80 and k.SMr and as a 2H doublet (J = 5 .5 Hz.) 
at 5 .927:.
The triol (118) was oxidised by stirring with "active11 manganese
dioxide in acetone under nitrogen for ^8 hr., to give a mixture of
the two isomeric alcohols (119» 20%) and 120, 30%) which were separated
by preparative t.l.c. The minor product (119) was crystalline, but
the major product (120) was isolated as a colourless oil. Both products
showed bands in the i.r. (CHCl^) corresponding to hydroxyl and phthalide
_1
carbonyl groups (3&20 and 1735 cm. ; 3525 and 1760 cm. ). The mass
m /
spectra of each of these compounds showed a molecular ion at e 306,
/
an ion at e 288, corresponding to loss of water, and an abundant 
(98% and 67%) ion at m^e 2^7* An ion of the latter m/^e is found 
in the spectra of mycochromanic acid and its methyl ester, probably 
due to the fragment (121).
In the n.m.r. spectrum of the alcohol (119) the chemical shift 
of the aryl methyl group (7-857:) is close to that found in the spectra 
of mycochromanic acid and its methyl ester, confirming assignment 
as the 2,^ f dioxygenated isomer, while in the spectrum of (120), the 
aryl methyl resonance appears as 7«502~ due to the deshielding effect 
°f the ortho carbonyl group.
Oxidation of the triol (118) with silver carbonate/celite in
COOH
MeO
(122)
COjMe
MeO
(123)
COOH
MeO
(124)
(125)
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refluxing benzene afforded a mixture of the alcohols (119) and (120) 
in lower overall yield. (16% and 24% respectively.) However the 
specificity of oxidation with this reagent appears identical to that 
of manganese dioxide, i.e. ^^^/(119) ” ^/2.
Treatment of an acetone solution of the triol (118) v/ith an 
excess of Jones' reagent gave a mixture of two polar compounds, 
presumably the acids (122) and (124), which could not be completely 
separated by analytical t.l.c. The corresponding methyl esters formed 
by treatment of the mixture with ethereal diazomethane were, however, 
separable and were obtained as oils (123, 20% and 125, 19%) by 
preparative t.l.c. The presence of a carbomethoxyl function was
.."I
indicated in each case by a band at 1740 cm. in the i.r. and a 3& 
singlet at 6.35^ in the n.m.r. The remainder of the n.m.r. spectra 
were similar in appearance to that of mycochromanic acid with the 
exception of the aryl methyl group in the spectrum of the 3,5 
dioxygenated phthalide (125) which appeared at lower field (7*^6^).
The 2 ,4 dioxygenated isomer (123) was identical (t.l.c., i.r., n.m.r.) 
with a sample prepared by treatment of mycochromanic acid with 
diazomethane.
The course of this oxidation,with Jones' reagent at 0°C,was 
followed by t.l.c. examination of aliquots withdrawn at J>0 sec. 
intervals, the reaction being quenched in each case by addition of 
ice water. Four intermediates were detected in this way. Two compounds 
corresponding in Rf.values and staining properties with the alcohols 
(119) and (120) were formed almost immediately together with small 
quantities of two less polar compounds. On a preparative scale work
MeChC
MeO
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up after oxidation for 30 sec. afforded the alcohols (119, 9%) and 
(120, 12%) together with two compounds whose i.r. spectra were very
similar. Neither showed significant absorption in the hydroxyl region
_ -|
but both showed a maximum at 1726 cm. which, together with weak
-1 -1
maxima at 2720 cm* and 2715 cm. respectively, suggested the presence
of a formyl grouping. The compounds are probably the aldehydes (126)
and (127) produced by oxidation of the corresponding primary alcohols.
From the relationship found between the phthalide carbonyl stretching
frequencies of the carbomethoxy compounds (123) and (125) the values
-1 —1
in this case, 1770 cm. and 1760 cm. allow tentative assignment
of structures (126) and (127), respectively, to the more and less
polar compounds.
In the above oxidations the desired selectivity was achieved
with manganese dioxide (and silver carbonate/celite) but the low
overall yield of the alcohol (120) and the fact that neither this
compound nor the triol (118) could be obtained in a crystalline form
are weak points in this particular degradative scheme. Preliminary
attempts to obtain crystalline derivatives of these compounds were
unsuccessful and in view of the work described subsequently these
were not further investigated.
Reduction of methyl O-methylmycophenolate (117) with lithium
aluminium hydride in tetrahydrofuran afforded the crystalline tridL
(128) in 72% yield. Again the absence of absorption in the carbonyl
-1region and a strong peak at 3500 cm. in the i.r. indicated that 
complete reduction of the carbonyl functions to the corresponding 
alcohols had been accomplished. This was confirmed by the appearance
OMe
MeO
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in the n.m.r. of two 2H singlets at 5 .30 and 5 .3 3 indicative of 
the presence of two aryl hydroxymethyl groups and a 2H triplet 
(J = 6 Hz.) at 6.53 cr corresponding to the presence of a terminal 
hydroxymethyl grouping in the side chain. In agreement with the 
structure (118) the n.m.r. spectrum showed a 1H triplet (J = 7 Hz.) 
corresponding to a single olefinic proton.
Oxidation of the triol ("128) with freshly prepared "active" 
manganese dioxide in chloroform gave a mixture of two compounds which 
could not however be separated by preparative t.l.c. In the i.r. 
(liquid film) of the mixture a broad peak at 1750 cm. suggested 
that oxidation of the phthalol system to the corresponding phthalides 
had occurred, but the presence of a peak at 3^50 cm. indicated 
that the aliphatic primary alcohol was intact. It could be inferred 
from the appearance of the n.m.r. spectrum of the mixture that the 
two products were the isomeric phthalides (131) and (132).
In order to establish whether the phthalide (13"l) waa indeed 
a product of the above oxidation an unambiguous synthesis of this 
compound was carried out as follows. The mixed anhydride prepared 
from mycophenolic acid and ethyl chloroformate was reduced with sodium 
borohydride in aqueous tetrahydrofuran affording the carbonate (133) 
in high yield. Hydrolysis of the carbonate with aqueous sodium 
hydroxide gave the alcohol (13^)• The presence of a terminal 
hydroxymethyl group in the side chain of this compound was reflected 
hy the presence in the n.m.r. of a 2H triplet (J = 6 Hz.) at 6.3575^
37
*1
and by a single carbonyl band in the i.r. (CHCl^) at 17A-2 cm.,
characteristic of a phthalide carbonyl group ortho to a free phenolic
hydroxyl group (cf. 1 -hydroxyphthalide"122 (CHC1_): 1738 cm71) .UU 5
Methylation of the alcohol (13*0 with ethereal diazomethane yielded
the methyl ether (131).
Comparison of the n.m.r. spectrum of (131) with that of the
mixture obtained by oxidation of the triol (128) showed that this
compound was the minor component. On the basis of its lower aryl
methyl group resonance (7*^7^) the other component can be assigned
the structure (132). Integration of the singlets at 7 •81 ^  and 7 -^7^
(the aryl methyl group resonances of (131) and (132) respectively)
showed that the selectivity of oxidation was greater in this case
(132) / ^ ^ ^  - 2/^ |:jiari j_n the oxidation of the triol (118). This
might be predicted on the basis of the greater steric bulk of a
methoxyl substituent as compared with that of the ring residue in
the corresponding position in the triol (118).
An effort was made to separate these compounds via their
6 -acetoxy derivatives, but these were even less distinguishable
by analytical t.l.c. An attempt to selectively remove the methoxyl
group ortho to the phthalide carbonyl group in (131) with "magnesium
iodide etherate" gave a mixture of two less polar compounds, which
were indistinguishable by t.l.c. The i.r. spectrum (liquid film)
—  1°f the mixture showed no absorption in the region J>000 - J>600 cm. 
indicating that the hydroxyl group was no longer present, while in 
the n.m.r. the absence of olefinic resonances and the high value 
(8.66?“) of the alkyl methyl group resonance (c.f. the spectrum of
MeO OMe
MeO
CO.JZ5
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the lactone (108) in which the C-Me group resonates at 8.5?-) indicated 
that cyclisation to the corresponding tetrahydrofurans (129, 130) had 
occurred. This cyclisation is analogous to the lactonisation of 
mycophenolic acid in the presence of Lewis acids described earlier.
Since the selectivity in the oxidation of the triol (128) was 
greater than that of the triol (118), attempts were made to prepare 
the tetrahydropyranyl, methoxy methyl and * butyl ethers of mycophenolic 
acid by recognised procedures. In each case very low yields of the 
desired product was obtained, which is understandable in view of 
the lowered reactivity of the phenolic hydroxyl due to hydrogen bonding 
with the adjacent carbonyl group and the steric limitations imposed 
by the bulk of the ortho alkyl substituent. It was possible to prepare 
the di-p-bromophenacyl derivative (135) in high yield, however, by 
reaction of the dipotassium salt of mycophenolic acid with 
p-bromophenacylbromide in refluxing acetone, but the low yield of 
the tetrol (138) obtained on reduction made this route impractical.
Reinvestigation of the oxidation of the triol (128) using "active" 
manganese dioxide which had been stored in the laboratory for twelve 
months, showed that oxidation with this reagent proceeded much more 
slowly than that with freshly prepared material. Complete oxidation 
over a period of three days gave a 9*1 mixture of (132) and (131) 
in an overall yield of 93% but the major product could still not 
separated from its isomer. In the course of monitoring this reaction 
by analytical t.l.c. the intermediacy of a compound slightly less 
polar than the starting material was observed. When the oxidation 
was stopped after 5 hr. (at which time none of the starting material
OMe
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MeO
MeO
OMe
39
was left) separation of the mixture by preparative t.l.c. afforded
a mixture of the phthalides (131) and (132) (5%) and the more polar
product, which was shown to be the hemiacetal (137* 82%).
The presence of the hemiacetal function was evident from the '
n.m.r. spectrum in which the methine proton appeared as a 1H singlet
at J>.6 t whose broadening was shown to be due to coupling to the ortho
oxymethylene protons (a broad 2H singlet at *f.8h) and also to a hydroxyl
proton (an exchangeable signal at ca. 81'). The position of the hydroxyl
group was also reflected in the low value of the aryl methyl resonance
(7.721") and the similar chemical shifts of the methoxyl groups (6.2Vb
and 6.28b). The remainder of the n.m.r. spectrum was virtually
identical to that of the phthalide (131)-
Since the n.m.r. spectrum of the mixture of phthalides formed
in the foregoing reaction showed that these were produced in the
ratio ^^^^(131) ” ^5» and since only the hemiacetal (137) was
detected, oxidation of the isomeric hemiacetal (138) is evidently
much faster, perhaps because the activity of the hemiacetal hydroxyl
group is enhanced by hydrogen bonding with the ortho methoxyl group.
The hemiacetal (137) was a fairly unstable compound, decomposing
under acidic and basic conditions. However, it was smoothly oxidised
to the phthalide (132, 95%) by prolonged treatment with manganese
dioxide. The identity of this compound was evident from the presence
-1
in the i.r. (CHC1_,) of a band at 1760 cm. characteristic of the
3
phthalide carbonyl group, and the low value of the aryl methyl group 
resonance (7.^77) in the n.m.r. The phthalide (132) could not, however, 
be obtained in a crystalline form. Oxidation of this compound with
HOOC
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Jones' reagent, however, afforded the corresponding crystalline acid 
(139) in high yield.
In view of the high overall yield of the acid (139) from the 
triol (128) (k7% ) and the crystallinity of both these compounds, 
this degradative scheme was subsequently used for the estimation 
of the amount of tritium located in the phthalide methylene group.
(ii) Cleavage of the terpenoid side chain
The ozonolysis of O-methylmycophenolic acid in chloroform at
room temperature and subsequent degradation of the ozonide with water,
102was reported by Raistrick et_ al. to yield the aldehyde (97) and 
laevulinic acid (98) in high yield. In our hands, however, this 
procedure gave a mixture of the aldehyde (97) and the corresponding 
acid (l*fO) in low yield, together with trace quantities of laevulinic 
acid, which was trapped as its 2 ,^- dinitrophenylhydrazone. No 
significant improvement was observed when the ozonolysis was carried 
out at lower temperatures. However, the ozonolysis of methyl 
O-methylmycophenolate (117) ia ethyl acetate at -80°C and reduction 
of the ozonide with sodium borohydride in aqueous methanol afforded 
the alcohol (1*4-1) in fair yield. The other expected product, methyl 
^“hydroxypentanoate, could not be detected by analytical t.l.c.
In view of the large excess of sodium borohydride employed it is 
possible that reduction to pentan-1,^-diol or hydrolysis and cyclisation 
to the volatile y-lactone (1^2) had occurred.
In order that the side chain fragment could be isolated, mycophenolic 
acid was converted to its p-toluidide (1^ -3i 90%) and methylated with
MeO
(143)R=H
(144)R=Me
p-Me.0.HN .OZ' ^  'O H
(145)
OMe 0
HOCHf
u-
*f1
ethereal diazomethane yielding the corresponding methyl ether (iMf) 
in quantitative yield. Ozonolysis of this compound and subsequent 
reduction of the ozonide (as above) yielded the alcohol (iVl) and 
the amide (1V?) both in J>QP/o yield. These compounds were easily 
separated by preparative t.l.c. and subsequent crystallisation. 
Oxidation of the alcohol (l^ fl) with an excess of Jones’ reagent 
afforded the acid (1^0) in 70% yield.
Pig. 2s4 - Degradation of labelled mycophenolic acid (95°)
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The incorporation of [2-T, 2-lZfc] acetate into mycophenolic 
acid
A strain of P. stoloniferum which was an efficient producer 
of mycophenolic acid was used in biosynthetic studies in ^ preference 
to the strain of P. brevicompactum used for production of various 
other metabolites. Production of mycophenolic acid in shake flask 
cultures (in which there is a higher metabolite turnover than in 
surface cultures) was found to progress almost linearly from the 
third day of growth onwards (see Part II).
'lb i t/ 178/
[2-T, 2- CJ Sodium acetate (isotopic ratio (dpm) = 1)»
was fed to two shake flask cultures late on the second day of growth 
and the cultures harvested on the fifth day. The crude acidic fraction 
of the material extracted with ethyl acetate was diluted with inactive 
mycophenolic acid and the labelled mycophenolic acid isolated and 
purified by repeated crystallisations. Difficulties were encountered 
in obtaining radiochemically pure material due to the presence of 
a small quantity of a highly active compound which was identified 
as orsellinic acid. However mycophenolic acid could be freed from 
this impurity by crystallisation after further dilution.
Crystallisation to constant activity finally gave material with an
T/ 55 6/
isotopic ratio \bn (dpm) of 1 containing Ogb% of the total
tritium, and VJJ/o of the total of the fed acetate.
The degradations carried out on the labelled metabolite are
summarised in Fig. Z'.b and the relative molar activities of the 
degradation products in Tables 2 :2 and 2 :3*
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Ozonolysis and reduction of the ozonide of the p-toluidide methyl
ether (144c) gave the alcohol (141c) which contained 59% of the total 
1 4
C of mycophenolic acid, and the amide (145c) containing 36% of 
1 4
the total C. Since the three labelled carbon atoms of the amide 
must be derived via mevalonate labelled in the 2,3 and 4 positions, 
the hydroxymethyl group of the alcohol (141c) must contain about
1 4
12% of the total C activity. Hence the total incorporation of 
acetate into the isoprenoid moeity is almost identical (48%) with
that into the polyketide nucleus (47%). This result is in agreement
114 r 14 iwith that found by Birch et_ al. in their experiments with L1- CJ
acetate. However, in a separate series of experiments the incorporation 
r 14 1
of [2- CJ acetate into mycophenolic acid was reported to give
115preferential labelling of the terpenoid side chain
The (dpm) ratio found for the amide (145c) 0 /^1) is lower
than expected (5 tritium atoms derived from [2—TJ acetate should 
give rise to a ratio of ~^ /^'\) but can be explained by the partial 
equilibration of the ketone (146c) during reduction with sodium 
borohydride. Oxidation of the alcohol (141c) to the corresponding 
acid resulted in the loss of 12% of the total tritium content, i.e. a 
drop in atomic ratio (^/l4p) from 3 * V 5 to 2 -6/5 , corresponding to 
the loss of one tritium atom. This indicates that 32% of the total 
tritium content is located in the nucleus (a ratio of 2*6A). 
Transformation of mycophenolic acid to the acid (139c) was effected 
with loss of 28% of the total tritium activity indicating that all 
(or almost all) of the tritium incorporated into the aromatic nucleus 
is located in the phthalide methylene group. The /1 4  (atomic)
(101)
HO
(102)
HO
OC0X CH2RMe
(103)
HO
HO
rr^COOH
Me 
Me
(147)
ratio of the polyketide derived moeity ( 2- y «  is incompatible with
the intermediacy of oxygenated compounds such as (101) and (102).
While this result does not directly distinguish between a pentaketide
intermediate (103i X = -CO.CH^) and a tetraketide intermediate (103,
X = H), the fact that the ratio is substantially higher than would
be predicted for equal incorporation into each of the ”acetate units”
in the polyketide chain seems to be consistent with a starter effect,
(ca. 130%). In view of the strong evidence which this provides for
the implication of a tetraketide precursor the proposed experiment 
r 1 i(p. 25 ) with [2-T, 2- CJ malonate was not carried out. It has been
r 1 lshown subsequently that [1- CJ 5-methylorsellinic acid (1 -^7) is
12k 126specifically incorporated into mycophenolic acid * , and in
the light of the above result this compound is probably the first 
aromatic precursor of the nucleus.
(jJompound
mycophenolic
acid
(95c)
Dilution
Table 2:2 P^CiTl Mycophenolic acid from acetate
Wt. dpm. dpm./mg.
dpm./mg. (for 
a dilution of 1%)
m./raM. (for Ratio % ,  
lution of 1 L/o) ( 1**
% (mg.) 1ifc T 1**C T T
2.65 (x2) 8802 **99161 3320 1888**0 391 222QQ
3.500
0 .90 (x3) 2955 158160 3280 176000 386 2070b
1.10 (x**) 3622 199100 3310 181000 390 21300
i.
O.85 (x5 ) 2818 15670** 3320 18**050 381 21620
2.02 (x2) 595 33875 295 16800 388 22100
0.760
2.20 (x3) 683 37****6 310 17000 **08 22**db
1.95 (x**) 57** 32**73 295 16700 388 21960
2.38 (x5) 717 38673 307 16250 395 21**0l>
i
2 .13 (x2) 505 27700 235 13150 398 22800
0.590 **.28 (x3) 683 37508 228 12550 386 21300S5'
1.83 (x*+) **21 2^055 230 12650 390
■ $
m m
)^ (x10 P)
71.0
66.3 
68.2
69.7
70.7
71.7
70.3
68.3
dpm. atomic
56.5
53.7
56.5  
55-5
57 .0
55 .0
56.8
53.2
C % of T % of 
total total
100% 100%
100% 100%
r7 73.0 56.0
I** 68.2 55 .0 100% 100%
fb 68.8 55.0
Compound
(128c)
(139c) -
(1 4 1 c)
(l 40c)
(145c)
r'l 4 1
Table 2:3 Degradation of [ C,TJmycophenolic g
j j ~ dpm./mg. (for
Dilution Wt. ^m * ^ a dilution of 1 °/o)
% (mg.) 1 4C T 1 4C T 1\: T
0.7600 1#51 364 20740 278 15800 366 20800
O.67 (x3) 192 20685 286 15950 376 21000
1;:325 2 ’59 (x2) 1283 68925 495
26600 376 20200
2.80 (x3) 2378 74802 492 26800 373 20300
1 .325
0.68 (x2) 323 13450 477 19900 362 15100
0 .37 (x3) 182 7260 489 19650 370 14900
1 .57 (x3) 250 11024 159 7030 270 11900
0.590 1.35 (x4) 215 9344 159 6920 270 11700
0 .75 (x5) 126 5220 168 7000 285 11900
2 .1 4 (x2) 280 87^9 131 4050 222 6860
O
O• (x3) 303 9335 152 5000 258 8500
0.66 (x4) 107 3208 163 5000 276 8500
1 .50 (x3) 193 14350 129 9660 219 16400
0.590 1.11 (x4) 138 9841 124 8850 211 15000
2 .09 (x5 ) 281 21031 134 9660 22 7 16400
dpm./mM. (for 
dilution of 1%) Ratio T/i*fc
25(x10 T-5  (x10 O
dpm. atomic
1.19 67^ 57.0
1.22 68.0 55.5
1.22 65.5 53.6
1.21 65.8 54.4
1.21 66.6 55.1 0.930
1.21 50.5 41.5
1.23 49.8 40.0
1.22 50.2 40.8 0.685
O.67 30.0 44.0
O.67 29.5 43.5
0 .72 30.0 41.7
0 .?4 29.8 40.3 0.684
0 .59 18.3 30.8
0.72 22.6 32.8
0 .74 22.6 30.6
0.73 22.6 31.0 0.520
0.45 33-0 75.0
0 .43 31.0 71.4
0 .47 33.0 72.0
C '% T %
97% 96%
98% 72%
59% 44%
36% 46%
0.45 32.0 72.7 1-23
DISCUSSION
PART 2
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The stage of biosynthesis at which the terpenoid side chain
is attached to the nucleus, by analogy with the biosynthesis of
Coenzyme Q* and the prenyl alkaloids (see p. 20) probably occurs
after aromatisation, although it may or may not precede O-methylation
or oxidation of the starter methyl group. The identity of the
alkylating species is also in doubt, since the possibility of
alkylation by a preformed unit cannot be entirely ignored, although
by analogy with the biosynthetic relationship elucidated between
127 128the prenyl coumarins and the co-occurring furans ’ , alkylation
by a geranyl or higher prenyl unit and subsequent oxidative cleavage 
is more probable. The metabolic oxidative degradation sequence 
established for the raenaquinone (148) giving the lactone (1^ -9) is 
analogous^^. The isolation of [2- ^ C  ] acetone and -^c]
mycophenolic acid of virtually the same specific activities from
r 1 4  i 1 "50
a culture of P. brevicompactum fed with [2- CJ mevalonic acid
implicates the latter hypothesis and has been generally accepted
as an indication of the intermediacy of a geranyl precursor (150)
although it does not exclude the possibility of more extensive
oxidation of a longer side chain.
C-geranyl compounds are known in higher plants, notably the
1 31 132prenyl coumarins ostruthin (151) and surangin A and B (152) ,
and the Cannabis phenols (15^)» (155) a^d (156) (which probably arise
1 33
by cyclisation of the simple derivative (153)) 1 but their occurrence
*Coenzyme Q9 was also isolated from the mycelium of P. brevicompactum 
(p. 72 ).
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in fungi has not been reported*. Consequently the postulate of an
intermediate with a geranyl side chain seems not entirely convincing.
The isolation of the farnesyl compound (157) as a cometabolite of
mycophenolic acid from the mycelium of submerged cultures of a strain
of P. stoloniferum suggested that this compound might be a precursor
of mycophenolic acid.
The structure (157) of the above metabolite was assigned by
comparison of its n.m.r. spectrum with those of mycophenolic acid
31and the antibiotic (20) , and the all trans nature of the side
chain inferred by comparison with the spectra of the isomeric methyl
135 136farnesoates and farnesols • The all trans structure ( 157) has
137subsequently been confirmed by synthesis •
T.l.c. examination of the light petroleum extract of the mycelia 
of these cultures showed the presence of another metabolite slightly 
less polar than the farnesyl compound (157) and present in smaller 
quantities but giving the same blue colouration with ferric chloride 
(t.l.c.) as the nrnesyl compound (157) and mycophenolic acid. 
Fractionation of the extract by column chromatography and subsequent 
purification by preparative t.l.c. afforded the pure metabolite as 
a colourless oil. The molecular formula C^t-H^O^ was assigned by 
high resolution mass spectroscopy. The base peak of the mass spectrum, 
corresponding to the fragment ( C ^ H ^ O ^ ) 4" was indicative of the ion (158)
*Monoterpenes as a class are not nearly as common in fungal systems 
as in the higher plants. The only authentic examples known to the 
author are the geranyl side chain of mycelianamide ( 2 ) and the 
production of geraniol, linalool, citranellol and neral by the 
filamentous fungus Ceratocystis variospora ‘ .
MeO
(159)
'b
(160)
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also found in the spectra of mycophenolic acid and its esters, and 
a fairly abundant ion ( C ^ H ^ ) *  (33%) , were consistent with formulation 
as a farnesyl derivative. The overall similarity of the n.m.r. 
spectrum to that of the farnesyl compound (157), with the exception 
r of an additional J>U singlet at 6.29^ was consistent with the structure 
(159)- Unambiguous assignment of this structure was obtained by 
synthesis from the farnesyl compound (157), methylation of which 
with methyl iodide in the presence of anhydrous potassium carbonate 
afforded the corresponding O-methyl and 0,0'-dimethylfarnesyl 
derivatives. The O-methylfarnesyl compound (159) was identical 
to the above metabolite (t.l.c., i.r., n.m.r.), while in the n.m.r. 
spectrum of the 0,0'-dimethylfarnesyl compound (160) the lower chemical 
shift of the second methoxyl group protons (5-95^0 was consistent 
with a position ortho to the phthalide carbonyl group.
The presence of the metabolites (157) and (159) in cultures 
which afford mycophenolic acid is in itself consistent with a bio­
synthetic sequence involving prenylation, 0-methylation and oxidative 
cleavage of the farnesyl side chain. In order to carry out the 
labelling experiments necessary to test this hypothetical scheme 
the growth of the mould under conditions more amenable to small scale 
experimentation had to be ascertained. Shake flask cultures were 
preferred to surface cultures since the former was taken to be nearer 
in type of growth to submerged cultures and to involve a faster 
metabolic turnover.
Analysis (by analytical t.l.c. and G.L.C. after silylation) of 
the extracts of shake flask cultures of P. stoloniferum grown on the
Pig. 2.J-8 - Production of metabolites by shake flask cultures of
P. stoloniferum
Half strength medium
60"
mycophenolic acid
20 *
ergosterol
lays
Full strength medium
m ycophenolic/acid
90
100ml.
AO
30
20- farnesyl compound 
Sn*^(157)
13 days
k8
same medium as used in the submerged culture experiments (half strength 
medium) showed that neither of the farnesyl metabolites, (157) and 
(159)i were produced in detectable quantities. These compounds were 
produced in substantial quantities however, when a medium of twice 
that concentration (full strength medium) was used. The metabolite 
concentrations vs. growth relationships for both media are reproduced 
graphically in Fig. 2 :8 .
H02C
*f9
The incorporation of labelled precursors into mycophenolic acid
r1 i
An aqueous solution of DL-[ CH_,, CT_J methionine (50 pCi. and
1 mCi. respectively) was fed to a two day culture of P. stoloniferum
grown on half strength medium and the culture harvested after a further
two days. The labelled mycophenolic acid isolated from extracts
of the culture possessed 26.6% of the total fed activity and had
an isotopic ratio (atomic) of approximately 1, indicating that no
exchange of tritium had taken place. This result is consistent with
*1 *16those of Lederer ejt al. who showed that the CD^ moeity of [CD^] 
methionine was incorporated intact. Demethylation of the labelled 
mycophenolic acid using lithium iodide in collidine afforded 
O-desmethylmycophenolic acid (161) with half of the specific activity 
and an identical isotope ratio. Since C- and 0- methylations would 
be expected to occur at different stages in the biosynthesis, this 
indicates that biosynthesis in this growth medium is extremely rapid. 
Labelled farnesyl compound (157) could not be detected by t.l.c. 
radioscan of the mycelial extracts.
r 1 -i
Feeding of [ CH^ ] methionine (10 pCi.) to a culture grown on
full strength medium, over the same period of time, led to the isolation
n
of labelled mycophenolic acid (3»08 x 10 dpm./mM), farnesyl compound 
(157) (2.38 x 107 dpm./mM) and 0-methylfarnesyl compound (159)
rj
(5.^-0 x 10 dpm./mM). The higher specific activities of the farnesyl 
derivatives (relative to the number of methionine derived carbon atoms)
is consistent with a precursor relationship.
1Reintroduction of the C labelled farnesyl compound (0.297 pCi.) 
from the above culture into a two day old culture grown on full strength
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medium gave, after 2k hr., mycophenolic acid containing k.5% of the 
fed label. However t.l.c. radioscan of the mycelial and culture 
filtrate neutral extracts showed that not all of the labelled farnesyl 
compound had been utilised and this was reisolated by preparative 
t.l.c. and introduced to a three day culture grown on the same medium. 
After a further four days, when t.l.c. radioscan of the culture filtrate 
showed that the farnesyl compound was essentially unlabelled, the 
contents of the flask were extracted giving mycophenolic acid containing 
3% of the total administered label. On the basis of the total reisolated 
activity (other than that located in mycophenolic acid) the overall 
incorporation of the farnesyl compound (137) into mycophenolic acid 
was 7.5% (a molar incorporation of 9.0%)•
The implication of the farnesyl compound (157) as a precursor 
means that O-methylation and cleavage of this side chain must occur 
after prenylation of the nucleus, but the order in which these processes 
occur is open to question. The presence of the 0-methylfarnesyl 
compound (159) as a metabolite does suggest that methylation precedes 
cleavage but is not proof of this since methylation of the farnesyl 
compound is possibly a side reaction. Dilution of the acidic extracts 
of the above culture with inactive 0-desmethylmycophenolic acid (161) 
and reisolation afforded material containing 0.05% of the administered 
label, indicating that desmethylmycophenolic acid might be a high 
activity precursor present in very small amounts.
In order to test this, desmethylmycophenolic acid prepared by
r 1 k idemethylation of mycophenolic acid derived from [ CH^, CT^ J methic 
(above) was pulse fed as its sodium salt (0 .3^7 pCi.) to a two day
Fig. 2:5*
OH Q
HOOC
OH 0
HOOC
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culture grown on full strength medium over 24 hr. Mycophenolic 
acid isolated from this culture after a further three days growth 
possessed only 0.8% of the administered label, showing that 
0-desmethylmycophenolic acid is not such an efficient precursor 
as the farnesyl compound.
The yields of the 0-methylfarnesyl compound (159) from shake
flask cultures were too low to permit use of biological labelling
as a method for preparation of radioactive material for precursor
studies, but material of high specific activity was prepared by
r 14 -]
methylation of inactive farnesyl compound with [ CJ methyl iodide 
(in 50% radiochemical yield). Methoxyl labelled 0-methylfarnesyl 
compound (2.16 pCi.) prepared in this v/ay was fed to a two day old 
culture of P. stoloniferum cultivated on full strength medium.
Harvesting the culture after a further three days gave mycophenolic 
\ acid containing 11.8% of the introduced label (14.5% molar
incorporation). The higher incorporation of the 0-methylfarnesyl 
compound (159) into mycophenolic acid than that of the farnesyl compound 
(157) is indicative of a biosynthetic sequence in which oxidative 
cleavage of the side chain is the last step.
Feeding of the labelled 0-methylfarnesyl compound (159) (1 •31 pCi.) 
to cultures grown on half strength medium, over the same period of 
growth as above, led to the isolation of mycophenolic acid with a 
Higher activity (25% molar incorporation). In view of the higher 
rate of production of mycophenolic acid in cultures grown on this 
medium, a higher incorporation of precursor is not unexpected.
The above results are clearly consistent with a major pathway
Pig. 2 :6 - Possible mechanisms for cleavage of the farnesyl 
side chain.
r
R"
OtH
(162)
R' -» R + ° H C ^
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from the farnesyl compound (157) via the 0-methylfarnesyl compound 
(159) (Fig. 2 :5 ’a ’), although the low incorporation of the farnesyl 
compound (157) into O-desmethylmycophenolic acid (161) and the 
incorporation of this compound into mycophenolic acid (Fig. 2 :5 fb') 
affords some evidence for the operation of two alternate pathways.
The utilisation of added O-desmethylmycophenolic acid (161) as a 
precursor, relative to that of the 0-methylfarnesyl compound (159)» 
may however be due to a permeability effect and is possibly not entirely 
representative of the process in vivo.
Various possibilities exist for the mechanism of double bond 
cleavage, the intermediacy of an epoxide seems most likely although 
hydroperoxidation and subsequent biological Baeyer-Villiger type
138
cleavage to the corresponding hemiacetal (162) is possible (Fig. 2 :6).
Cleavage of an epoxide, in the absence of neighbouring group participation
probably involves thiamine pyrophosphate (TH) (163) as a cofactor.
Addition of TH across the epoxide followed by retro-aldol fission
of the C-C bond would afford the aldehyde (16^) (Fig. 2 : 6).
Since the aldehyde of mycophenolic acid is oxidised to the acid on
exposure to air, it would not be detected as an intermediate.
It is unknown whether the terminal double bond of the farnesyl
side chain is also cleaved, and if so, if it is cleaved before, at
the same time as, or after the cleavage of the central double bond.
The isolation of [ 2 - ^ C  ] acetone by Birch discussed previously (p. 45 )
does however indicate that this cleavage occurs at the same time
or earlier than the central bond cleavage. If the oxidative loss 
of acetone is the first step then the acid (165) would presumably
OHC
(164)
MeO
0
MeO
(166)
HO
(167)
Fig. 2:7 - Proposed biosynthetic sequence for mycophenolic acid.
OH
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be an intermediate precursor. This compound has not been detected
in P. stoloniferum or P. brevicompactum cultures, but modification
139of a recent synthetic method may enable it to be synthesised and
tested as a precursor.
Attempts to trap [3-^c] laevulinic acid from shake flask ferment- 
r
a-tions fed with L2- CJ mevalonate were inconclusive. Although t.l.c. 
radioscan of the ethereal extracts of the culture filtrate showed 
the presence of a highly active compound similar in and staining 
properties to laevulinic acid, attempts to trap this as its
-6p-bromophenacyl ester gave material of very low activity. (1.2 x 10™ %
r 1 Zj. -i
incorporation based on L~[2- CJ mevalonate.)
Subsequent to the work described above, extensive studies on
the biosynthesis of mycophenolic acid have been reported by Canonica
*125 *126 12k
et al. * and Honey e_t al. . Both groups have shown that
5-methylorsellinic acid (1^ -7) is a specific precursor of mycophenolic
acid in P. brevicompactum. A molar incorporation of 5^.8% has been
y\ 'J 25
reported . Canonica ejt al. have shown that whereas 2-hydroxy~
^-■methoxy-5-methylphthalide (166) is not incorporated, the corresponding
O-desmethyl compound (167) is incorporated to an extent of 97% (molar),
indicating that C-prenylation occurs after oxidation of 5-methyl-
orsellinic acid to the phthalide (167), but prior to O-methylation.
126These workers also succeeded in trapping the farnesyl compound (157)
by feeding large quantities of the phthalide (167) to cultures of
P. brevicompactum and have shown that this compound is a precursor.
The biogenesis of mycophenolic acid can be envisaged as outlined in 
Fig. 2: 7.
CHAPTER 3
MeO
(168)
O ^ X )
(106)
HOOC
COOH
(170)
OH ,9
HO ^ / C 0 2Et
HO
(175) R = H
(176) R = OMe (177)
A feature of the metabolism of the strain of Penicillium
brevicompactum described previously is the occurrence of a number
of metabolites related to mycophenolic acid. Ethyl mycophenolate 
119
(168) is the only simple ester* of mycophenolic acid reported
from this strain although methyl mycophenolate was isolated from
submerged cultures of P. stoloniferum during the work described in
the previous chapter. The remainder of these co-metabolites appear
to be formed _in vivo by oxidation of the 2! double bond of the
terpenoid side chain. It was thought that study of these compounds
might provide some insight into the mechanism of side chain cleavage
involved in the biosynthesis of mycophenolic acid.
119The hydroxylactone (106) was assigned threo-stereochemistry 
by comparison with the synthetic erythro- and threo- diasteriomers 
prepared respectively by osmylation and peracid oxidation of the 2/3>/ 
double bond of mycophenolic acid, and can be considered to be formed 
in vivo by epoxidation and subsequent cyclisation of the acidic side 
chain of mycophenolic acid.
119
Mycochromenic acid (170) could be derived by the attack of 
the phenolate anion upon the 2/3/ epoxide of mycophenolic acid followed 
by dehydration of the resultant hydroxypyran (169), or alternatively 
by a direct oxidation process (Fig. In favour of the latter
pathway mycochromenic acid (170) has been prepared from mycophenolic
*Ethyl esters are comparatively rare in nature, a number of example^Q
have however been isolated from fungi, e.g. ethyl curvulinate (175) 1
1 1 1 h-2
ethyl c^rvulate (176) 1 ethyl st'ipitatate (177) » and ethyl
acetate •
C02H
MeO
MeO
MeO
(173)
MeO
CO.H
MeO
(172)
(174)
MeO
(178)
acid by the action of 2 ,3-dichloro-5 »6-dicyano-1 benzoquinone 
119
(DDQ) , and independently by the action of alkaline potassium 
1^3
ferricyanide • It could not be obtained by the action of base
119
on the hydroxylactone (106) . However, formation from the epoxide
of mycophenolic acid (or a related compound) cannot be ruled out
since mycochromenic acid (170) has been prepared by treatment of
the bromolactone (171) with refluxing pyridine and by the action
of aqueous base on the bromopyran (172), which can be prepared by
treatment of the bromolactone (171) with concentrated acid, and the
^-lactone (173) has been prepared by treatment of the hydroxylactone
1 ^ 3
(106) with concentrated acid • It may also be significant that
the hydroxylactone (106) and mycochromenic acid (170) are not only
co-metabolites of P. brevieompacturn but are both produced by cultures
1^3Helminthosporium bicolor fed with mycophenolic acid . It is also
possible that the biosynthesis of mycochromenic acid (170) may involve
the 0-methylfarnesyl compound (139) and that the immediate precursor
is in fact the chromene (17^)*
Mycofuranolide (178) has been isolated from a number of
fermentations of P. brevicompactum and the structure confirmed by
29
synthesis from mycophenolic acid , but whether biosynthesis of this 
compound involves direct formation from the 0-methylfarnesyl compound 
(159) or formation via mycophenolic acid is uncertain. The growth 
of the mould in the presence of radiolabelled mycophenolic acid and 
the O-methylfarnesyl compound (159) would be required to clarify 
the biogenesis of this compound and of mycochromenic acid (170).
Another metabolite, related to mycophenolic acid was detected
(179)
(180)
(181)
HO
'M eO
(106)
(182)
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in trace amounts in several fermentations of P. brevicompacturn by
29
C. Hernandez Calzadilla who managed to obtain sufficient quantities 
for examination. The compound was non-phenolic, as indicated by 
its failure to give a colouration with ferric chloride (t.l.c.) and 
the lack of change in the u.v. spectrum with base. The presence 
of the substituted phthalide nucleus of mycophenolic acid was evident 
from the n.m.r. spectrum which was very similar to that of the 
hydroxylactone (106). However the absence of hydroxyl absorption 
in the i.r. suggested the dihydrobenzofuran structure (179)* This 
was substantiated by the appearance, in the mass spectrum, of ions 
at m^e 99 (100%) and 219 (98%), which can be assigned to the fragments 
(180) and (181) respectively.
Biogenetically a compound of this gross structure could arise 
by intramolecular attack of the phenolate anion on the 2/ position 
of a 2/ epoxy intermediate, followed by lactone formation giving 
a product with threo-stereochemistry (182), or alternatively from 
the threo-hydroxylactone (106) by Sn2 elimination of the 2 / hydroxyl 
group by a phenolate anion to give the erythro-dihydrobenzofuran (183)• 
In order to determine the stereochemistry of the naturally occurring 
dihydrobenzofuran, attempts were made to prepare the two possible 
diasteriomers.
Treatment of mycophenolic acid with bromine in chloroform gave
1 ^ 3the bromolactone (171) in high yield • Since this compound could 
also be prepared, albeit in slightly reduced yield, by the reactions 
of mycophenolic acid with N-Bromosuccinamide, N-bromoacetamide and
(171)
0.
(182)
MeO
(183)
MeO
(184)
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dibromo-dimethyl hydantoin it is presumably formed by backside attack
by the carboxylate grouping on the bromonium ion formed from the
2/5/ double bond. This has been reported as a general reaction of
1 A-3,*f and *f,5 unsaturated acyclic acids . The bromolactone (171) 
would therefore be expected to have threo-stereochemistry• Internal 
Sn^ displacement of the 27 bromine atom by a phenolate anion would 
give the erythro-dihydrobenzofuran ('[83). Treatment of the bromolactone 
(171) in methanol with dilute aqueous sodium hydroxide afforded the 
desired product in good yield.
The naturally occurring material and the synthetic erythro- 
diasteriomer (183) were identical by t.l.,c. and mixed m.pt., but 
the G.L.C. of the former showed the presence of a small amount (~5%) 
of impurity with a shorter retention time. This was borne out by 
the slightly lower melting point of the sample (197-200°G) cf. that 
of the synthetic material (200-201°C.). The n.m.r* spectrum of a 
sample of the metabolite was essentially the same as that of the 
synthetic erythro-dihydrobenzofuran (183)*
It was hoped that the concerted lactonisation which occurs in 
the bromination of mycophenolic acid might be avoided.by protection 
of the carbonyl group as a dimethylamide and that the resultant trans 
2'3/ dibromo derivative might be hydrolysed to give the erythro- 
bromolactone (18^) which could (presumably) be converted to the desired 
threo-dihydrobenzofuran (182) by treatment with base. Bromination 
of N,N dimethyImycophenolamide (185) afforded a crystalline compound 
much more polar (t.l.c.) than mycophenolic acid. This was shown 
to be phenolic by its blue stain (characteristic of mycophenolic
HO
MeO1
(186)
H O
MeO
(187)
Br.-CH
BrT Br
NR2 Br
(188) (189)
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acid derivatives) with ferric chloride (t.l.c.) and by the presence
of a band at 5500 cm. in the i.r. In the n.m.r. the 3H singlets
corresponding to the amide methyl groups appeared at much lower field
(6 .^5 and 6.6629 than in the spectrum of the starting material (7 .0
and 7.120 suggesting the formation of an immonium salt. A 1H triplet
(J = 7 Hz.) at 5 .202" indicated the presence of a proton geminal to
a bromine substituent in the 2/ position. These data can be
accommodated by formulation as the cyclic immonium bromide (l86).
The highest ion in the mass spectrum of this compound appeared at 
/
e 3^7 corresponding to loss of bromine from the immonium cation 
to give the fragment (187)•
Hydrolysis of the immonium bromide (186) with water at room 
temperature afforded the threo-bromolactone (171) in good yield. 
Analogous cyclisations of the amides of 2 ,2 diphenyl-^-pentanoic acid 
(188) to the immonium bromides (189) have been reported, although 
in these cases the stability of the salts of tertiary amides to
1 b5hydrolysis was found to be greater
Derivatives of the carboxylic acid group were equally ineffective
in preventing carboxylate participation in peracid reactions. Thus
peracid oxidation of N,N diethylmycophenolamide (190) gave the
hydroxylactone (106) as the sole product; peracid oxidation of ethyl
mycophenolate (168) gave in addition to the hydroxylactone (106)
trace amounts of the erythro-dihydrobenzofuran (183).
At this point we received from Dr. D. F. Jones a sample of the
threo-dihydrobenzofuran (182) which had been obtained by treatment 
of the bromolactone (171) with lithium chloride in refluxing
3:
(183)
(182)
2 NMR comparison of the diasteriomeric dihydrobenzofurans
J V
765
Metabolite isolated from P. brevicompactum
Fig* 3s3 - Possible interrelationship between P. brevicompactum 
metabolites.
M=02C
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MeO
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dimethylformamide, and also as a minor product in the synthesis of
1 if 3
mycochromenic acid (170) from the bromolactone (171) - The
diasteriomeric dihydrobenzofurans could be distinguished by t.l.c., 
G.L.C., i.r. and n.m.r. (Fig. 3 *2), but the presence of the threo- 
isomer could not be detected in the material isolated from 
P. brevicompactum. Consequently the only natural stereoisomer is 
the erythro-dihydrobenzofuran (183).
A tentative biosynthetic scheme for the formation of the 
oxygenated metabolites related to mycophenolic acid in P. brevicompactum 
is outlined in Fig. 3 :3 *
The instability of the 2/3/ epoxy derivatives of the esters 
and amides of mycophenolic acid can be attributed to the presence 
of a neighbouring free phenolic hydroxyl group in the molecule which 
is capable of protonating the epoxide, creating an electrophilic 
centre at the 3 X position. In contrast the peracid oxidation of 
methyl O-methylmycophenolic acid (117) afforded the epoxide (191) 
in good yield. The product was fairly stable at room temperature 
but was converted quantitatively to the threo-hydroxylactone (192) 
on treatment with trifluoroacetic acid.
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Introduction
A large number of fungal metabolites can be classified
biosynthetically as being derived from amino acids. Many of these
compounds are simple derivatives of the common amino acids found
151in both animal and plant systems. Slaframine (193) and'1-amino-
1522-nitrocyclopentane carboxylic acid (194) are derived from lysine
and (3-nitropropionic acid (195) which has been isolated from a numbe
193
of Aspergillus spp. has been shown to be derived from aspartic
15^
acid • Fusaric acid (19&) a metabolite of several Fusarium spp.
has been shown to arise from the condensation of a triketide unit
155
with aspartic acid
The prenylation of tryptophan with a C,_ unit derived from
mevalonic acid is the first stage in the biosynthesis of the ergot
156alkaloids of Claviceps spp. (Fig. 4 :1) . The 4-dimethylallyl-
tryptophan moeity is also present in cyclopiazonic acid (197) where
157it has undergone (formal) condensation with an acetoacetyl unit .
The substitution of tryptophan by isoprene units also occurs in the
158
formation of echinulin (198) a metabolite of Aspergillus spp. in
which the C_, unit of the diketopiperazine ring is derived from 
5
159alanine • Brevianamide E (199) isolated from P. brevicompactum 
can be formally derived from tryptophan, proline and mevalonate 
(Fig. 4 :2), and brevianamide A (200) may be a rearrangement product
y| ^  6 3
In gliotoxin (201) and sporidesmin (202) the diketopiperazine 
ring is bridged by sulphur.
Cyclic peptides and cyclodepsipeptides have also been isolated
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from fungi, e.g. islanditoxin (203) the toxic principle of
16k . 165
P. islandicum , maliformin A (2.0k) from several Aspergillus spp..
166
the toxins of Amanita spp. (e.g. a-Amanitin (205)), the 
sporodesmolides (e.g. sporodesmolide I (206) from Sporodesmium
. 167
bakeri and the insecticide destructuxin B (207) from Oospora 
168
destructor . In common with the large number of peptide metabolites
isolated from other microbial sources, especially the Streptomycetes
and Bacilli, fungal peptides possess certain features which are rare
in proteins. Many contain proline, N-methylated amino acids and
imino acids, which may prohibit helix formation and hence favour
cyclisation, while arginine, histidine and methionine which are
commonly found in proteins are rare. The occurrence of both D- and
L- forms of certain amino acids is common in a number of cases being
found in the same molecule^^.
Some bacterial cyclic peptides are known to function as metal
170transport agents, and their role in sporulation has been discussed 
It has also been suggested that these compounds may be "fossils” of 
an earlier less specific metabolic process^
62
Brevigellin
Brevigellin (208) was isolated from the neutral extract of the
culture filtrate of P. brevicompactum by column chromatography and
subsequently purified by preparative t.l.c. The pure metabolite
was a colourless hydroscopic glass (m. 209-212°C.) which could not
be obtained in a crystalline form; addition of light petroleum to
a chloroform solution of the metabolite resulted in the formation
of a gel. The molecular formula C^H^N^O,., was assigned on the basis
of high resolution mass spectroscopy (Table *f:l). Bands .at J>bOO,
1658 ( 8 = 836), and 1500 cm. ^  in the i.r. (CHC1-) suggested the5
presence of at least one secondary amide group which was supported
-1
by the presence of a low intensity peak at 3061 cm. in the solid
state spectrum (KBr.)^^. A band at 1758 cm. ^  (e = 236) could be
assigned to an ester grouping. A sharp peak at 1600 cm. indicated
the presence of an aromatic ring, which was confirmed by the n.m.r.,
in which the pattern characteristic of a benzoyl group was evident,
/
and by the presence of an ion e 105.03;+5 (73-9%) in the mass spectrum, 
corresponding to the fragment (C^H^O)+. The presence of a minor ion 
^ e  121.0531 (5*5%) corresponding to (C^H^NO)+ suggested that the 
benzoyl fragment resulted from fragmentation of a benzamide grouping.
Only one exchangeable proton (a 1H doublet, J = 9 Hz., at 3 »3 '^) 
was observed in the n.m.r. spectrum, exchange of which did not take 
place on shaking with D^O but did in the presence of a trace of 
trifluoroacetic acid indicating that this was an amide proton. On 
exchange of this proton a 1H doublet (J = 9 Hz.) at -^.91^  was reduced
Y h-nh-co-
(2 0 3 )
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to a broad singlet indicating the presence of the system (209) in 
which the methine.proton is not further coupled.
The above data suggested that brevigellin might have a ’peptide' 
type structure and this was also indicated by a characteristic yellow 
stain with a blue halo, which it gave on t.l.c. when sprayed with
17k
sodium hypochlorite and then potassium iodide/O-toluidide reagent •
In keeping with this hydrolysis with 2 .5N aqueous hydrochloric acid 
afforded a mixture of four polar ninhydrin staining compounds, which 
could be separated by analytical paper chromatography. The three 
most polar of these compounds gave colourations with ninhydrin in 
the cold (indicative of an a-amino acid) and were identified as 
threonine, a-alanine and proline on the basis of their Rf. values 
and staining properties with ninhydrin and isatin. Comparison with 
authentic samples of these amino acids, by paper chromatography 
confirmed these assignments. The least polar of the four ninhydrin 
positive products (Rf. 0 .^2), gave a lilac stain with ninhydrin on 
heating and a green-blue stain with isatin. Chromatographic comparison 
with |3- and y- amino butyric acids, which have almost identical Rf. 
values in the solvent system used, suggested that the product was 
P-aminobutyric acid.
Amino acid analysis of the hydrolysis mixture confirmed the 
presence of threonine, a-alanine and proline and showed the presence 
of an additional compound v/hich had a longer retention time than 
a-alanine. Under the conditions of analysis (3-aminobutyric acid 
is not observed, which suggested the presence of another nitrogen 
containing compound in the mixture. When brevigellin was hydrolysed
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under more forceful conditions, however, (6N HC1 , 12 hr. at 120° 
in a sealed tube) this compound was not observed indicating that . 
it is not especially stable under acid conditions.
The presence of the four identified amino acid residues in the 
molecule accounts for some additional features of the n.m.r. spectrum. 
The 9H multiplet at 8.712" can now be assigned to the protons of the 
methyl groups of threonine, alanine and p-aminobutrate, while a 1H 
quartet (J = 6 Hz.) at ^.6^2, which collapses to a broad singlet 
on irradiation of the 8.712" multiplet, can be assigned to the 
P-methine proton of threonine.
Subtraction of the four identified residues from the molecular
formula (C^.H, -N^ O,..) leaves the residue C QH NO to be accounted for.
51 H-1 7 { oil
The lack of free carboxyl or amino groups in the molecule was evident 
from its non-polar nature and the absence of the characteristic 
absorption bands in the i.r., suggesting that the CgH NO moeity 
is part of a ring residue. In the n.m.r. eight of the protons of 
this unit are observed at 8.252" typical of C-CH^,-C,and a further 
2H appear at 6.312* indicating the presence of a C-CH^-N grouping.
The remaining proton appears 2 .2 2 in CDCl^, and is obscured by the 
resonances of the ortho-protons of the benzoyl group. When the spectrum 
was recorded in 5% trifluoroacetic acid/CDCl^ however, the resonance 
of this proton appeared as a doublet (J = 9 Hz.) at 1.752" suggesting 
that it was an olefinic proton a- to nitrogen. In addition, integration 
of the multiplet between 5«2 and 6.02" in this spectrum indicated 
the presence of an additional proton, irradiation of which (ca. 5»^ 2T) 
resulted in the collapse of the 1.752" doublet to a broad singlet.
Pig. 4:4 - Fragmentation of Torevigellin (208)
13,
“C4H7
526 N 4 O 7
'CO
V
498 C 26H3 4 H ; O5
r 597 C 29 C 2H V IN 5 O7
596 C3013Cl H 41N 5 O 7 
595 C31H 41N 5 O 7
■CO
13
568 C 29 C l H 1N 5O 6
,567 C 3 0 H 41N 5 O 6 13.(514 C2 5C1 H33N4O7 
l513 C26H33N4O7
\  *co
513 C 25C 1 H 32N 4 O 7
,512 C25H 32N 4O 7 *
|  485 C25H 3GN4 O 6
484 C25H32N^O0
r
/
HH
/
CH3-CH
I
c h 2
I
CO
° : ch
c h 3
C O ' '  C H 2 ' C H 2 , 4 / ^  513 (512)
485; 
/498'-^
388
I J
/ I /'
>  567
CO ,
/ .. v--H- - - <- r
"CH — CO 
HNCO.0
NH
> Q 0
CH-
526
CH3
Ta
bl
e 
4:
1 
Th
e 
Ma
ss
 
Sp
ec
tr
um
 
of
 
Br
ev
ig
el
li
n 
(2
08
)
+>
£<D
B
£bC•H
toCOctJ
-4" in tn tn OJ OJo o o o o otn OJ m OJ OJa a a a a aOJ r- OJ in m  i oOJ cm CM V i v~
a W a W a WON oo CO -4" tn v-r~ <r“ r~ s—
O o O O o O
O
ffior-
O
oinO ffi
a oO- tn
a  V-
cn vo o o
o
ina
ino
o
o
£ctJ
2&CtJ
m o CO o in 00 m co O s m in o ON• • • • • • • • • • • • •
ON o o CSV in r- -4* -4* OJ in in o inm m V" r- T*. V- r~ tn v~ n-
o VO in OJ CN vo -4* VO tn c* ON ino -4* VO CO CM V O ON CO in tn e'­ -4*vo -4- vo o r- OJ ev­ OO OO cn in en mV” r~ r~ v r~ r~ es o o o o o o• • • • • • • • • • • • •
vo in 00 ON v CO CO CO tv- o r~ VO inin -4* CM in tn O CO VO VO vo OJ o otn k\ tn OJ CM OJ V v~ v- V K~ v~ V
in
en
Din
(1) r~ v~ CN VO cn CN cn vo VO vo in -4" tn
B -4* -i- O o o O o o o o o O o£ W a m in -4- -4’ -4* -4* -4' -4" -4- '-4* mto CM a a a a a a a a a a aH O o r- r- -4* tn CM -4" tn OJ OJ v— voto NV m -4" -4* tn tn m tn tn tn tn m CMCO x— T- a a a a a a a a a a aCtJ ON o V o CN vo vo vo in m in -4- o
OJ m m m CM OJ OJ OJ OJ CM OJ OJ CMO o o o O o o o o o o o O
<do
cCtJ'Oa
CtJ
r* O CM OJ vo OJ 00 OO OO vo tn O O• • • • ■ • • • • • • • •
-4" ONV OO-4- m o -4" vo o o OJ V V x~
O OO tn r~ IN CO ON o -4* in O (N OJON m V- in OJ V -4" vo CSN tn vo tn !No o O o •ih tn CM -4" • tn m tn tn COm tn tn tn OJ CM OJ CM CM CM OJ OJ• • • • • • • • • • • • •CN vo in CN VO m CM OO tn -4" co ON OOON ON ON VO OJ T~ v ON CO CO vo m COin in in in in in m -4" -4- -4* -4- -4" tn
65
These features can be accommodated in the partial structures (210) 
and (212), protonation of which would give the salts (211) and (213) 
Although neither of the amino acids (21*f) or (215) have been reported 
the latter could be derived biogenetically by condensation of lysine 
derived piperideine (216) with {3-alanine imine or oxaloacetic acid 
(Fig. k:3)»
The order in which the amino acid residues are coupled in the
molecule was elucidated from the mass spectrum (Table +^:1). An ion 
/
at e 3^5.1H 6  (C^gH^^N^O^, 3®%) could be assigned to the fragment
(217) in view of the presence of ions at m^e 2591 231» 188, 121 and
105 which correspond to sequential fragmentation of this ion^m^rL^
The presence of an ion e 356.1600 (C. „.H_-N_,0., 10%) could be ascribed
1y 22 3 ^
to the fragment (218) loss of CO from which would give the ion 
m^e 328.16^6 (C^gH^N^O^,, 0.75%) and subsequent fragmentation of 
this ion could also give rise to the fragments 259» 231, 188, 160,
121 and 105- From the order of the amino acid residues indicated 
by these ions the partial structure (219) can be written. The upper 
region of the spectrum is characterised by low intensity ions (Table ^:1) 
which can be assigned to the fragmentations proposed in Fig.
The observed losses of 82 (C^HgN) , 83 ( C ^ N )  , 110 (CgHgNO) , 207
C^10H15N20  ^ and 207 CC^ | ^ ^^2^2  ^ ^avour structure (215) proposed 
for the fifth amino acid rather than (21 *f).
Specific hydrolysis of the ester linkage was achieved using
0.5N methanolic potassium hydroxide yielding a single polar product, 
which gave no stain with ninnydrin indicating the absence of a free 
amino group. Esterification with ethereal diazomethane afforded
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Fig. 4:5 - Mass spectral fragmentation of the methyl ester (220),
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a product slightly less polar than brevigellin. The highest ion
/
in the mass spectrum of this compound appeared at e 609*31^3 
( C ^*5%) corresponding to loss of water from the structure 
(220). However the presence of the ions m^e 37^.1713 (0^ 0 »
Vl.5%) 277.1206 (Cl2fH21N20Zf1 9-5%) and 206.0867 ( C ^ H ^ N O  , 9.h%) 
suggests that the structure of the hydrolysis/methylation product 
is in fact (220) and that loss of water occurs in the mass spectrometer. 
A plausible fragmentation scheme for this molecule is outlined in 
Fig. *f:5-•
In view of the extremely low yields of brevigellin from 
P. brevicompacturn (ca. 0 .2 mg./I. of culture filtrate after 20 days) 
insufficient material was available to obtain samples of the 
constituent amino acids for specific rotation measurements. However 
the almost negligible coupling ( < 1  Hz.) between the adjacent methine 
protons of the threonine residue and ^.91^) indicates that
these lie at almost 90° to one another, a configuration which can 
be accommodated in a structure where the (3-aminobutyrate carbonyl 
forms a hydrogen bond with the nitrogen atom of alanine residue.
This is shown in Fig. k: 6, in which a hydrogen bond between the 
carbonyl of proline and the nitrogen atom of {3-aminobutyrate has 
also been constructed.
An unusual feature in the structure of brevigellin (208) is 
the presence of an N-benzoyl substituent; benzoyl groups, which are 
presumably derived via phenylalanine, are uncommon in microbial
172metabolism, although pebrolide (15) (Chapter I) and candipolin (221) 
from P. canadense both contain benzoyl substituents. Benzoyl
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173esterases have been isolated from a number of fungi, e.g. 
Aspergillus terricola and P. dahlea which suggests that this grouping 
may be a more common feature in metabolism than previously supposed.

EXPERIMENTAL
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General - Instrumental
Melting points were determined on a Kofler hot-stage apparatus 
and are uncorrected, boiling points are uncorrected. Ultraviolet 
spectra were obtained on a Unicam SP 800 recording spectrophotometer. 
Infra red spectra were measured with a Unicam SP 200, and Perkin 
Elmer 225 and 257i spectrometers. Nuclear magnetic resonance spectra 
were recorded with Varian HA-60 and HA-100 spectrometers. Unless 
otherwise stated all values quoted were recorded in deuterochloroform 
with te.tramethyl silane as internal standard. Routine mass spectra 
were obtained with an A.E.I. M.S . 12 mass spectrometer and exact mass 
determinations on an A.E.I. M.S . 9 mass spectrometer.
Thin layer chromatography (t.l.c.)
Rf. values were determined from elution on 0.1 mm. layers of 
Kieselgel GF the compounds being located under ultra violet light,
with iodine and 3% methanolic ferric chloride spray (FeCl ), and 
standardized by comparison with the Rf. values of sudan yellow and 
p-amino azobenzene.
p-amino azobenzene sudan yellow
chloroform O.65 0.30
5% methanol/chloroform 0.70 0.50
Values quoted for other solvent systems refer to analytical t.l.c.
(below) and are approximate.
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Analytical t.l.c. was performed on 0.25 mm- layers of 
Kieselgel G, and the compounds located by spraying with 3% methanolic 
ferric chloride (FeCl^) or 1% eerie ammonium nitrate in 10% sulphuric
k+
acid (Ce )• The colours observed with the above reagents are 
abbreviated as follows: gr. (grey), y. (yellow), bn. (brown),
bk. (black), gn. (green), r. (red) and pur. (purple).
Radioactive compounds were located on thin layer chromatograms 
by scanning with either a Packard or Texas Instruments1 radioscanner.
Counting of radioactive materials
Radioactive assays were carried out using a Phillips Liquid 
scintillation counter. In experiments with doubly labelled precursors 
the external channel ratio method was used invariably.
Solid samples were weighed on metal foil, transferred to Packard 
scintillation vials and -dissolved in toluene scintillation solution 
(15 ml.) 2 ,5-diphenyloxazole (6 g.); 1 ,^4— bis-2 (k methyl-5-pbenyl 
oxazalyl) benzene (0.1 g.); toluene (1 1.) . Liquid samples were 
weighed directly into the vials. Aqueous solutions were counted 
in toluene scintillator (13-5 ml.). Bio-solv. BBS-2 solution (1 ml.) 
made up to 15 ml. with distilled water. Samples were counted for 
sufficient time to achieve a counting error of less than -5%«
General
Acetone was dried over anhydrous magnesium sulphate, and
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tetrahydrofuran dried over metallic sodium and redistilled from 
lithium aluminium hydride prior to use*
1 kGDiazomethane was prepared by the method of Moore and Reed 
from bis (N-methyl-N-nitroso)-terephthalimide• Jones1 reagent was 
prepared by the procedure of E. R. H. Jones ejb alV^nd Fetizon's 
reagent by the procedure of Fetizon and Golfier ^ ^  . ’’Active”
1 ^-9manganese dioxide was prepared by the method of Attenburrow e_b al. 
’’Magnesium iodide etherate” was prepared, immediately prior to use, 
as described by Attenburrow e_t all^Q All organic extracts were routinely 
v/ashed with water and dried over anhydrous magnesium sulphate.
Solvents were removed using a rotary film evaporator. Light petroleum 
unless otherwise stated refers to a light petroleum fraction 
b.pt. if0-60OC.
The following abbreviations are used in reporting spectral data: 
s., singlet; d., doublet; t., triplet; q., quartet; m., multiplet; 
br., broad; obs., pattern obscured by other resonances.
In the following typical description of n.m.r. data 
5 .6 (2H, q, J = 8Hz., irr. 8.6 — » s, -OCE^-CH^) irradiation at 
8.622"has resulted in the collapse of the 2H quartet at 5»GV.
Table I Composition of Czapek Dox medium (g./l.)
sodium nitrate 2
dipotassium hydrogen phosphate 1
potassium chloride 0.5
magnesium sulphate 0.5
ferric sulphate 0.01
glucose 50
corn steep liquor 10
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The growth and extraction of surface cultures of P. brevicompactum
The strain of Penicillium brevicompactum described was originally 
supplied by the Commonwealth Mycological Institute (No. ^9162) and 
has been cultured in the Glasgow University Joint Mycology 
Laboratories since 196*f.
Typically a spore suspension of this strain was used to inoculate 
100 Roux bottles, each of which contained 200 ml. of sterile Czapek 
Dox medium (Table I ). The cultures were allowed to grow undisturbed 
at 25°C and 70% relative humidity, under artificial lighting. After 
the prescribed period of growth the mycelial mats were physically 
separated from the culture filtrate, dried, pulverised and extracted 
in a Soxhlet apparatus with acetone for 2k hr. The culture filtrate 
(20 1.) was stirred with charcoal (200 g.) for 2 hr., the charcoal 
removed by filtration and extracted in a Soxhlet apparatus with 
acetone for 2k hr.
Separation of the metabolites present in the culture filtrate extract
A typical procedure for the extract of an 18 day culture was 
as follows. The acetone extract was dried and the solvent evaporated 
to give a brown gum (1 .8 g.). This was partitioned between chloroform 
and water. The chloroform solution was extracted with saturated 
aqueous sodium bicarbonate. Neutralisation of the bicarbonate extract 
with dilute hydrochloric acid gave mycophenolic acid (0.*f g.), which 
was purified by crystallisation from aqueous methanol.
The chloroform solution was dried and the solvent evaporated
Table II Separation of the neutral fraction of P. brevicompactum 
culture filtrate by column chromatography on silica gel
Eluant
benzene
10% chloroform/benzene
10-90% chloroform/ 
benzene
chloroform
2% methanol/chloroform 
5% methanol/chloroform
unidentified mixture
acetyl trinbutyl citrate 
deoxypebrolide
ethyl mycophenolate 
(erythro)-hydroxylactone 
mycophenolic acid
pebrolide
brevigellin
desacetylpebrolide
Yield (mg.)
100
20
k
2
5
30
30
k
^5
Table III Separation of the mycelial extract of P. brevicompactum 
by column chromatography on silicic acid
Eluant
50% light petroleum 
(6O-8O0)/benzene
benzene
10% chloroform/benzene 
10-90% chloroform/benzene
Coenzyme Q9 
unidentified mixture
n-butyl phthalate
tetracosanoic acid
’’fatty acids” 
ergosterol
Yield (mg.)
1
10
250
2
500
20
-chloroform mycophenolic acid 30
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to give a brown gum (1 g.). This was chromatographed on a column 
of silica gel (*f0 g.) (Table II).
Mycophenolic acid (95)» ethyl mycophenolate (168) , the (erthro-) 
hydroxylactone G106) , pebrolide (15) » deoxypebrolide (17), desacetyl- 
pebrolide ( 16) and acetyl tri-nbutyl citrate were identified by 
comparison (t.l.c., mixed m.pt., i.r.) with authentic samples isolated 
and characterised by previous workers in this laboratory.
Separation of metabolites present in the mycelial extracts
The acetone extract of the mycelium (18 day culture) was dried, 
and the solvent evaporated to leave a brown oil (2 g.). This was 
chromatographed on a column of silicic acid (90 g.) (table III ).
Coenzyme Q9(222)
P.I.e. of the crude fractions and subsequent crystallisation 
from methanol gave orange prisms, m. *f1°C (lit. *f2-*+3 .5°C) •
T.l.c.: benzene, Rf. 0.9 , bn.-bk. (Ce^+).
I.R.'/max. (CCl^):. 2920, 2870, 1665, 1651, 161^, 1*f51 , 138*1-,
1267 cm.’\
UV.Xmax. (Et0H): 210 (£=51000), 270 (E=36200) nm.
NMR. (100 Mc/s.) 2r CDC1 : k.90 (*fH, m. , = CH.CHg-) , 6.08
(3H, s., MeO-) , 6.09 (3H, s., MeO-) , 6.88 (2H, d. , J  = 
6 .5Hz., ArCH^CH = ), 8.07 (3H, s., Ar.Me), 8.32, 8.38,
8.*f6 (27H, 3s., -CH2CH2- and C-Me).
MS:, m/e (rel. abundance): 806 (30, M+) , 235 (100), 197 (67),
69 (68).
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Tetracosanoic acid
This compound crystallised from fractions eluted with 10% 
chloroform/benzene. Crystallisation from methanol gave colourless 
prisms, m. 82-86°C. (lit. 88°C.), identical (t.l.c., mixed m.pt.,
i.r., m.s.) with an authentic sample.
EXPERIMENTAL
CHAPTER 1
Pebrolide ( 15 ) and desacetylpebrolide ( 16 ) were isolated from 
the neutral fraction of the culture filtrate extract of 
P. brevicompactum as described in the previous section (Table 31 )•
Pebrolide ( 13 ) crystallised as colourless needles, m. 167-170°C., 
from chloroform/light petroleum.
L.
T.l.c.: 10% methanol/chloroform, Rf. 0 .6 : bn. (Ce ).
Desacetylpebrolide ( ) crystallised as colourless needles,
m. 252-255°Ci from chloroform/light petroleum.
A ,
T.l.c.: 10% methanol/chloroform, Rf. O.A; bn.-bk. (Ce ).
The following transformations were carried out in order to obtain 
sufficient quantities of the degradation products as were required 
for radiotracer studies. The identity of these compounds was 
established by comparison (t.l.c., mixed m.pt., i.r.) with authentic 
samples. Rf. values were determined using 10% methanol/chloroform 
as eluant.
Desacetylpebrolide ( 16 )
To a solution of pebrolide ( 15 ) (105 mg.) in acetone (10 ml.),
6N sulphuric acid (2 ml.) was added and the solution left at room 
temperature for 6 hr. Extraction with chloroform (20 ml.) and 
subsequent evaporation of the solvent afforded desacetylpebrolide ( 16 )
75
(70 mg., 70%) which crystall ised from chloroform/light petroleum 
as colourless needles, m. 252-255°C.(Rf. 0 .4).
Pebrolide ketone (2 7)
Pebrolide (15) (20 mg.) in acetone (3 ml.) at 0°C was treated 
with Jones' reagent (0.1 ml.) for 10 min., the solution diluted with 
ice water (5 ml.) and extracted with chloroform (10 ml.). Evaporation 
of the solvent gave the ketone ( 27) (15 mg., 75%) which crystallised 
from diethyl ether as colourless needles, m. 187-190°C. (Rf. 0 .8).
Keto acid ( 29)
Desacetylpebrolide (16) (30 mg.) was oxidised with Jones' reagent 
using a procedure similar to that used in the previous reaction. 
Evaporation of the solvent yielded the keto acid (29) (35 mg., 65%) 
which crystallised as colourless needles, m. 123-125°C. from 
chloroform/light petroleum (Rf. 0 .43).
Diketo methyl ester (32)
The keto acid (29) (35 mg.) was dissolved in 4N sodium hydroxide
(5 ml.) and the solution refluxed for 4 hr., acidified with dilute
hydrochloric acid and extracted with chloroform (10 ml.). Evaporation
of the solvent gave the alcohol (30) which, without purification,
was dissolved in acetone (5 ml.) and treated with Jones' reagent
(0.1 ml.) at 0°C. for 10 min. Ice water (5 ml.) was added and the
mixture extracted with chloroform (10 ml.). Evaporation of the solvent
gave the crude diketo acid (3 )^ (16 mg.). The crude acid was dissolved 
in methanol (2 ml.) and treated with an excess of ethereal diazomethane
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far 5 min. Filtration and evaporation of the solvent gave an oil, 
from which the diketo methyl ester (32) crystallised on standing.
The crystals were washed with light petroleum to remove traces of 
methyl benzoate. Recrystallisation from chloroform/light petroleum 
gave the diketo methyl ester (32) (10 mg., 30%) as colourless needles, 
m. 182-186°C. (Rf. 0 .7).
Table 1 :1 Degradation of [ ^ G , t ] pebrolide (I)
Compound wt,/mg.
dpm.
1 4C T
T/lZfC 
(dpm.)
pebrolide
(15a)
(27a)
1.60 (x6)
1.55 (x7)
2.10 (x2) 
2.20 (x3)
113 3340 
107 3060
150 3580
158 3810
29
22.5
Table 1:11
Compound wt./mg. dpm.14
C T
T / lZfC 
(dpm.)
pebrolide (15a)
desacetylpebrolide
(16a)
1.09 (x6) 
0 .67 (x7)
1.22 (x6) 
•
3 4 .0 914
21.1 552
7 .9 190
26.5
24 .2
Table 1:III Degradation of P^C,t] pebrolide (II)
Compound wt./mg. dpm.14
C T
T/ lifC 
(dpm.)
(29a)
1.99 (x2) 
2.00 (x3)
75-0
74.3
907
825 11.5
(32a)
0.62 (x2) 
0 .64 (x3)
30.0
31.1
530
324 10.8
(32b)
0.70 (x2) 
0.71 (x3 )
34.4
33-4
6.38
8.08 —
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?r: • . ’ .
Feeding of labelled precursors to cultures of P. brevicompactum (I) 
r 1 ^  iDL-[2- CJ mevalonic acid lactone (0.05 mCi; 5*03 mCi/mM) and 
DL-[2-T] mevalonic acid lactone (2 mCi; 90 mCi/mM) were dissolved 
in sterile water (11 ml.). 10 ml. of this solution was added to
the culture filtrates of a b day old surface culture of 
P. brevicompactum (5 Roux bottles). The cultures were harvested 
after a further ^8 hr.
r 1 k I
Isolation of L C,TJ pebrolide
The culture filtrate and mycelial washings (1 1.) from the above, 
were stirred with charcoal (10 g.) for 2 hr. and the charcoal 
subsequently extracted in a soxhlet apparatus with acetone. The 
acetone extract was partitioned between chloroform and water, and 
the chloroform extract washed with saturated aqueous sodium bicarbonate. 
To the dried chloroform extract, inactive pebrolide (187 mg.) was 
added. After precipitation with light petroleum, crystallisation 
gave pebrolide (150 mg.), homogeous by t.l.c. Seven successive 
crystallisations yielded material of constant activity (Table 1:1).
Fit i
Degradation of I C,TJ pebrolide 
P^C/f] Pebrolide ketone
[1^C,T] pebrolide (100 mg.) was oxidised to pebrolide ketone 
as described gibove. Two successive crystallisations gave chemically 
pure (t.l.c., mixed m.pt., i.r., identical with an authentic sample) 
pebrolide ketone (50 mg.). Repeated preparative t.l.c. on H F ^ ^
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silica, using chloroform as eluant, followed by further 
crystallisation gave material of constant activity (Table1;l)
Feeding of labelled precursors to cultures of P. brevicompactum (II)
r Z|- T
DL-[ 2- CJ mevalonic acid lactone (0.1 mCi.; 99 mCi*/mM) and 
DL-[2-T] mevalonic acid lactone (b mC:L/mM) were dissolved in sterile 
water (25 ml.). 2.b ml. of this solution was added to the culture
filtrates of a 3 day old surface culture of P. brevicompactum (11 
Roux bottles). The cultures were harvested after a further 20 hr.
Determination of total activity of precursor added
0 .25 ml. of the precursor solution (containing 1/100 of the
total activity) was diluted to 100 ml. with distilled water. 0 .2 ml.
aliquots of this solution were counted in biosolve/toluene scintillator.
1 b
Total activity fed (2^/25 of precursor solution): 0.090 mCi- C;
3.15 mCi. T;T/1ZtC = 36.0.
r 1 b 1 r 1 b 1Isolation of L C,Tj pebrolide and I C,TJ desacetylpebrolide
The procedure followed was essentially that of the previous 
experiment. To the dried chloroform extract, inactive pebrolide 
(205 mg.) and desacetylpebrolide (l*fO mg.) were added and the mixture 
chromatographed on a column of silica gel (*f0 g.). Fractions eluted 
with chloroform contained crude pebrolide (260 mg.). Fractions eluted 
with 3% methanol/chloroform contained crude desacetylpebrolide (150 mg.)
1 b[ C,T] Pebrolide (t.l.c., mixed m.pt., i.r. identical to an 
authentic sample) was isolated from the crude column fractions by 
preparative t.l.c. on EF^  ^silica, using 3% methanol/chloroform
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as eluant, and subsequent crystallisation. Six successive 
crystallisations yielded material of constant activity (Table 1:11)• 
The crude desacetylpebrolide v/as purified by crystallisation
r1 A* 1from chloroform/light petrol giving [ C,T j desacetylpebrolide 
(t.l.c., mixed m.pt., i.r. identical to an authentic sample). Five 
successive crystallisations gave material of constant activity 
(Table 1 :II) •'
Mif I
Degradation of L C,TJ pebrolide
P^CjT] Pebrolide (120 mg.) was hydrolysed to (28b) (83 mg.) and 
(28a) oxidised to (29a) (69 mg.). Basic hydrolysis of (2.9a) (60 mg.) 
afforded (30a) (25 mg.) which was oxidised to (31 a) (16 mg.). 
Methylation of (31a) afforded (32a). (15 mg.).
The diketo methyl ester (32a) (9 mg.) was refluxed with sodium 
hydroxide (5 ml.) for k hr., the solution neutralised with dilute 
hydrochloric acid and extracted with chloroform (5 ml.). Evaporation 
of the solvent afforded the diketo acid (31b) which was esterified 
with ethereal diazomethane in methanol giving the diketo methyl ester 
(321$ (*f.5 mg.)
The above compounds were purified to constant activity by 
successive crystallisation (Table 1 : III) •
EXPERIMENTAL
CHAPTER 2:1
8o
Methyl O-methylmycophsnolate (117
Mycophenolic acid (200 mg.) in methanol (10 ml.) was treated 
with an excess of ethereal diazomethane and the solution left overnight 
at room temperature. Filtration and evaporation of the solvent 
afforded methyl O-methylmycophenolate (11 7 (216 mg., 99%) which 
crystallised from diethyl ether/light petroleum as colourless needles, 
m. i5? -'5S°C (lit.^S^8°C) , identical (t.l.c., mixed m.pt., i.r.) 
with an authentic sample.
O-Methylmycophenolic acid ( 9&)
A solution of methyl O-methylmycophenolate (h 17) (170 mg.) in 
methanol (2 ml.) was refluxed with 2N sodium hydroxide (20 ml.) for 
15 hr. After acidification with dilute aqueous hydrochloric acid, 
extraction v/ith chloroform (30 ml.) gave O-methylmycophenolic acid 
(96) (120 mg., 75%) which crystallised from ethyl acetate/light 
petroleum as colourless needles, m. 109-112°C (lit. 112°C), identical 
(t.l.c., mixed m.pt., i.r.) with an authentic sample.
L.
T.l.c.: 5% methanol/chloroform, Rf. O.38, gr. (Ce ).
(er.ythro-) 5 17-Dimethoxy-6 2-hydroxy-2(methyl-5-oxotetrahydro-2-furyl) 
ethyl -A-methylphthalan-1 -one (105)
To a solution of O-methylmycophenolic acid (96) (100 mg.) in 
2N aqueous potassium hydroxide at 100°C, 0.5 ml. aliquots of a solution 
of potassium permanganate (1 g.) in 0.4-5N aqueous potassium hydroxide 
(20 ml.) were added at 5 min. intervals until the purple colour 
persisted (approximately 6 ml. added). The solution was filtered, 
reduced to 20 ml., acidified to pH 2 with dilute aqueous hydrochloric
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acid, and subjected to constant extraction with ether overnight. 
Evaporation of the ether and subsequent p.I.e. of the residue on 
silica, using 5% methanol/chloroforra as eluant, gave the 
dimethoxy-hyaroxylactone (105) (15 mg., 1 **%) which crystallised from 
chloroform/light petroleum as colourless needles, m. 150-151°C.
(mixed m.pt. with the (threo-)dimethoxy-hydroxylactone (192) - 
130-135°C.)
4+
T.l.c.: chloroform, Rf. O.5 6; bn. (Ce ).
Analysis: Found C: 61.58%, H: 6.19%.
C18H22°7 recluires C: 81-71%, H: 6.35%.
I.R.Vmax. (KBr): 3^80, (y QH), 2980, 2940, 2870, 1755 ( VCQ),
1604, 1477, 1203, 1130, 1075, 943, 870, 789 cm71.
UV. Xmax. (EtOH): 226 (€=20000), 251 (£-9930), 296 (£=3180) nm. 
NMR. (60 Mc/s.) 't CBCly. 4.85 (2H, 1., ArCI^O-) , 5-92 (3H, s., 
MeOl), 6.16 (3H, s ., MeO-), 6.36 (1H, m., -CH(OH)-),
8.9-7-5 (^H, m.), 7.15 (1H, exchangeable with D^O),
7 .6-8.0 (2H, m.), 7.80 (3H, s., ArMe), 8.49 (3H, s., C-Me)
MS. M/e (rel. abundance): 350 (M) (13), 251 (100), 221 (68),
99 (40).
(er.ythro-) 5 ,7-Dimethoxy-6 2-hydroxy-2 (methyl-5-oxotetrahydro-2-furyl) 
ethyl -4-methylphthalic anhydride (104)^^
O-Methylmycophenolic acid (96) (70 mg.) in 2N aqueous potassium 
hydroxide (2 ml.) was treated at reflux with an alkaline solution 
of potassium permanganate as before. The solution was refluxed for 
2 hr., filtered, made acid with dilute aqueous hydrochloric acid and
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subjected to constant extraction with ether overnight. Evaporation 
of the solvent gave a yellow oil. After drying in a desiccator over
potassium hydroxide, the oil was treated with a small volume of ether
to give the dimethoxyphthalic anhydride (10*9 , as colourless crystals, 
which crystallised from chloroform/light petroleum as prisms, 
m. 1^9-151°C. (10 mg., 13%).
Ll.
T.l.c.: chloroform, Rf. 0.55* y.-bn. (Ce ).
Analysis: Found C: 59*37%» H: 3*^8%
Calculated for C^gH^Og C:. 59-3^%, H: 5-53%.
I.R.Vmax. (KBr): 3560, 3*f6o, 2985, 2958, 2860, 18*1-0. ( V co
anhydride), 1770 (Vqq Y-lactone), 1616, 1588, 1*f71 , 1220,
978, 752, 639 cm.-1.
NMK. (60 Mc/s.) '2'CDCl,: 5.83 (3H, s., MeO-), 6.16 ( 3H ,  s.,
5 —
MeO-), 6.35 (1H, m., -CH(OH)-), 6.8-7-^ (5H, m., 1H
exchangeable with I^O)> 7-^5 (3H, s., ArMe), 7*5-8.0 (2H, m.),
8.52 (3H, s., C-Me).
MS. m/e (rel. abundance): 36^ (M+) (6), 3^6 (5), 266 (99)j 
. 99 (100).
Lactonisation of mycophenolic acid
(a) A solution of mycophenolic acid (100 mg.) in trifluoroacetic 
acid (5 ml.) was left at room temperature for 1 hr. Evaporation
gave the lactone (IPS) (95 mg., 95%) which crystallised from chloroform/ 
light petroleum as colourless needles, m. 161-162°C. Identical (t.l.c., 
mixed m.pt., i.r.) to an authentic sample.
(b) Mycophenolic acid (100 mg.) in chloroform (5 ml.) was treated
with 3 drops of borontrifluoride etherate solution and the solvents
S3
evaporated almost immediately giving the lactone Cl 0£) (98 mg. , 98%) 
identical (t.l.c*, mixed m.pt., i.r.) to an authentic sample.
5 ,7-Dime thoxy-^--me thy 1-6 2(2-me thyl-5-oxo be trahydro-2-furyl) ethyl 
phthalan-1 -one Cl 09)
The lactone (108) (50 mg.) in ether (5 ml.) was treated with 
an excess of ethereal diazomethane and the solution left overnight 
at room temperature. Filtration and evaporation of the solvent gave 
a colourless oil, b.pt. 150°C/0.003 mm. (50 mg., 96%), The distillate 
crystallised from chloroform/light petroleum giving the dimethoxylactone 
(109) as needles, m. 72-73°C.
Ll I
T.l.c.: chloroform, Rf. 0.60, y. (Ce ).
Analysis: Found C: 6^.71%, H: 6.^8%
^19^22^6 reclu^res 8 f^.66%, H: 6.63%
I.R.Vmax. (film): 2980, 1759, 1605, 11^0, 768.cm."1.
NMR. (60 Mc/s.) t'CDCl : ^+.86 (2H, s., ArCH_0-), 5*90 (3H, s.,
5 2
MeO-), 6.16 (3H, s., MeO-), 7.0-7.5 (^H, m.), 7.80 (3H, 
s., ArMe), 7-7-8.3 (^H, m.), 8.50 (3H, s., C-Me).
MS. m/e (rel. abundance): 33^ (M+) (W , 221 (100), 220 (99),
99 (^2).
Oxidation products of thedimethoxylactone (109 3-Hydroxy-5,7-
dimethoxy-^--methyl-6 2 (2-methy1-5-oxotetrahydro-2-furyl)ethyl phthalan-
1-one (110) and 1 ,2-Carbomethoxy-5 ,5-dimethoxy-6-methyl-A- 2(2-methyl-
5-oxotetrahydro-2-furyl)ethyl - benzene (112)
A refluxing solution of the dimethoxylactone (109) (200 mg.) 
in aqueous potassium hydroxide (^ ml.) was treated with alkaline
potassium permanganate solution and extracted as before. The
products, in methanol (5 ml.), were treated with an excess of J
ethereal diazomethane for 30 min. The solution was filtered and
the solvent evaporated. P.I.e. of the residue on silica, using
10% methanol/chloroform as eluant, gave starting material (90 mg.),
the pseudo acid (110) (30 mg. , 29%) and the dimethyl phthalate Q12)
(6 mg., 5%).
The pseudo acid (11Q was obtained as a yellow oil which
decomposed slightly on distillation (b.pt. 170°C/0.01 mm.).
Ll.
T.l.c.: 10% methanol/chloroform, Rf. 0.7; gr. (Ce ).
I.R.Vmax.(CHCl ): 3^00 (br.,VQH), 3022 ( V QH) . 2981 , 2950,
176^ ( V co), 1600 cm.-1.
Vmax. (film) : 2^50 (br.,VQH), 1760 ( V CQ)i 1603, IV78,
1390, 1312, 1150, 970, 777 cm.'1.
NMR.(60 Mc/s.)^CDC1 : 3.52 (1H, s., ArCH(OH)O-), 5*92 (3H, s.,
5 —
MeO-), 6.19 (3H, s., MeO-), 7.0-7.5 (5H, m., 1H exchangeable 
with DO), 7.68 (3H, s., ArMe), 7.83-8 .3 (^H, m), 8.52 
(3H, s., C-Me).
MS. m/e (rel. abundance): 350 (M+) (23), 332 (100), 235 (26),
H 9  C^O), 99 ( W .
The dimethyl phthalate (11^ ) was isolated as a viscous oil.
Zf+
T.l.c.chloroform, Rf. O.65, bn. (Ce ).
I.R.Vmax- (CCl^): 2955? 1780 (V  qq y-lactone) , 17^ +1 ( V qq phthalate),
-1
NMR. (60 Mc/s.) fCDCl : 6.03 (6H, s., 2MeO-), 6.11 (3H, s., MeO-), 
6.19 (3H, s., MeO-), 7.0-7.5 (AH, m.), 7.66 (3H, s., ArMe),
7 .7-8.1 (AH, m.), 8.A5 (3H, s., C-Me).
1 ,2-Dihydroxyme thyl-3-hydroxy-A(6-hydroxy-3-methylhex-2-enyl)-5-
methoxy-6-methylbenzene (115)
A solution of mycophenolic acid (95 mg.) in dry tetrahydrofuran
(5 ml.) was slowly added to a stirred suspension of lithium aluminium
hydride (65 mg.) in dry tetrahydrofuran (5 ml.) and the solution
refluxed for 3 hr. To the cooled reaction mixture saturated aqueous
sodium sulphate (2 ml.) was added and the solution stirred for a
further 30 min. The reaction mixture was diluted with water (5 ml.)
and extracted with ethyl acetate (2 x 10 ml.). Evaporation of the
solvent and p.I.e. of the residue on H F ^ ^  silica, using 10% methanol/
chloroform as eluant, gave the triol ( 115) (20 mg., 21%) as a yellow gum,
A+
T.l.c.: 10% methanol/chloroform, Rf. O.A; bl. (FeCl ), bn. (Ce ).
5
I.R.Vmax. (film): 3500 (br.,V0H), 1605, 1A?5» 1100, 975,
-1720 cm.
NMR. (60 Mc/s.)'fc'CDCl,: A.80 (1H, m., =CHCH„-), 5.A (AH, m.,
ArCH OH), 6.35 (3H, s., MeO-), 6.55 (AH, m., ArCILjCH =
-CH2°H), 7.76 (3H, s., ArMe), 7.5-8.5 (7H, m., 3H 
exchangeable with D ^ )  , 8.22 (3H, br., s., C-Me).
Mycochromanic acid ( 116)
(a) A solution of mycophenolic acid (A30 mg.) in 3% sulphuric acid/ 
glacial acetic acid was refluxed for A hr. The cooled solution was
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extracted with chloroform (20 ml.). Evaporation of the solvent and 
crystallisation of the residue from chloroform/light petroleum afforded 
mycochromanic acid (11(9 (380 mg., 90%) as colourless needles, 
m. 172-175°C, identical (t.l.c., mixed m.pt., i.r.) with an authentic 
sample.
Addition of light petroleum to the mother liquor of the fore­
going crystallisation gave the lactone (108) (20 mg., 5%) as colourless 
needles, ra. 161-162°C, identical with an authentic sample.
(b) A solution of the lactone (108) (60 mg.) in 3% sulphuric acid/ 
glacial acetic acid was refluxed for 12 hr. Extraction with chloroform 
(10 ml..), evaporation of the solvent and subsequent p.I.e. on 
silica, using 5% methanol/chloroform as eluant, gave starting material 
(25 mg.) and mycochromanic acid (116 (30 mg., 50%).
2 ,3-Dihydroxyme thy 1-8 (3-bydrox.ypropyl) -5-methoxy-^f, 8-dime thyldihydro 
1 benzopyran (118)
A suspension of lithium aluminium hydride (100 mg.) in dry 
tetrahydrofuran (10 ml.) was slowly added to a stirred solution of 
mycochromanic acid (200 mg.) in dry tetrahydrofuran and the solution 
refluxed for 1 hr. To the cooled reaction mixture saturated aqueous 
sodium sulphate (2 ml.) was added and the solution stirred for a 
further 30 min. The reaction mixture was diluted with water (10 ml.) 
and extracted with ethyl acetate (20 ml. x 2). Evaporation of the 
solvent gave the triol (118) (200 mg., 98%) as a colourless oil, which 
decomposed on attempted vacuum distillation.
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T.l.c.: 5% methanol/chloroform, Rf. 0.45; r.-pur. (Ce ).
I.R.Vmax. (film): 3500 (br.V> ), 3000, 1630, 1580, 1450, 1320,
OH
1110, 1000, 770 cm."1.
NMR. (60 Mc/s.y^CDCl^: 5-39 (^H, m., 2ArCH20H), 6.36 (3H, s.,
MeO-), 6.50 (2H, m., CH CH20H), 7-2-7.5 (2H, m., ArCH2CH2 -),
7.60 (3H, s., exchangeable with ^ O ) , 7-75 (3H, s., ArMe),
8.2 (6H, m.), 8.90 (3H, s., C-Me).
The triol (118) (50 mg.) was dissolved in pyridine (1 ml.), acetic 
anhydride (0 .5 ml.) and allowed to stand overnight at room temperature. 
Evaporation of the reagents afforded the triacetate (118^ ) (60 mg.), 
b.pt. 190°C/0.03 mm.
4+T.l.c.: chloroform, Rf. 0.8; bn. (Ce ).
Analysis: Found C: 63.83%, H: 7-53%,
C23H3208 reclu^res C: 83.30%, H: 7.40%.
I.R.Vmax. (CCl^): 3385, 335^, 1747, 1604, 1590, 1384, 1366,
1331, 124-1, 1118, 1028 cm."1.
V max. (KBr): 3318, 3282, 1744, 1603, 1590, 1390, 1370,
133^, 1250, 1119, 1031 cm."1.
NMR. (60 Mc/s.yfrCDCly 4.80 (2H, s., ArCI^OH) , 4.81 (2H, s.,
ArCH2°H), 5.92 (2H, t., J = 5.5'Hz.,-CH2CH20H), 6 .30 (3H, 
s., MeO-), 7.21 (2H, t., J = 6 .5 Hz., ArCH2CH -), 7.76 
(3H, s., ArMe), 7-97 (3H, s., Me.C0.0-), 7-98 (6h, s., 
2Me»C0.0-), 8 .0-8.4 (4H, m.), 8.73 (3H, s., C-Me).
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MS. m/e (rel. abundance): A36 (M+) (67), **08 (17), 376 (73),
3^8 (87), 33^ ( W ,  316 (69), 233 (67), 215 (100), 193 
(95).
m*: 32*f (^3 6 -^376), 296.5 (376^335), 265.6 (376-*3l6),
1^6.5 (316-^215).
Oxidation of the triol (118)
(a) With "active” manganese dioxide
The triol (118) (160 mg.) in dry acetone was stirred with 
powdered manganese dioxide (1 .6 g.) for **8 hr. under nitrogen. The 
mixture was filtered and the solvent evaporated leaving an oil (90 mg.). 
Multiple p.I.e. on silica, using 5% methanol/chloroform (xl)
and chloroform (x3) as eluants, afforded the isomeric alcohols (119) 
and (120) •
2(3-hydroxyprop,yl) -5-methoxy-2 ,6-dimethyldihydro 1 benzopyran-9 7H - 
one (119)
(33 mg*, 20%) crystallised from chloroform/light petroleum as colourless 
prisms, m. 148-150°C.
it.
T.l.c.: chloroform, Rf. O.^ f; bn. (Ce ).
Analysis: Found C: 66.8A%, H: 7.35%,
^17^22^5 relu -^res 66.65%, H: 7 »2*f%.
I.R.Vmax. (CHC13): 3525 ( V 0H), 2935, 2875, 1760 (V cophthalide) , 
—1
1607 cm. . _
Vmax. (KBr): 3^25 (Vqjj), 2925, 2860, 1760 (V cophthalide) , 
l60*f, 1325, 1133, 110^, 1032, 787 cm.”1.
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NMR. (60 Mc/s.) t'CDCl : ^.93 (2H, s., ArCI^O-) , 6.18 (3H, s.,
MeO-), 6.25 (2H, m. , -CH2CH OH), 7-21 (2H, t., J = 6Hz.,
ArCH^CH^-), 7«83 (3H, s., ArMe), 7-95 (1H, exchangeable
with D20), 8.21 (*fH, br., s.), 8.0-8.k (2H, obs.), 8 .65  
(3H, s., C-Me).
MS. m/e (rel. abundance): 306 (M+) (37), 288 (10), 2^7 (98),
207 (100), 159 (98), 85 (97),
ra*: 271 (306-^288), 122.5 (207-^159).
2(3-hydroxypropyl)-5-methoxy-2,6-dimethyldihydro 1 benzopyran-7 9H - 
one (120)
(*f8 mg., J>0%) a colourless oil, b.pt. l60°C/0.003 mm.
A .
T.l.c.: chloroform, Rf. 0.A8; bn. (Ce ).
Analysis: Found C.: 66.^0%, H: 7.16%,
requires C: 66.65%, H: 7-2*f%.1 ( 22 5
I.R.Vmax. (CHC1 ): 3620 (V0H) ’ 295°» 288° ’ 1755 ^CO Phthalide  ^» 
1618 cm."1.
Vmax. (KBr): 3^30 ( V 0H), 2935, 286*f, 1755 (V c0 phthalide), 
1620, 1^77, 1380, 1329, 1116, 1030, 782 cm."1.
NMR. (60 Mc/s.)^CDCl : ^.95 (2H, s., ArCH^O-) , 6.25 (3H, s.,
MeO-), 6.38 (2H, m., -CH2CH20H), 7.20 (2H, t., J = 6Hz., 
ArCH2CH -), ‘7.50 (3H, s., ArMe), 8.19 feH, t., J = 6Hz., 
ArCH^CH^,-) , 8.3 (1H , exchangeable with D 0), 8.32 (^H, 
br., s., -CH2CH2CH20H), 8.68 (3H, s., C-Me).
90
MS. m/e (rel. abundance): 306 (M+) (83), 2V 7 (67), 207 (93),
177 (67), 85 (100).
(b) With silver carbonate/celite (Fetizon's reagent)
The triol (118) (33 mg.) and silver carbonate/celite (1.1/ 1)
(60 mg.) were weighed into a dry flask and benzene (10 ml.) was 
distilled (from sodium) into the flask. The mixture was stirred 
and refluxed for 20 hr. The solvent was evaporated and the residue 
extracted in a Soxhlet apparatus using ethyl acetate (30 ml.) for 
12 hr. Evaporation of the ethyl acetate and multiple p.I.e. of the 
residue, as above, gave the isomeric alcohols (119 (8 mg., 16%) and
(12C) (12 mg., 7Lh%) • The products were identified by t.l.c. and i.r.
comparison with samples from the previous oxidation.
(c) With chromium trioxide (sulphuric acid (Jones1 reagent)'
(i) A solution of the triol (11§ (l*fO mg.) in acetone (10 ml.) was
treated with Jones’ reagent (0.2 ml.) for 3 min., diluted with ice 
water (3 ml.) and extracted with ethyl acetate (20 ml.). The extract 
was dissolved in methanol (3 ml.) and treated briefly with ethereal 
diazomethane. Filtration, evaporation of the solvent and multiple 
p.I.e. of the residue on H F ^ ^  silica, using 2% methanol chloroform 
as eluant, afforded methyl mycochromanate (123) (28 mg., 19%) identical 
(t.l.c., i.r., n.m.r.) with an authentic sample, and the isomeric 
ester, 2 (2-carbomethoxyethyl)-3-methoxy-2 ,6-dimethyldihydro 1 
benzopyran-7 9Ii -one (125) (30 mg., 20%) as a colourless oil, b.pt. 
l60°C/0.003 mm.
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JLl«_
T.l.c.: chloroform, Rf. 0.50, bn. (Ce ).
Analysis: Found C; 64.41%, H: 6.61%,
^18^22^6 reclu^res 0: 64.66%, H: 6 .36%.
I.R.Vmax. (CCl^): 2940, 1764 (V  CQ phthalide) , 1742 ( V co ester),
1615, 1323, 1112, 1030, 1015 cm.*"1.
Vmax. (KBr): 2930, 1760 ( V co phthalide), 1740 (Sh.VC0
ester), 1618, 1472, 1325, 1112, 1024, 993, 780 cm."1.
NMR. (60 Mc/s.)'fc'CDCl^: 4.92 (2H, s., ArCH-0-), 6.21 (3H, s.,5 — 2
MeO-), 6.33 (3H, s., MeO.C0-), 7.14 (2H, t. , J = 7-5 Hz.,
ArCH2CH ), 7.48 (3H, s., ArMe), 7-4-7.7 (2H, m.),
7.8-8.1 (2H, m.), 8.16 (2H, t., J = 7.5 Hz., ArCH2CH2-),
8 .7 (3H, s., C-Me).
MS. m/e (rel. abundance): 334 (Mt) (100), 274 (59), 208 (82),
207 (56), 177 (47), 149 (43), 95 (35).
(ii) A solution of the triol (118) (137 mg.) in acetone at 0°C was
treated with Jones’ reagent (0.1 ml.) for 3° sec., diluted with ice 
water and extracted as before. Evaporation of the solvent and p.I.e. 
of the residue on H F ^ ^  silica, using 2% methanol/chloroform as eluant, 
afforded starting material (10 mg.), the isomeric alcohols (120) (14 mg.,
12%) and (119) (11 mg., 9%) and two less polar compounds (126) (3 mg.)
and (127) (4 mg.).
4+
(126) T.l.c.: chloroform, Rf. 0.60; m. (Ce ).
I.R.Vmax. (CCl^): 2940, 2715 (V CH aldehyde) , 1760 ( V co phthalide)
1726 ( V Pn aldehyde), 1610, 1470 cm . " 1 . uu
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Cl27) T.l.c,: chloroform, Rf. 0.65; bn. (Ce^+).
I.R.Vmax. (CCl^): 2950, 2720 ( V CH aldehyde), 1770 (V CQ
phthalide), 1726 aldehyde), 1610, 1^73 cm.  ^.ou
Methyl mycochromanate (125)
Mycochromanic acid (116) (2^ f mg.) in methanol (5 ml.) was treated 
with an excess of ethereal diazomethane for 5 min., the solution 
filtered and the solvent evaporated to give methyl mychromanate (123) 
(26 mg.), a colourless oil, b.pt. l65°C/O.OOif mm.
Ll 1
T.l.c.: chloroform, Rf. 0.^5; bn. (Ce ).
Analysis: Found C: 6^+.^0%, H: 6.57%,
^18^22^6 relu^res 6^.66/0, H: 6.63%.
I.R.Vmax. (CCl^): 2985, 2955, 2880, 177^ ( V CQ phthalide),
17^0 ( V a s t e r ) ,  1608, 1^73, 1335, 1327, 1302, 1036,
872 cm.”1.
Vmax. (KBr): 2950, 1763 ( V co phthalide), 1738 ( V CQ ester), 
1606, 1334, 1323, 1300, 1032, 870, 787 cm.”1.
NMR. (60 Mc/s.) tCVCly ^.95 (2H, s., ArCE^O-) , 6.20 (3H, s., 
MeO-), 6.35 (3H, s., MeO-), 7.20 (2H, t., J = 7-5 Hz., 
ArCH2CH2-), 7.1-7.6 (2H, m.), 7.9-8.3 (2H, m.), 7.88 (3H, 
s., ArMe), 8.16 (2H, t., J = 7-5 Hz., ArCH CH -), 8.66 
(3H, s., C-Me).
MS. m/e (rel. abundance): 33^ (M+) (58), 316 (^9), 2^7 (100),
207 (98.5), 159 (61). 
m*: 299 (33^316).
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1 ,2 Dihydroxymethyl-3 15-dimethoxy-M6-hydroxy-3-rce thylhex-2-enyl) -
6-methylbenzene (12£|
To a stirred solution of methyl O-methylrnycophenolate (117) (570 
mg.) in dry tetrahydrofuran (15 ml.) at room temperature, a suspension 
of lithium aluminium hydride (153 mg.) in dry tetrahydrofuran (15 ml.) 
was added over 15 min. The mixture was stirred for 2 hr., saturated 
aqueous sodium sulphate (5 ml.) added and stirred for a further 30 min. 
The solvent was partially evaporated and the mixture extracted with 
ethyl acetate (2 x 20 ml.). Evaporation of the solvent gave the 
triol (128 (370 mg., 72%) which crystallised as colourless prisms, 
m. 91°C, from chloroform/light petrol.
ij. 1
T.l.c.: 5% methanol/chloroform, Rf. 0.^5, r.-bn. (Ce ).
Analysis: Found C: 65.89%, H: 8.67%,
^17^26^5 relu^res C: 85.78%, H: 8 .^%.
I.R.Vmax. (CHCl^): 3610, 1^80 ( V QH, br.), 29^0, 1572 cm."1.
V max. (KBr): 3300 (V 0Hi bl*.), 29^0, 2903, 1579, 1VI0 ,
1101, 97^, 722 cm."1.
UV.Xmax. (EtOH): 260 (E*10*0, 275 (£«Vl40), 283 (€» ^ 660) nm.
NMR. (60 Mc/sJ^CDCl,: *f.82 (1H, t., J = 7 Hz., = CH.CH_-),5 2
5.30-(2H, s., ArCH^OH), 5-33 (2H, s., ArCHgOH), 6.27 (3H, 
s., MeO-), 6.3^ (3H, s., MeO-), 6.3-6 .8 (3H, obs., 
exchangeable with i^O) , ^*53 (2H, t., J = 6  Hz., -CH^CH^OH), 
6.65 (2H, t., J = 7 Hz., ArCH2CH=), 7.69 (3H, s., ArMe),
7.8-8.5 (^H, m., -CH2CH2-), 8.21 (3H, s., C-Me)
MS. m/e (rel. abundance): 32** (M+) , 306 (80) , 288 (62), 275 
(33), 2V7 (58), 207 (83), 193 (58), 85 (100).
m*: 271 (306-^288).
Oxidation of the triol (128)
(a) With "active” manganese dioxide
The triol (128) (60 mg.) in dry chloroform (20 ml.) was stirred 
with powdered manganese dioxide (600 mg.) under nitrogen for 2*f hr. 
Filtration and evaporation of the solvent gave an oily mixture of 
the isomeric alcohols, 5 ,7-dimethoxy-6(6-hydroxy-3-methylhex-2-enyl)- 
*f-methylphthalan-1 -one (131) (10 mg.) and *f,6-dimethoxy-6(6-hydroxy-
3-methylhex-2-enyl)-**-methylphthalan-1 -one (132) (20 mg.) which could 
not be separated by p.I.e.
Conversion to the corresponding 6-acetoxy derivatives was 
accomplished using a procedure similar to that used in the acetylation 
of the triol (11• The 6-acetoxy derivatives could not be distinguished 
from each other on t.l.c.
Attempted selective demethylation of the alcohol 0 31)
The above mixture of alcohols (27 mg.) in refluxing dry benzene 
(10 ml.) was treated with "magnesium iodide etherate" reagent (0 .2 ml.) 
and the solution stirred and refluxed for 3 hr. under nitrogen.
The cooled solution was washed with 5N hydrochloric acid (10 ml.), 
water (10 ml.), added, and extracted with chloroform (10 ml.).
Evaporation of the solvent and p.I.e. of the residue on H F ^ ^  silica, 
using 2% methanol/chloroform as eluant, gave an oil (15 mg.),
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apparently homogeneous by t.l.c. but consisting of a mixture of the 
isomeric tetrahydrofurans (129) and (130).
T.l.c.: chloroform, Rf. 0.6; bn. (Ce^+).
I.R.Vmax. (film): 3500, 3000, 17^5 ( V nn phthalides) , 1610,ou 
1V75, 1050, 770 cm."1.
NMR. (60 Mc/s.^CDCl *. ^ .68 (2H, s., ArCH-O-), f^.86 (1H, s.,5 d
ArCH20~), 9.51 (1^H, s., MeO-), 6.08 (3H, s., MeO-), 6.16 
(1-J-H, s., MeO-), 6.22 (3H, s., MeO-), 7.0-7.5 (6H, m.),
7.^2 (3H, s., ArMe), 7.80 (1-jH, s., ArMe), 7.8-8 .6 (9H, 
m.), 8.66 (^--g-H, s., C-Me).
(b) With "aged" manganese dioxide ^-,6 dimethoxy-1 -hydroxy-5(6-
hydroxy-3-methylhex-2-enyl)-3-methylphthalan (137)
"Active” manganese dioxide prepared by the method of Attenburrow 
1^9
et al., and stored at room temperature and humidity for 12 months was
used in the following experiments.
The triol (128) (97 mg.) in dry chloroform was stirred at room
temperature under nitrogen with powdered manganese dioxide (1 g.)
until t.l.c. of the mixture indicated that no starting material 
remained (5 hr.). P.I.e. of the product on EF^  ^silica, using 2% 
methanol/chloroform as eluant, gave a mixture of the isomeric alcohols 
(13-1) and (132) (10 mg.) and the he.miacetal (137) (70 mg., 82%) as an 
unstable colourless oil.
T.l.c.: 5% methanol/chloroform, Rf. 0.5; bn. (Ce^+).
I.R.Vmax. (CHClj): 3500 (br-V0H)i 2835, 1655, 1600 cm.-1.
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NMR. (60 Mc/s.) ^ CDCl^: 3-6 (1H, br. s., irr. *f.8-*s.,
ArCH(OH)O-), k.75 (1H, m. = CHCH -), *f.8 (2H, br.,S, 5 . .
irr. 3.6-*s., ArCH20), 6.2k (3H, s., MeO-), 6.28 (3H, s., 
MeO-), 6.28 (3H, s., MeO-), 6.A-5 (2H, t., J = 6 .5 Hz.,
-CH CH OH), 6.65 (2H, d., J = 7-5 Hz., ArCH2CH=), 7.72 
(3H, s ., ArMe), 7*6-8.^ (6H, m., 2H exchangeable with O^O), 
8.22 (3H, br., s., C-Me).
5 (5-carboxy-3-methylpent-2-enyl) - A-, 6-dime thoxy-7-methylphthalan-1 -one
The hemiacetal 03'j) (70 mg.) was dissolved in dry chloroform 
.(15 ml.) and stirred with powdered manganese dioxide (700 mg.) under 
nitrogen for 12 hr. Filtration and evaporation of the solvent afforded 
the alcohol 053 (65 mg., 95%) as an oil.
I.R.Vmax. (CHCl^): 3500 (br.,VQH), 29^0, 1760 (V co phthalide), 
1600 cm. £
NMR. (60 Mc/s.) ^ CDCl^: k.60 (2H, s., ArCIh 0 -) , *f.8l (1H, ra. ,3 — ^
= CH.CH2-), 6.1 (3H, s., MeO-), 6.25 (3H, s., MeO-), 6.41
. (2H, t., J = 6.5 Hz., -CH2CH OH), 6.58 (2H, d., J = 6 .5 Hz., 
ArCH2CH=), 7.^7 (3H, s., ArMe), 7.7-8.6 (5H, m., 1H 
exchangeable with D20), 8.20 (3H, br., s., C-Me).
The alcohol (133 (65 mg.) in ice cold acetone (2 ml.) was treated 
with Jones’ reagent (0.2 ml.) for 15 min. Ice water (2 ml.) was 
added and the solution extracted v/ith chloroform (10 ml.). The extract 
was v/ashed with water (5 ml.) and extracted with saturated aqueous 
sodium bicarbonate (10 ml.). The bicarbonate extract was made acid
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with dilute hydrochloric acid and extracted with ethyl acetate (10 ml.).
\
Evaporation of the solvent gave the acid Cl 39) (55 nig., 83%) which 
crystallised as colourless needles, m. 107-110°C, from chloroform/ 
light petroleum, (mixed m.pt. with O-methylmycophenolic acid (96)
91-96°C).
k+
T.l.c.: 5% methanol/chloroform, Rf. 0.4-; gr. (Ce ).
Analysis: Found C: 64.4-2%, H: 6.78%,
^18^22^6 reclu^res C: 64.66%, H: 6.63?£
I.R.Vmax. (CHCl^): 3520 (br.), 2940, 1760 ( V CQ phthalide),
1711 ( V co acid), 1595 cm.”1.
Vmax. (KBr):. 3200-2850 (br.), 1754 (V co phthalide), 1695 
( V c0 acid), 1595, 1^59, 1^26, 1295, 1116, 1052 cm.-1.
UV. Xiax. (EtOH): 210 (E*16000), 250 (6 = 10900), 295 (6* 5^50) nm. 
NMR. (60 Mc/s.)^CDCl^: 0.5 (1H, br., exchangeable with I>20 »
-C00H), 4.96 (2H, s., ArCH^O -) , A . 88 (1H, obs., =CH.CH2-), .
6.15 (3H, s., MeO-), 6.28 (3H, s., MeO-), 6.58 (2H, d. ,
J = 7 Hz., ArCH2CH=), 7.44 (3H, s., ArMe), 7.64 (4h, br., s., 
-CH2CH2-), 8.20 (3H, s., C-Me).
7-Hydroxy-o(6-hydroxy-3-methylhex-2-enyl)-3-methoxy~A-methylphthalan~
1-one (154)
Ethyl chloroformate (0.88 ml.) in tetrahydrofuran (2.5 ml.) 
was added to a solution of mycophenolic acid (1.4-6 g.) and 
triethylamine (1.28 ml.) in tetrahydrofuran (30 ml.) at -10°C. The 
mixture was stirred for 1 hr., filtered and the filtrate added over 
30 min. to a stirred solution of sodium borohydride (1.05 g.) in
98
water (10 ml.) at 10-15°C. The mixture was stirred at room 
temperature for 18 hr., acidified with 3^ hydrochloric acid and 
extracted with ethyl acetate (30 ml.). Evaporation of the solvent 
gave the carbonate (133) (1.68 g., 97%) a colourless oil, b.pt. 180°C/
0.005 nim.
Zl .
T.l.c.: chloroform, Rf. Oj+7; bl. (FeCl^), bn. (Ce ).
Analysis: Found C: 63.50%, H: 7.08%,
^20^26^7 reclu^res C: 63.^8%, H: 6.93%*
I.R.y max. (film): 3550 ( V ATt phenol), 3000, 1760 phthalide)
Uii O U
1725 (V> carbonate), 1620, 12^5, 1218, 10^8 , 775 era.-1.
UV.X max. (EtOH): 222 (6*13580), 2^7 (6 =7830), 291 (€=1960),
308 (6=1730) nra.
NMR. (60 Mc/s.)£'CDC1.,: ^.82 (2H, s., ArCHo0-), ^ .8 3 (1H, t.,
5 — 2
J = 6.5 Hz., = CH.CH0-), 5.62 (2H, q., J = 8 Hz., CH^CH^O-'),
2 5— 2
6.16 (3H, s., MeO-), 6.A5 (2H, t. , J = 6. Hz., -CH2CH 0C0-) ,
6.60 (2H, t., J = 6.5 Hz., ArCH2CH=), 7.76 (3H, s., ArMe),
7.8-8.^ (^H, m., -CH2CH2CH20-), 8 .23 (3H, s., C-Me), 8 .60  
(3H, t., J = 8 Hz., CH CH20-),
MS. m/e (r.el. abundance): 379 (M + 1) (0.5) , 306 (35), 288 (31), 
2V7 (98.5), 229 (*f6), 207 (100), 159 (57), 85 (93).
The carbonate (133) was Heated with 3N aqueous sodium hydroxide 
(20 ml.) at 110°C for 3 Hr., the solution made acid with dilute 
hydrochloric acid and extracted with ethyl acetate (60 ml.). The 
extract was washed with saturated sodium bicarbonate (10 ml.) and 
water (10 ml.) and dried. Evaporation of the solvent afforded the 
alcohol (13^ ) (970 , 70%) which crystallised as colourless needles,
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m. 105-106°C.(ref. 106-107°C.) from ethyl acetate /light petroleum
( 6 o - 8 o ° c . ) .
L,
T.l.c.: chloroform, Rf. 0.45; bl. (FeCl7), bn. (Ce ).j
Analysis: Found C:. 66.50%, H: 7*19%,
Calculated for C ^ H ^ O ^  C: 66.65%, H: 7.21%.
I.R.Vmax. (CHC1,): 3630 (br.,V^TT phenol), 3100 (br. Vr.tr alcohol), 5 CH UH
3016, 2945, 1742 ( y cQ phthalide), 1631, 1493 cm.“1.
V^ax. (KBr): 3436 ( V qh Phenol), 3100 (br-Vg^ alcohol),
2940, 1735 ( V rn phthalide), 1622, 1614, 1459, 1089, uu
-1
1003 cm.
NMR. (60 Mc/s.) ^CDCl,: 2.22 (1H, s., exchangeable with Do0,5 2
ArOH), 4.68 (1H, t., J = 7-5 Hz., = CH.CH -), 4.73 (2H, 
s., ArCH^O-),, 6.15 (3H, s., MeO-), 6.35 (2H, t., J = 6 Hz.,
-CH CH OH), 6.54 (2H, d., J = 7.3 Hz., ArCH2CH=), 7-79 
(3H, s., ArMe), 7.8-8.4 (4H, m., ~CH2CH2-), 8.16 (3H, s.,
C-Me), 8.38 (1H, s., exchangeable with ~0H) •
MS. m/e (rel. abundance): 306 (M+) (27), 288 (20), 247 (87),
229 (28), 207 (91), 159 (45), 85 (100). 
m*: 271 (306-^288), 253 (288->270), 122 (207^159).
5 ,7-Diniethoxy-6(6-hydroxy-3-rnethylhex-2-enyl) -4-methylphthalan-1 -one 
(131)
The alcohol (134) (60 mg.) in methanol (10 ml.) was treated with 
an excess of ethereal diazomethane overnight. Filtration and evaporation 
of the solvent gave the dimethoxy alcohol (131) (62 mg.) as a colourless 
oil, b.pt. l65°c/0 .005 mm.
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L,
T.l.c.: 2% methanol/chloroform, Rf. 0.4-; bn. (Ce ).
Analysis: Found C: 67.33%, H: 7.^-6%,
Cl8H2if°5 reHuires C: ^7.^8%, H: 7.55%.
I.R.Vmax (KBr): 3^00 (>> ), 2930, 1760 (*V™ phthalide), 1600,
UrL UU
1V73, 1399, 1316, 1128, 1033, 99^, 966, 91^ cm.”1.
NMR. (60 Mc/s.^CDCl : ^.82 (1H, t., J = 8 Hz., = CH.CH^) ,
89 (2H, s., ArCH^O-), 5-96 (3H, s., MeO-), 6.21 (3H, 
s., MeO-), 6.hl (2H, t., 6.5 Hz., -CH2CH20H), 6 .62 (2H, 
s., J = 8 Hz., ArCH2CH = ) 7 - 8 1  (3H, s., ArMe), 7-8-8.5 
(5H, m., 1H exchangeable with D20), 8 .20 (3H, s., C-Me).
MS.. m/e (rel. abundance): 320 (M+) (58), 261 (*f0) , 221 (73),
207 (60), 85 (100).
2 , A— Pimethoxy-3(2-hydroxyethyl)-3-methylphthalan-1 -one (1^ 1)
Methyl O-methylmycophenolate (117 (115 mg.) in ethyl acetate 
(10 ml.) was treated at -80°C. with a stream of ozone (2 mg./min.) 
for 30 min. The solution was brought to room temperature, the solvent 
evaporated and the oily residue in methanol (2 ml.) added to a solution 
of sodium borohydride in methanol (3 ml.)/water (5 ml.). The mixture 
was stirred for 2 hr. at room temperature and extracted with ethyl 
acetate (20 ml.). Evaporation of the solvent afforded the alcohol (1^ 1) 
(^-0 mg., k3%) which crystallised from chloroform/light petroleum 
as colourless needles, m. 98-100°C.
T.l.c.: 5% methanol/chloroform, Rf. 0.63; bn. (Ce^+).
Analysis: Found C: 61.99%, H: 6J+1%,
^13^16^5 reHu^res C: 81.90%, H: 6.39%.
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I.R.Vmax. (CHC1 ): 175^, 1597 cm."1.
V max. (KBr): 3^20 (V 0H alcohol), 2955, 1761, 1738, 1590, 
1*f66, 135**, 1301, 112^, 1100, 95^ cm."1.
UV.Xmax (MeOH): 217, 2^ -9 (£ = 5500), 295 (£ = 1520) nm.
NMR. (60 Mc/s.)frCDCl^: 4.89 (2H, s., ArCH20-), 5-92 (3H, s., 
MeO-), 6.20 (3H, s., MeO-), 6.25 (2H, obs., ~CH20H), 7-01 
(2H, t., J = 6.5 Hz., ArCH2CH2-), 7.81 (3H, s., ArMe),
8.0 (1H, br., s., exchangeable with D20).
MS. m/e (rel. abundance): 252 (M+) (60), 234 (26), 221 (100),
220 (57), 191 (80), 163 (59), 161 (57), 133 (7*0, 91 (51), 
77 (44).
m*:: 217.5 (252-^23^), 192 (252-*221), 165 (221-*191), 139 
191-^163), 136 (191-^161), 110 (161-^133).
3-Carboxymethyl-2,4-dimethoxy-5-methylphthalan-1 -one (140)
The alcohol (141) (17 mg.) in acetone (1 ml.) at 5°C, was treated 
with Jones' reagent (0.05 ml.) for 10 rain. The solution was diluted 
with ice water (3 ml.) and extracted with chloroform (3 ml.). The 
chloroform solution was extracted with saturated aqueous sodium 
bicarbonate (5 ml.). Neutralisation of the aqueous fraction with 
dilute hydrochloric acid, extraction with ethyl acetate (5 ml.) and 
evaporation of the solvent afforded the acid (140) (12 mg., 70%), 
which crystallised from chloroform/light petroleum as colourless 
prisms, m. 148-150°C.
Lj. 1
T.l.c.: 5% methanol/chloroform, Rf. 0.15? bn. (Ce ).
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Analysis: Found C: 58.30%, H: 5-21%,
C13H14°6 reluires 58.63%, H: 3.30%.
I.R.Vmax. (CHCl^): 1759 (V CQ phthalide), 1710 ( V CQ acid),
1601 cm. 1.
Vmax. (KBr) : 3000 (br.), 29^0, 1752 ( V co phthalide) , 1699 
( V co acid), 1599, 1355, 1297, 1228, 1200, 1129, 1100,
1070, 1035, 989, 965 cm."1.
UV.A max. (EtOH): 217 (£*26000), 250 (€=5360), 295 (8=1515) nm.
NMR. (60 Mc/s.) fc'CDCl,: 3-0 (1H, br., exchangeable qith D„0) ,
if. 86 (2H, s., ArCH^O- ), 5-91 (3H, s., MeO-), 6.21 (3H, s., 
MeO-), 6.24 (2H, s., ArCH C0-) , 7-82 (3H, s., ArMe).
MS. m/e (rel. abundance): 266 (M+) (92), 2if8 (77), 221 (63),
207 (100), 163 (59), 161 (57), 133 (7*0, 91 (51), 77 (44).
m * 231.5 (266 248), 165 (221 191), 139 (191 163), 136
(191 161), 110 (161 133).
Note: treatment of the ozonide of methyl O-methylmycophenolate (117)
(previous reaction) in tetrahydrofuran with water afforded the acid 
(140) (30%) identical (t.l.c., mixed m.pt., i.r.) with a sample obtained 
above.
Mycophenolic acid p-toluidide (1^ 3)
To a stirred suspension of mycophenolic acid (520 mg.) in dry 
benzene (50 ml.) an excess of oxalyl chloride ( 1 ml.) was added 
and the mixture stirred for 2 hr. at room temperature. The solvent 
and reagent were evaporated and the residue dissolved in dry benzene 
(30 ml.). To this a solution of P-toluidine (230 mg.) in benzene (20ml.!
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was added and the solution stirred at reflux for 2 hr. The cooled 
reaction mixture was washedwith water (10 ml.), dilute hydrochloric 
acid (3 ml.) and saturated aqueous sodium bicarbonate (3 ml.).
Evaporation of the solvent afforded mycophenolic acid p-toluidide (143) 
(590 mg., 90%) which crystallised from aqueous ethanol as colourless 
prisms, m. 103-104-°C.
T.l.c.: chloroform, Rf. 0.45> r.-bn. (Ce^+).
Analysis: Found C: 70-23%i H: 6.55%» N: 3-4-6%,
^24-^27^3 reclu^res C: 70.4-0%, H: 6 .63%, N: 3-4-2%.
I.R.Vmax. (nujol) : 34-50 ( V ^ ) ,  3360 (Vjgg), 1752 ^ C O  Ph‘t'3ial^ de »^
1660 (V amide), 1618, 1600, 1535 cm. ou
UV.X max. (EtOH): 217 (£*33000), 250 (£- 174-00), 306 (6*4-500) nm.
NMR. (60 Mc/sO^CDCl-: 2.5 (1H, br., exchangeable with D O ,
ArOH), 2.60 (1H, br., s., exchangeable with D^O/TFA,
-C0NH-) , 2.86 (4-H, ABA* B* system, J 3 Hz., ArH),’4-.70 
(1H, t., J = 7 Hz., * CHCH -), 4-.89 (2H, s., ArGH^O-) ,
6.82 (3H, s., MeO-), 6.61 (2H, d., J = 7 Hz., ArCH2CH=),
7-60 (4H, s., “GH2CH2-), 7-72 (3H, s., ArMe), 7-95 (3H,
S., ArMe), 8.18 (3H, s., C-Me).
O-Methylmycophenolic acid p-toluidide (144)
Mycophenolic acid p-toluidide (180 mg.) in toluene (10 ml.) was 
treated with an excess of ethereal diazomethane and allowed to stand 
overnight at room temperature. Filtration and evaporation of the 
solvent afforded the methyl ether (l44) as a yellow oil (200 mg.) 
homogeneous by t.l.c.
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T.l.c.: chloroform, Rf. 0.50*,r.bn. $Ce^+).
I.R.Vmax. (film): 3390 (V NH^  1850 ( V co phthalide) , 1659 
( V co amide), 1600, 1535, 1315, 1132, 770 cm."1.
NMR. (60 Mc/s.) ^  CDC1-,.: 2.63 (1H, br., s., exchangeable withj
D20/TFA, -C0NH-), 2.88 (4-H, ABA' b' system, J -3 Hz., ArH) ,
4-.78 (1H, t., J = 7 Hz., = CH.CH -), 4-.95 (2H, s., ArCH^O-), 
5.95 )3H, s., MeO-), 6.26 (3H, s., MeO-), 6.61 (2H, d. ,
J = 7 Hz., ArCH2CH=), 6.60 (4-H, s., -CH CH -) , 7 .72 (3H, 
s., ArMe), 7.89 (3H, s., ArMe), 8.17 (3H, s., C-Me).
Ozonolysis of O-methylmycophenolic acid p-toluidide (14-4)
O-Methylmycophenolic acid p-toluidide (180 mg.) was ozonised 
in ethyl acetate and the ozonide reduced with sodium borohydride (50 mg.) 
using the procedure described for the ozonolysis of methyl 
O-methylmycophenolate (p. 100).
The products were separated by p.I.e. on H F ^ ^  silica, using 
5% methanol/chloroform as eluant, giving the alcohol (14-1) (30 mg.,
30%), identical (t.l.c., mixed m.pt., i.r.) with an authentic sample, 
and
4—hydroxypentanoic acid p-toluidide (14-5) (25 nig.) 30%) which crystallised 
from chloroform/light petroleum as colourless prisms, m. 114— 115°C.
4-+T.l.c.: 5% methanol/chloroform, Rf„0 4 ; r.-bn. (Ce ).
Analysis: Found C: 69.38%, H: 8.04-%, N: 6.85%,
C12^17^2 reRu;*-res C: 89.54-%, H: 8.27, N: 6.76%.
I.R.Vmax. (CHC1 ) : 34-35, 2960, 1623, 1598, 1510 cm."1.
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"V max. (KBr): 5330 (br.\> ), 3250, 3180, 3120, 2065, 2960,Uxl
2920, 1670 (Vco amide), 1608, 1550, 1511, 1310, 1128, 1 
816 cm. \
NMR. (60 Mc/s.) CDCl^: 1.9 (1H , br., s., exchangeable with
D20/TFA, -C0NH-), 2 .80 (AH, ABA' B* system, J - 3 HZ., ArH) ,
6.15 (1H , m., -CH(OH)-), 6.79 (1H, br., s., exchangeable
with DO), 7.57 (2H, t., J = 6 .5 Hz., -CE^CO-), 7-70 (3H,
s., ArMe), 8 .0-8.A (2H, m., -CH -), 8.80 (3H, d., J =
6.5 Hz., CH_CH(OH)-).—j
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Feeding of labelled sodium acetate to shake flask cultures of 
P. stoloniferum
1 ^4-
[2- c ]  sodium acetate (0.5 mCi., 55 mCi./mM.) and [2-T] sodium 
acetate (25 mCi., 500 mCi./mM.) were dissolved in water (10 ml.) 
and the solution sterilised (15 min. with steam at 2^0°C and 15 p.s.i.).
9 ml. of this solution was added to a shake flask culture of 
P. stoloniferum (2 day old, 2 shake flasks each containing 100 ml. 
of culture filtrate) growing on full strength medium. The cultures 
were harvested on the fifth day of growth.
Determination of total activity of precursor added
0 .05 ml. of the precursor solution (containing 1/200 of the 
total activity) was diluted to 20 ml. with distilled water. 0.1 ml. 
aliquots of this solution were counted in toluene/biosolv. scintillator 
solution. Total activity fed (9/10 of precursor solution)
57.25 x 106 dpm. lZfC; SkA x 10§ dpm.T; T/l*f (dprrO: 1?8/1.
Isolation of P^C, t ] mycophenolic acid
The mycelial tissue was removed by filtration, dried, and 
extracted with ethyl acetate (100 ml.) for 6 hr. in a Soxhlet apparatus.
The culture filtrate (200 ml.) was extracted with ethyl acetate (100 ml.)
at natural pH, acidified with concentrated hydrochloric acid and 
again extracted with ethyl acetate (100 ml.). The combined ethyl 
acetate solutions were extracted with saturated sodium bicarbonate, 
and the crude acidic metabolites (150 mg.) recovered, after 
acidification with concentrated hydrochloric acid, by extraction
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with ethyl acetate. To this, inactive mycophenolic acid (815 mg-) 
was added and reisolated by crystallisation from methanol/water, 
giving chemically pure (t.l.c., mixed m.pt.) mycophenolic acid after 
3 crystallisations (810 mg.). Further crystallisation gave material 
by constant activity (Table 2:2) •
k
Hence the activity of undiluted mycophenolic acid: 3-9 x 10
•1 Ll Ll
dpm C/mg., 217 x 10 dpm T/mg., (T/lA-^ (dpm): 33-8) and
r 1!{. ,
incorporation (based on [2- Cj acetate) 1.05%- 
r 1 if . I
Degredation of l C,TJ mycophenolic acid
r i  if  -i
The following degredations were carried out on [ C,TJ mycophenolic 
acid obtained as above, further diluted with inactive mycophenolic 
acid. Experimental details are described in the previous section.
(a) P^C,t] Mycophenolic acid (220 mg., % dilution 0.39) was 
converted to the p-toluidide (l^ 3c) (230 mg.) which afforded ClVk) on 
methylation. Ozonolysis followed by reduction gave (l^fc) (60 mg.) 
and (1^-38 (63 mg.). The alcohol (#1c) ( 50 mg.) was oxidised to the 
corresponding acid (l^fOc) (^0 mg.)
(b) [14C,T] Mycophenolic acid (200 mg., % dilution 1.325) was
converted to (117) on methylation. (1179 ( 205 mg.) was reduced to
the triol (1289 (l*f0 mg..) with lithium aluminium hydride and the triol 
(128c) (100 mg.) oxidised to the hemiacetal (137) (80 mg.) which was 
oxidised to the acid 039c) (50 mg.).
The above compounds were purified to constant activity by 
successive crystallisation (Table 2:3)•
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Orsellinic acid (38 )
P.I.e. of the acidic fraction of the culture filtrate extract 
of P. stoloniferum shake flask cultures afforded the crude metabolite 
which was purified by crystallisation from ethyl acetate/light 
petroleum giving colourless needles, m. 162-166°C. (lit, 176°C.- 
monohydrate).
T.l.c.: ethyl acetate/benzene/formic acid (33/66/1), Rf* 0.5,
k ,
r. bn., (FeCl_) , bn. (Ce ).
3
I.R.Vmax. (KBr): 3370, ( V QH phenol), 3000 (br.), 1627 (V  CQ) ,
1595 (sh.), 1^ -30, 1358, 1259, 1176 cm.’1.
UV, X max. (EtOH) : 223 ( g = 20,000), 255 (8 = 13,000), 300 ( £ =
1715 ,000) nm.
NMR. (60 Mc/s.) d^ acetone: 2.7-^.0 (3H, br., exchangeable 
with DO), 3.65 (2H, m., ArH), 7.5 (3H, s., ArMe).
MS. m/e (rel. abundance): 152 (M+) (^ f6) , 13^ (100), 108 (60),
106 (77), 93 ( W ,  78 (^0).
EXPERIMENTAL
CHAPTER 2:2
Table 2:1 Composition of culture media (g./l.)
Component
Full strength 
medium
Half strength 
medium
Dextrose monohydrate 
Ammonium nitrate 
Potassium hydrogen phosphate 
Magnesium sulphate (hydrate) 
Yeast extract 
*Minor element concentrate
120
5.0
1.0 
1.0
2 ml.
60 
2.3 
2.5 
0.5 
0.5 
1 ml.
*Minor element concentrate: ferric sulphate (1 g.), zinc sulphate (1 g.), 
potassium molybdate (0 .2 g.), copper sulphate (0.15 g*)» manganese 
sulphate (0.1 g.)/litre.
Fig. 2:1 Production of the farnesyl compound (157) by 
P. stoloniferum in deep culture (half strength medium)
1 2 0 -
mg/l
80-
2 0 -
time - days.
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Growth of P. stoloniferum in deep culture
The strain of Penicillium stoloniferum (P. brevicompactum group) 
used was a mutant developed by Imperial Chemical Industries 
Pharmaceutical Division (I.C.I. culture collection No. A^ t-08) •
Spores of this fungus were used to inoculate 80 1. batches of 
sterile half-strength medium (Table 2:1). The cultures were grown 
at 25°C with constant stirring and aeration in stainless steel deep 
culture vessels.
The concentration of the farnesyl compound (157) with respect 
to growth was estimated as follows. From a continuous culture, 250 ml. 
aliquots were taken at regular intervals (2^ hr.) over a period of 
14 days. Each of the samples was treated as follows. The mycelium 
was removed by filtration, dried and extracted with ethyl acetate 
in a Soxhlet apparatus for 12 hr. The extract was evaporated to 
5 ml., and 25 ml. of this was treated with 0 .5 ml. of (bis-) trirnethyl 
silyl acetamide (B&A) for 20 min. at room temperature. 5 1. of
this were injected into a 2% E 501 GAC column at 250°C and the 
intensity of the resulting peak (RT: 8.5 min.), corresponding to 
the silylated farnesyl compound (157) » compared with that produced 
by 5 pi. of a standard solution.
The variation of concentration with growth is shown graphically 
in Fig. 2:1.
Table 2:11 Separation of the mycelial extract of P. stoloniferum 
by column chromatography on silica gel
Eluant Yield (mg.)
benzene Unidentified mixture 500
5-80% chloroform/ 0-methylfarnesyl compound (159) 300
benzene
80% chloroform/ farnesyl compound (157) 500
benzene- 
chloroform
chloroform methyl mycophenolate 20
ergosterol 50
I
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Extraction of P. stoloniferum mycelium
The mycelium of a 7 day culture was removed by filtration, 
washed with ethyl acetate, dried and extracted with light petroleum 
(60-30°C.) for 12 hr. in a Soxhlet apparatus. Evaporation of the 
solvent gave 9-7 g. of a brown oil. This was chromatographed on 
a column of silica gel (320 g.) (Table 2:11)
The farnesyl compound (132>
P.I.e. of the appropriate column fractions (Table 2:Il) on 
H F ^ ^  silica, using chloroform as eluant, and successive crystallisation 
from methanol and diethyl ether/light petroleum gave colourless 
needles, m. 85-87°C. The melting point was unchanged on sublimation 
(1 A-0°C/0.01 mm.) followed by crystallisation from diethyl ether/ 
light petroleum. The identity of this compound was confirmed by
comparison (t.l.c., mixed m.pt., i.r., n.m.r.) with authentic samples.
L,
T.l.c.: chloroform, Rf. 0.60; bl. (FeCl^), r.-bn. (Ce ).
I.R.Vmax. (CCl^): 2^ +20 ( V 0H). 2920, 1738 ( V CQ phthalide) ,
1635, 1625, lMf9, 1358, 1307, 11V7, 1091, 1060 cm.”1.
NMR. (100 Mc/s.)2"CDC1 • 2.32 (1H, br. s., exchangeable with
D^O) , 3.80 (1H, br. s., exchangeable with f^O) , if. 82 (1H, 
t., J = 7 Hz., =CHCH2Ar), if.8-5.1 (2H, m. , -CH2CH=) , if. 89 
(2H, s., ArCH^O-), 6.58 (2H, d., J = 7 Hz., ArCH2CH=),
7.8-8.1 (8h, m., -CH2CH2-), 8.18 (3H, s., =C(CH )-), 8.36 
(3H, s., =C(Cg5)-), 8.if4 (6H, s ., =C(CH )2).
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The O-methylfarnesyl compound (159}
(a) P.I.e. of the appropriate column fractions (Table 2:11) on
silica, using chloroform as eluant, gave the O-methylfarnesyl
compound (157); as a colourless oil.
T.l.c.: chloroform, Rf. 0.^5; bl. (FeCl^), r.-bn. (Ce ).
MS. gives M+ at 398.2^67, C ^ H ^ O ^  requires 398.2^57*
I.R.Vmax. (CCl^): 3^50 (V 0R) » 2920, 1750 QQ phthalide) ,
1630, 1^55, 1370, 12^-0 cm.”1.
UV.A max. (EtOH): 252 (6*1^800), 360 (£*8000) nm.
NMR. (100 Mc/s.) ^ CDCl *. 2.0-3.0 (1H, br., exchangeable with
5
D20), ^.8^ (2H, s., ArCH20-), ^.75-5.05 (3H, m. , = CHCH2-), 
6.29 (3H, s., MeO-), 6.6k- (2H, d. , J = 7 Hz., ArCH2CH=-) , 
7.90 (3H, s., ArMe), 8.0-8.1 (8H, m. , 8.22 (3H,
s., = C(CH^) *") , 8.36 (3H, s. ,=C(CH^)-) , 8.^5 (6H, s., .
= cX c h3)2)..
MS. m/e (rel. abundance): 398.2^67 (C^H^O^)* (6), 329.1732 
(C2QH250if)+ (5) , 261.112^ (C15H170Zf)+ (39), 207.0636 
(C11H110ivI+ (100), 191.1716 (C1ifH23)+ (33).
(b) The farnesyl compound (157) (65 mg.) in dry acetone (5 ml.) was 
stirred and refluxed with anhydrous potassium carbonate (28 mg.).
A solution of methyl iodide (3^ mg.) in dry acetone (5 ml.) was added 
to the mixture in 0.5 ml. aliquots at 0.5 hr. intervals. After hr. 
the solvent was evaporated and the residue partitioned between ethyl 
acetate (10 ml.) and water (5 ml.). Evaporation of the ethyl acetate 
and p.I.e. of the residue on HF2^  using multiple elution with
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benzene as eluant, gave starting material (5 nig.), the 
0 ,(/ -dimethylfarnesyl compound (l60) (20 mg. , 31%) j identical 
(t.l.c., i.r., n.m.r.) to material isolated in (a) above, and the 
O-methylf arnesyl compound (139) (15 nig., 24%) as colourless oils.
The 0 ,07 -dimethylfarnesyl compound (l60)
Prepared as described in (a) above, as a colourless oil, 
b.pt. 175°C/0.05 mm.
L,
T.l.c.: chloroform, Rf. 0.50; r.-pur. (Ce ).
MS. gives M+ at 412.2610, C2gH gO^ requires 412.2613*
I.R.Vmax. (film): 2920, 1760 ( V CQ phthalide) , 1603, 1478,
1315, 1130, 1045, 979 cm.’1.
NMR. (60 Mc/s.)TcDCl •. 4.75-5.15 (3H, m., = CHCH -), 4.91 (2H,5 —  2
s., ArCH 0-), 5.95 (3H, s., MeO-), 6.22 (3H, s., MeO-),
6.60 (2H, d., J = 6.5 Hz., ArCH2CH=), 7.81 (3H, s., ArMe),
7.9-8.15 (8H, m., -CH2CH2-), 8.22 (3H, s., = C(CH )-),
8.34 (3H, s., = C (CH-,) -), 8.42 (6H, s ., = C(CH,).).— 5 — 5 2
MS. m/e (rel. abundance): 412.2610 (C^gH g0^)+ (8), 3^3*1959 
(C21H2 olt)+ (2), 275.1288 (C1gHigOit)+ (86) 221.0814
(C12H 0if)+ (100), 191.1807 (C^H ) + (13).
Demethylation of the 0 ,Q/ -dimethylfarnesyl compound (160) with 
lfmagnesium iodide etherate"
The 0 ,0y -dimethylfarnesyl compound (160) (15 nig.) in dry refluxing 
benzene (10 ml.) was treated, under nitrogen, with freshly prepared 
"magnesium iodide etherate" reagent (70 p.l.)„ The solution was
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stirred, and refluxed for 3 hr,, cooled, washed with 5N hydrochloric 
acid (10 ml.), water (5 ml.) added and the solution extracted with 
chloroform (10 ml.). Evaporation of the solvents and p.I.e. of the 
residue on silica, using '\2% ethyl acetate/light petroleum as
eluant, gave a mixture of compounds apparently homogeneous by t.l.c.
Ll .
T.l.c.: chloroform; Rf. 0.A5: bl. (FeCl^), r.-bn. (Ce ). 
I.R.Vmax. (CCl^): 3^50 ( V QH), 2920, 1750 ( V co phthalide), 
1630, 1^56, 1775, 12^0 cm.“1.
NMR. (100 Mc/s.)ZfCDC1_): 2.35 (1H, br., s., exchangeable withj
d2°, ArOH), A.95 (2H, s., ArCH^O-), 6.30 (3H, 3s., MeO-),
7.2-7.6 (2H, m.), 7-9^ (3H, s., ArMe) ,’ 7.7-8.9 O^H, m.),
9.05 (12H, m., A-CHj.
Methyl mycophenolate
(a) Mycophenolic acid (80 mg.) in 3% methanolic hydrogen chloride 
(10 ml.) was left at room temperature for 3 hays, the solvent 
evaporated and the residue crystallised from chloroform/light 
petroleum as colourless prisms, m. 102—10if°C.
li,
T.l.c.r chloroform, Rf. 0 .6 6; bl. (FeCl^), bn. (Ce ).
Analysis: Found C: 6^.19%* H: 6.35%»
C18H22°6 reHuires C: 6^.66c/°i H: 6 .63%.
I.R.Vmax. (nujol): 3^75, 1720, 1620, 1170, 1075 cm.-1.
UV.X max. (EtOH): 220 (£=36000), 250 (6=10000), 300 (6=^600) nm. 
NMR. (60 Mc/s. )t CDCl^: 2.32 (1H, s., exchangeable with D20) ,
A-.78 (1H, t., J = 7 Hz., = CHCH2-), k.S'i (2H, s., ArCH^O’-) , 
6.21 (3H, s., MeO-), 6.38 (3H, s., MeOCO-),.6.63 (2H, d.,
7.85 (3Hf s., ArMe), 8.20 (3H, s., C-Me.).
(b) P.I.e. of the appropriate column fractions (Table 2:11 ) on 
HF^c^ silica, using chloroform as eluant, afforded methyl 
mycophenolate ( ) which was identified by comparison (t.l.c.,
mixed m.pt., i.r.) with material from (a).
Ergosterol
P.I.e. of the appropriate column fractions (Table 2:11) on 
HF25Zf silica, using chloroform as eluant, and crystallisation from 
ethanol, gave ergosterol as colourless needles, m. 160-16A-°C, 
identical (t.l.c., mixed m.pt., u.v.) with an authentic sample.
O-Desmethylmycophenolic acid (1t>1)
Mycophenolic acid (29 mg.) in collidine (2 ml.) was added to 
a stirred solution of lithium iodide (dried at J>00°C. under nitrogen 
for 1 hr.) (200 mg.) in re fluxing collidine (6 ml.). The solution 
was stirred and refluxed for 7*5 hr., allowed to cool and dilute 
hydrochloric acid (10 ml.) added. Extraction with ethyl acetate, 
evaporation of the solvent and p.I.e. of the residue on ^ 251+ silica, 
using benzene/ethyl acetate/formic acid as eluant, afforded starting 
material (10 rag.) and 0-desmethylmycophenolic acid (161) (5 mg., 28%) 
v/hich crystallised from acetone/light petroleum.as colourless prisms, 
m. 1^7-1^9°C., identical (t.l.c., mixed m.pt., i.r.) with an authentic 
sample.
Table 2:IIA Retention times (R^) of P. stoloniferum metabolite
TMS derivatives
R^ (min.)'
Metabolite 2% E301 V6  XE60
mycophenolic acid 3*2 ^ -5
O-methylfarnesyl compound (139) 6 .8 10.5
farnesyl compound (157) 8 .5 11.2
ergosterol 8 .6 11.5
O-desmethylmycophenolic acid ( 161) 2.0
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Growth of P. stoloniferum in shake flask cultures
250 ml. shake flasks containing 100 ml. of sterile medium were 
inoculated with spores of P. stoloniferum. The flasks were shaken 
continuously on a Gallenkamp rotary shaker (200 rev./min.) at 25°C 
under continuous illumination from fluorescent tubes.
The variation in metabolite concentration with growth for different 
medium strengths was determined as follows:
Two series of shake flasks containing full strength and half 
strength media respectively (Table 2:1 ) were inoculated and grown 
as described above. At regular intervals (2k hr.) two flasks of 
each series were removed and extracted in identical fashion.
The mycelium was removed by filtration, dried and extracted 
with ethyl acetate (25 ml.) in a Soxhlet apparatus for 12 hr. The 
culture filtrate was extracted with ethyl acetate (25 ml.), acidified 
with concentrated hydrochloric acid to pH 2, and again extracted 
with ethyl acetate (.25 ml.). The extracts were combined, dried and 
reduced to 5 ml., and 2.5 ml. of this solution was silylated with
0.5 ml. of BSA for 20 min. at room temperature. 5 1* of this were
injected into a 2% E301 GLC column at 250°C. and the intensity of 
the resulting peaks corresponding to the silylated metabolites, 
compared with those produced by standard solutions (Table 2A).
This procedure was repeated on a "]% E60 GLC column at 2^fO°C.
The variations of metabolite concentrations with growth are 
shown in Fig.>2:3.
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FEEDING OF LABELLED PRECURSORS TO SHAKE FLASK CULTURES
OF P. STOLONIFERUM
General
In the following experiments solutions of the appropriate 
precursors were sterilized by passage through a sterile Sykes’ 
filter, added to shake flask cultures between the second and third 
day of growth and the cultures harvested between the fourth and 
seventh day.
The mycelium was removed by filtration, dried and extracted 
with ethyl acetate in a Soxhlet apparatus for 2k hr. The culture 
filtrate was extracted with ethyl acetate at natural pH, acidified 
to pH 2 with concentrated hydrochloric acid, and again extracted with 
ethyl acetate. The combined extracts were separated into acidic and 
neutral fractions as described earlier.
The farnesyl compound (157) » its O-methyl ether {159) and ergosterol 
were isolated by p.I.e. of the mycelial and culture filtrate neutral 
extracts. Mycophenolic acid was isolated from the culture filtrate 
acidic fraction.
Total activities of aqueous precursor solutions were determined 
by counting diluted aliquots in toluene/biosolv. scintillator
■z
solution. The purity of sufficiently radioactive compounds (^  10 dpm/ 
mg.) was determined by TLC radioscan, prior to determination of 
activity by dilution with inactive material and crystallisation to 
constant activity.
Compound
Mycophenolic
acid
Ergosterol
Unidentified • 
metabolite
Table 2:131 Feeding of DL-[lZfC,T]
dilution ... /o/0 Wt./mg. Iif
7.95
5.4
100
dpm.
C T
dpm./mg.
14,
1.06 (x1) 34976 743560 33050 702500 4 .16
0.72 (x2) 23892 534381 33200 7^3500 4.17 i
0.74 (X3) 2^39 550213 32950 7^2500 4.15 :j
0.17 (x1) 2033 38687 11970 227900 2.22 I
0.20 (x2) 2420 45602 12100 228000 2.24
to half strength cultures of P. stolonifernrn
T/ ^ Estimated
C ratio total wt. from 
dpm. atomic culture (mg.)
total activity 
dpm.
14_
C T
0.5 9725 220110 19450 440220 194? 20 226 1 .15 1 x 105 2 .2 x 106
Incorporation
%
105 i - s #  x 106 2 1 .0 1.05
1#^ 3^  X
.' 4E? • '
106
r
22 .4 1 .12 64 2 .6 6  x 107 5 .9 8  x 10^ 2 3 .6
10pJf
i: .VI:
10 22 .4 1 .12
1i
10* 4.21  x 106 . 19 0 .9 6
j
^©^4 . 2J |x
■ .*3
106 1 8 .9 0.95
10 1 .3  x 10^ 24 .6  x 107 1 .26
0.078
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Feeding of labelled DL-methionine to P. stoloniferum 
I Using half strength medium
r 1 Zf. -i
11.7 ml. of a solution, of DL-1 CH-, J methionine (50 Ci^j
60 mCi./mM) and DL~{ CT_ ]-methionine (1.0 mCi.; 100 mCi/mM) in waterj
(12 ml.), were added to 2 shake flask cultures (200 rnl. of medium)
on the third day of growth. The cultures were harvested on the fifth
day. (Total fed activity: 1.129 x 10^ dpm^C, 22.^- x 10^ dpmT;
T/14C (dpm): 19.8)
L C,t] Mycophenolic acid (65 mg.) was isolated by crystallisation
r1 b i
of the residue of the culture filtrate acidic fraction. [ C,TJ 
Ergosterol (6 mg.) was isolated by p.I.e. of the mycelial extract 
and subsequent crystallisation (Table 2:III).
P.I.e. of the mycelial extract oh GF25^ silica, using chloroform 
as eluant, gave an unidentified sterol ester (5 mg.) as a colourless 
oil.
T.l.c.: chloroform, Rf. 0.90; bk. (chromic acid), bk. (Ce ).
GLC.: 2% E501 (250°), R.T.: 1.2 min.
I.R.Vmax. (CCl^): 2920, 17^0, 1365, 12*f0, 10'+5, 6^ -5 cm."1.
«
UV.A max. (MeOH): 210, 1.75nm .
II Using full strength medium
r 1 Ll  -
12.5 ml. of a solution, of DL-[ CH^j-methionine (10 Ci;
60 mCzL/mM) in^ water (13 ml.), were added to one shake flask culture
(100 ml. of medium) on the third day of grov/th. The culture was
7 1 k-
harvested on the fifth day. (Total fed activity 2.06 x 10 dpm. C.)
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r1 k 1
[ CJ Mycophenolic acid (20 mg.) was isolated by p.I.e. of the 
culture filtrate acidic fraction and subsequent crystallisation.
M  Zf 1 j.'] Zj. ,
The L C J farnesyl compound Cl57) (12.6 mg.) and the [ CJ 
O-methylfarnesyl compound ( 2 mg.) were isolated by p.I.e. of the
mycelial and culture filtrate neutral extracts and purified by 
crystallisation and p.I.e. respectively (Table 2:IE).
-j
Feeding of [ CJ farnesyl compound (157) to cultures of P. stoloniferum
grown on full strength medium
A solution of [^c] farnesyl compound (157) (10.60 mg., 6 .6 x 10^
dpm) in acetone (0 .5 ml.) was added to one shake flask culture (50 ml.
of medium) on the second day of growth. The culture stopped growing
between the second and third day, and was harvested on the latter.
Inactive mycophenolic acid (3-5 mg.) was added to the culture and
reisolated as described above (Table 2:IV).
r1 1The remaining [ CJ farnesyl compound was isolated by p.I.e. 
of the appropriate extracts, dissolved in acetone (0.1 ml.) and added 
to one shake flask culture (50 ml. of medium) on the third day of 
growth and the culture harvested on the seventh day. [^cj Mycophenolic 
acid (20 mg.) was isolated by crystallisation of the culture filtrate 
acidic fraction. To the remainder of this fraction inactive 
O-desmethylmycophenolic acid (161) (30 mg.) was added and reisolated 
by p.I.e. on silica, using benzene/ethyl acetate/formic acid
(66/33/1) as eluant, and crystallisation from acetone/light petroleum. 
Inactive farnesyl compound (157) (9*8 mg.) was added to the mycelial 
and culture filtrate neutral extracts and reisolated by p.I.e. and
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subsequent crystallisation (Table 2: V ,)• ^he mycelial tissue was 
finally extracted with ethyl acetate for 3 days in a Soxhlet apparatus. 
The resulting material (10 mg.) was found to have an activity of 
2650 dpm/mg.
r1k 1
L C,Tj Q-Desmethylmycophenolic acid (161)
r 1 Zf i 5 '\L
[ C,TJ Mycophenolic acid (29 mg., 4.95 x 10 dpm/mg. C;
8.50 x 10^ dpm/mg. T) isolated from P. stoloniferum fed with ^CT^,----------------  5
methionine (p. 117) was demethylated by the procedure outlined previously
14(p. if) giving C,T O-desmethylmycophenolic acid (161) (5 mg., 18%) 
identical (t.l.c., mixed ra.pt., GLC (TMS derivative)) to an authentic 
sample. The specific activity was determined by dilution (Table 2:VI).
Feeding of P^C, t] 0-d esmethylrnycophenolic acid to cultures of
P. stoloniferum grown on full strength medium.
r 1 4  i
A solution of [ C,TJ O-desmethylmycophenolic acid (3-80 mg.)
in 3N sodium hydroxide (0 .5 ml.) was diluted with distilled water
and neutralised with 3N hydrochloric acid (Total volume 7.0 ml.).
Aliquots of the sterilised solution were added to a shake flask
culture (100 ml. of medium) at the following times: 30 hr. (3 ml.),
43 hr. (2 ml.), 51 hr. (1.8 ml.). The culture was harvested after
100 hr. (Total fed activity 7.45 x 10^ dpm , 14.2 x 10^ dpm T,
14
T/ C (dpm):. 19/1)..
[^C,t] Mycophenolic acid (11 mg.) was isolated from the culture 
filtrate acidic fraction by p.I.e. on GF^,_^ silica, using benzene/ 
ethyl acetate/formic acid (66/33/1) as eluant, and subsequent
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crystallisation (Table 2:VII),
[ methyl-^C 3 O-Me thylf arnesyl compound (159!)
r -I Zf i
L Cj Methyl iodide (0.2^ mg,, 100 Ci.) was diluted with inactive 
methyl iodide (3^ mg.) in dry acetone (5 ml,), 1 ml, aliquots of
this solution were added at 30 min. intervals to a stirred refluxing 
solution of the farnesyl compound 057) (63 mg.) and anhydrous potassium 
carbonate (31 mg.) in dry acetone (10 ml.). A dry ice condenser was 
used to prevent loss of the methyl iodide. The reflux was continued 
for 1-gr hr. after all the methyl iodide solution had been added. The 
solvent was evaporated and the residue partitioned between water (1 ml.) 
and chloroform (5 ml.). Evaporation of the chloroform fraction and 
p.I.e. of the residue on IiF^^ silica, using chloroform as eluant,
f 11f- 1
gave starting material (23 mg.) and [methyl- CJ 0-methylfarnesyl 
compound (157) (22 mg., 53%) identical (t.l.c., u.v . , n.ra.r.) with 
an authentic sample. The specific activity was established by dilution 
(Table 2:IIX).
r  ^ 1Feeding of [methyl- CJ 0-methylfarnesyl compound (157) to cultures 
of P. stoloniferum
I Using half strength medium
[methyl-^c] 0-Methylfarnesyl compound (3-1& mg., 4.80 x 10^ dpm) 
in acetone (0.1 ml.) was added to one shake flask culture (100 ml. 
of medium) on the second day of growth. The culture was harvested 
on the fifth day.
1 ij. _
[ Cj Mycophenolic acid was isolated by crystallisation from
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the residue of the culture filtrate acidic fraction (Table 2:IX).
II Using full strength medium
[methyl-^c] O-Methylfarnesyl compound (2.70 mg., k.0J> x 10^ dpm)
in acetone (0.1 ml.) was added to one shake flask culture (100 ml.
of medium on the second day of grov/th. The culture was harvested
on the fifth day. 
r 1 ^  l[ CJ Mycophenolic acid was isolated by p.I.e. of the residue
from the culture filtrate acidic fraction on silica, using
benzene/ethyl acetate/formic acid (66/33/1) as eluant, and subsequent 
crystallisation (Table 2 :X).
r 1 ^ + iFeeding of [2- Cj mevalonic acid lactone to cultures of P. stoloniferum 
grown on full strength medium
9.5 ml. of a solution of [2-^ c^] mevalonic acid lactone (50 Ci.) 
in distilled water (10 ml.) was added to one shake flask culture 
(100 ml. of medium) on the second day of growth. The culture was 
harvested on the fourth day.
The mycelial tissue was removed by filtration and the culture 
filtrate concentrated to 50 ml. in. vacuo on a rotary film evaporator.
The filtrate was passed through an Amberlite IR-120 (Na+) column,
the pH adjusted to 7 and extracted with ethyl acetate (50 ml.).
The aqueous layer was acidified to pH 2 with dilute hydrochloric
acid and subjected to. constant extraction with ether overnight.
The ether extract was evaporated to dryness and the residue p.l.c'd 
on HF2^  silica, using pyridine/light petroleum (60-80°) as eluant.
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The band corresponding in Rf. to laevulinic acid was removed and 
extracted with water (5 ml.). The pH of the aqueous extract was 
adjusted to 8 with dilute sodium hydroxide, 5N hydrochloric acid (2 
drops) and p-bromophenacyl bromide (500 mg.) in ethanol (5 ml.) were 
added and the solution refluxed for 2 hr. The cooled mixture was 
extracted with chloroform (20 ml.) and to the extract p-bromophenacyl 
laevulinate (38 mg.) was added. Evaporation of the solvent and p.I.e. 
of the residue on silica, using chloroform as eluant, gave
r'] 4 ,
[ CJ p-bromophenacyl laevulinate (25 mg.). Successive crystallisation
from diethyl ether/light petroleum gave material of very low constant
1
activity. Total activity (for 38 mg.) = 65 dpm C. .
EXPERIMENTAL
CHAPTER 3
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(three)-) 6 2-Bromo-2 (methyl-5-oxotetrahydro-2-furyl) ethyl -5-me thoxy-
^--methylphthalan-1-one (1 71)
To mycophenolic acid (220 mg.) in chloroform (12 ml.) a solution
of bromine in chloroform was added until the colour persisted. The
mixture was extracted with aqueous sodium metabisulphite, saturated
aqueous sodium bicarbonate and brine. Evaporation of the solvent
afforded the bromolactone (171) (200 mg., 73%) which crystallised
from chloroform/light petroleum as colourless prisms, m. 180-182°C.
L.
T.l.c.: chloroform, Rf. 0.58; bl. (FeCl^), gn. (Ce ).
Analysis: Found C: 50.95%^ H: ^f.72%,
C17H1906 Br requires Cl 51.20%, H: ^.76%.
I.R.Vmax. (CHC1 ) : 3^18 ( V QH), 29^0, 1736 ( VQQ phthalide) ,
17^6 (V pn lactone), 1630 cm. ^. 
ou
V  max. (KBr): 3;+25 ( V QH) , 2970, 1763 (v co Phthalide),
1722 (V__ lactone), 1618, 1138, 1068, 62*f, 609 cra.“1. 
ou
NMR. (60 Mc/s.) CDCl^: 2.15 (1H, s., exchangeable with D^O),
.^7>+ (2H, s., ArCH 0-), 5-^1 (1H, t., J = 8 Hz., -CHBr-)',
6.18 (3H, s., MeO-), 6.68 (2H, d., J = 8 Hz., ArCH^CHBr-} ,
7.2-7.8 (JfH, m., -CH2CH2-), 7.83 (3H, s., ArMe) , 8.33 (3H, 
s., C-Me)'.
O yt O *4
MS. m/e (rel. abundance): ^00 (M , Br) (2 .6), 399 ( Br) (5.2), 
382 ( Br) (2.5), 319 (31), 318 (33), 301 (26), 220 (99), 
219’(99). 207 (W , 205 (38), 109.5 (1.7), 99 (99), ^  (100).
12 +^
(erythro-) *+-Methoxy-5-me th,yl-2(2-me thyl-5-oxote trahydro-2-furyl) -2 ,3-
dihydrobenzo 2 ,1 -6 : 3-k-C -8(6H)-one (185)
To the bromolactone (171) (100 mg.) in methanol, 3N aqueous sodium
hydroxide was added to pH 11. The solution was immediately neutralised
with dilute hydrochloric acid and extracted with chloroform (10 ml.)
Evaporation of the solvent gave the dihydrobenzofuran lactone Cl8j)
(35 mg*» 60%) which crystallised from chloroform/light petroleum as
colourless needles, m. 201-202°C. (lit. 201-202°C.), identical (t.l.c.,
mixed m.pt., i.r., n.m.r.) with an authentic sample.
l±.
T.l.c.:. chloroform, Rf. O.5 6; bn. (Ce ).
GLC: 0V1? (255°C.), RT. 8 .5 min.
I.R.V max. (CHC1 ): 3006, 2935, 1763 (V CQ phthalide), 1751
_  -1
(shoulder, V  CQ y-lactone) , 1637, 1613 cm. .
UV.Amax. (EtOH): 252 (£=5900), 305 (£=3650) nm.
NMR. (100 Mc/s.) FCDC1,:. *+.90 (2H, s., (ArCHo0 -) , 5-02 (1H,
5 £
q., JAV + J„v = 8.5 Hz., irr. 6.62 s., CH(0)CHo-),
Aa .da   c.
6.06 (3H, s., Me 0-) , 6.62 (2H, octet, — 3 Hz., =
3.5 Hz., J . -q = 8 Hz., irr. 5-02 s., -CH.CHCO)-) ,
Ad  d
7.2-9.7 (*+H, m., -CH2CH2->, 7.96 (3H, s., ArMe) , 8.58  
(3H, s., C-Me).
MS. m/e (rel. abundance): 318 (M+) (13-5), 317 (65), 220 (98),
219 (98), 205 (63), 175 (*+2), 99 (100).
N,N-Di methyl my co phenol amide (185)
Mycophenolic acid (^50 mg.) was converted to the dimethylarnide 
(185) (375 mg., 77%) using a procedure similar to that used in the
125
preparation of mycophenolic acid p-toluidide (1^ 3) (p. 102). The 
dimethylamide (185) crystallised from benzene/light petroleum as 
colourless needles, m. 86°C.
A .
T.l.c.: chloroform, Rf. 0.50; bl. (FeCl^), bn. (Ce ).
Analysis: Found C: 65.38%, H: 7.12%, N: 3-93%,
C _H._p.N0j_ requires C: 65.60%, H: 7.20%, N: k.0k%.
I 5 2b b
I.R.Vmax. (CHCl^) : 3^50 (V QH) , 1733 (br. , V CQ V lactone , phthalide) 
1632 cm. 1 .
Vmax. (KBr): 3^20-3000 (br.V^), 1753, 1620, 1597 cm.”1.
(J r l
UV. X  max. (CHG1,) : 250 5050), 305 (£• 38OO) nm.
3
NMR. (60 Mc/s.) ^ CDCl^: 2.85 (1H, br. s., exchangeable with Do0) ,
5 ^
*f.7^  (1H, t., J = H Hz., = CHCH2-), A.80 (2H, s., ArCHgO-) ,
6.20 (3H, s., MeO-), 6.60 (2H, d., J = Hz., ArCH2CH=),
7.0 (3H, s., N.Me), 7.1 (3H, s., N.Me) , 7.63 (^H, s.,
-CH2CH2-), 7.82 (3H, s., ArMe), 8.18 (3H, s., C-Me).
MS. m/e (rel. abundance): 3^8 (M+) (13), 3z»-7 (M+) (57), 261 
(3^.5), 207 (3^.5), 173.5 (M2+) (2.8), 159 (3^.5). 1^0 
(63), 87 (100), 72 (97).
N,N-Diethylmycophenolamide Q90) was prepared by a similar procedure. 
Crystallisation from benzene/light petroleum gave colourless needles, 
m. 9^.5-96°C.
T.l.c.: chloroform, Rf. 0.52; bl. (FeCl^), bn. (Ce^+).
Analysis: Found C: 67.20%, H: 7.80%, N: 3-0%,
C HooN0c requires C: 67.24%, H: 7.74%, N: 3-7%21 25 5
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I.R. V  max. (CCl^): 3^ +50 (V QH) » 1750 (br.,V  CQ y-lactone ,
phthalide) , 1650, iMfO, 1^0 7, 1^20 cm.-1.
UV. Xmax (CHCl^) : 250 (£=5000), 505 (£*3800) nm.
NMR. (60 Mc/s.) *£* CDC1_: ^.75 (1H, br. s., exchangeable with
5
D20), f^.75 (1H, m., = CHCH2-), ^.80 (211, s., ArCH^O-) ,
6.20 (3H, s., MeO-), 6.5-6.9 (6H, m., -N(CH2CH ) 2 
ArCH2CH=), 7.7 (^H, s., -C^CH^-) , 7-90 (3H, s., ArMe),
8.20 (3H, s., C-Me), 8.9 (6h, 2t. superimposed, -N(CH2CH^)2). 
MS. m/e (rel. abundance): 376 (M+1) (2), 375 (M+) (10), 207
(19.5), 187.5 (M2+) (2.3), 168 (37), 159 (2*0, 155 (11..*0,
115 (100), 100 (97).
(threo- ) 6 2-Bromo-2(methyl-5-dimethylirnmonium-tetrahydro-2-furyl) 
ethyl -7-hydroxy-5-methoxy-*t— methylphthalon-1-one bromide (186)
N,N dimethylmycophenolamide (160 mg.) in chloroform (20 ml.) 
at 0°C, was treated with a solution of bromine in chloroform until 
the colour persisted. After evaporation of the excess bromine and 
the solvent, crystallisation from chloroform/ethyl acetate afforded 
the immonium salt (186) (238 mg., 9Wo) as colourless prisms, 
m. 129-13^°C.
T.l.c.: 10% rnethanol/chloroform, Rf. 0.05; bl. (FeCl^), bn.
(Ce^+).
I .R. V  max. (CHCl^ ):.. 3^30 (V  QH phenol} 29^0, 17^0 ( V co phthalide), 
1700 , -. 16^ 50., 1-0QO • 1 .
Vmax. (KBr): 3^15, 29^0 , 1730, 1703, 1623, 5 80, 5*K)
. ( V q ~ Br) ^  1 •
NMR. (60 Mc/s.) 2TCDC1 : k.8k (2H, s., ArCf^O-) , 5.20 (1H, t.,
-CHBr-), 6.11 (3H, s., MeO-), 6.*f5 (3H, s., = ), 6.66
(3H, s., = ftCH ), 6.86 (2H, d., J = 7 Hz., ArCH„CHBr-), eL
6 .0-6.5 (2H, m.), 7-3 (2H, m.), 7.83 (3H, s., ArMe), 8.02 
(3H, s., C-Me).
MS. m/e (rel. abundance): 3^7 (M-Br) (15), 3^6 (M-HBr) (l*t),
3^5 (28), 273 (2*0, 259 (37), 2^5 (98), 207 (23), 159 (23),
1*K) (39), 138 (zf2), 87 (99), 72 (100).
Hydrolysis of the immonium bromide (186)
The immonium salt (186) (30 mg.) in benzene (5 ml.) was stirred 
with 2 drops of water for 2 hr. at room temperature. Evaporation 
of the solvent afforded the(threo-)bromolactone (171) (25 mg., 90%) 
which crystallised from chloroform/light petroleum as colourless needles,
m. l80-l82°Cn identical (t.l.c., mixed m.pt.,i.r.) to an authentic
sample.
(threo-) 7-hydroxy- 6 2-hydro xy-2(2-rne thyl-5-oxote trah,ydro-2-fur.yl) 
ethyl -5-methox.y-4-methylphthalan-l-one (106)
(a) From mycophenolic acid
m-Chloroperbenzoic acid (150 mg.) in chloroform (10 ml.) was 
added to a solution of mycophenolic acid (150 mg.) in chloroform 
and the solution left overnight at room temperature. Extraction 
with saturated aqueous sodium carbonate (10 ml.) and evaporation 
of the solvent afforded the crude hydroxylactone (70 mg.).
Crystallisation from aqueous acetic acid gave pure (threo-)hydroxy- 
lactone (106) (50 mg., 32%) as colourless needles, m. 215-218°C.,
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identical (t.l.c., mixed m.pt., i.r.) with an authentic sample.
(b) From ethyl mycophenolate (168)
m-Chloroperbenzoic acid (50 mg.) in chloroform (5 ml.) was added
to a solution of ethyl mycophenolate (168) (50 mg.) in chloroform
(5 ml.) and the solution left for 5 days at room temperature. 
Extraction with saturated aqueous sodium carbonate (5 ml.), 
evaporation of the solvent and p.I.e. of the residue on H F ^ ^  silica, 
using 10% methanol/chloroform as eluant, gave the (threo~)hydroxy~ 
lactone (106) (10 mg., 20%), identical (t.l.c., mixed m.pt., i.r.) 
with an authentic sample, and the (erythro-)dihydrobenzofuran (185)
(5 mg., 11%), identical (t.l.c., mixed m.pt., i.r.) with an authentic 
sample•
(c) From N ,N-diethylmycophenolamide (190)
m-Chloroperbenzoic acid (50 mg.) in chloroform (5 ml.) was added
to a solution of the amide (190) (50 mg.) in chloroform (5 ml.) and
the solution left at room temperature overnight. Extraction with 
saturated aqueous sodium carbonate (10 ml.) followed by evaporation 
of the solvent afforded the (threo-)hydroxylactone (106) (kO mg., 90%) 
which crystallised from chloroform/light petroleum as colourless 
needles, m. 216-218°C., identical (t.l.c., mixed m.pt., i.r.) to 
an authentic sample.
(threo-)Dihydrobenzofuran (182)
The following data were obtained from a sample gifted by Dr.
D. Jones (I.C.I. Pharmaceuticals), m. 252-253°0.
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Ll .
T.l.c.: chloroform, Rf. 0.57; bn. (Ce ).
GLC: 0V17 column (255°C.) RT: 6.5 min.
I.R.Vmax (nujol ): 17b0 (Vqq pbthalide, ^ -lactone) , 1650,
1608, 1160, 991 , 950, 78^ cm."'1.
NMR. (100 Mc/s.)?TCDCl : >+.97 (2H, s., ArCHo0-) , 5.16 (1H, q. ,5 — 2
JAX + JBX = 9 Hz'’ -£H(°)CH2-), 6,12 (3H> 6'6Zf
(2H, br. d., ArCH2CH(0)-) , 7.0-8.0 (*fH, m. , -CH Ctt -) ,
8.03 (3H, s., ArCK^), 8.56 (3H, s., C-Me).
Methyl O-methylmycophenolate epoxide (191)
Methyl O-methylmycophenolate (117) (100 mg.) in chloroform (10 ml.)
was added to a solution of m-chloroperbenzoic acid (100 mg.) in
chloroform (5 ml.) and the solution left overnight at room temperature.
Extraction with saturated aqueous sodium bicarbonate (10 ml.),
evaporation of the solvent and p.I.e. of the residue on silica,
using chloroform as eluant, gave starting material (10 mg.) and the
more polar epoxide (191) (75 mg., 80%), as a colourless oil.
L,
T.l.c.: chloroform, Rf. 0.72; y.-bn. (Ce ).
I.R.Vmax. (CCl^): 2990, 29^ -0, 2870, 1768 ( V CQ phthalide),
17^1 ( V co ester), 1355, 1128 cm."1.
NMR. (60 Mc/sO'fc'CDCl : ^ .8 6 (2H, s., ArCH20-) , 5-90 (3H, s.,
MeO-), 6.19 (3H, s., MeO-), 6.38 (3H, s., MeO.CO), 7-06 
(3H, br. s., ArCH CH-), 7.^-7.8 (2H, m.), 7.81 (3H, s.,
ArMe), 7.9-8.3 (2H, m.), 8.59 (3H, s., C-Me).
MS. m/e (rel. abundance): 3^ (M+) (8), 333 (25), 235 (100),
221 (*f8), 1^3 (23), 115 (28), 99 (28).
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(threo- ) 6 2-Hydroxy-2 (2~methyl-5~oxotetrahydro-2-furyl)ethyl -3,7- 
dime thoxy-A— methylphthalan-1 -one (192)
A solution of the epoxide (191) (^5 mg.) in trifluoroacetic acid 
(5 ml.) was left at room temperature for 2 hr. Evaporation of the 
acid afforded the dimethoxy-hydroxylactone Cl92) (42 mg. , 95%) which 
crystallised from chloroform/light petroleum as colourless needles, 
m. 158-159°C. (mixed m.pt. with the (erythro-)dimethoxy-hydroxylactone 
(105) - 130-135°C.)
T.l.c.: chloroform, Rf. 0.53; bn. (Ce^+).
Analysis: Found C: 61.68%, H: 6.01,
^18^22^7 recLu^res C: 61.71%, H: 6.33%*
I.R.Vmax. (CHC1 ): 3500 (br.V0R), 2940, 1764 ( V CQ phthalide, y-
-1
lactone), 1604 cm.
V  max. (KBr): 3450 (br.), 2950, 1760, 1597, 1475, 1355,
1300, 1201, 1124 cm.”1.
NMR. (60 Mc/s.) 7? CDCl-: 4.95 (2H, s., ArCH„0-) , 5.98 (3H, s.,
5 ^
MeO-), 6.22 (3H, s., MeO-), 6.2 (1H, obs., -CH(OH)-), 7.2 
(1H, s., exchangeable with D^O), 7.1-8.2 (6H, m.), 7.84 
(3H, s., ArMe), 8.54 (3H, s., C-Me).
EXPERIMENTAL
CHAPTER 4
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General
Paper chromatography was carried out on Whatman's No. 1 grade 
paper using n-butanol/acetic acid/water (12/3/5) as eluant. The 
chromatograms were developed with either ninhydrin (0 .5% indane-trione 
in n-butanol) or isatin (0 .2% w/v in acetone).
Amino acid analyses were carried out on a Beckmann Unichrom 
autoanalyser, using a 69 x 0.9 cm. column, resin type PA-28, and 
eluting with 0.20 N citrate buffer at 50 ml./hr.
Brevigellin
This compound was isolated from the neutral extracts of the 
culture filtrate of P. brevicompacturn as described earlier (p. 72 ). 
Purification by p.I.e. afforded the metabolite as a colourless glass, 
m. 209-212°C•
T.l.c.: 10% methanol/chloroform, Rf. 0.6, y. (i^); l.bn., blue 
fluorescence at 35^ nm. (Ce^+).
Analysist Found C: 59-8%, H: 6 .8%, N: 10.2%
C ^ H ^ N  0?.ljH20 requires C: 59-7%, H: 7.05%, N: 11.2%.
MS. gives M+ at 595-30132, C H ^ N  0 requires 595-30058.
I.R.Vmax. (CHC1 ): 3^00, 2295, 2920, 2845, 1758 (£= 236,j L/U
ester), 1658 (g= 836, amide I), 1600, 1500 cm. 10 
V max. (KBr. ) 3^2 2, 3295 (br.,VNH); 3016 (VNH), 29^3,
2870, 1758 ( y cQ ester), 1660, 163A (amide I), 1519 (amide II),
1A90, 1265, 1240, 1175, 755, 720 cm."1.
\
UV.A max. (EtOH): 230 (s = 10000) nm.'
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NMR. (100 Mc/s.)t'CDCl : 2.2 (3H, m. , 0-H of Ar.CO-, =CH-N.C0-),
2.5 (3H, m.; m-, £- H of Ar.CO-), 2 .86 (1H, d., J = 9 Hz.,
irr. *f.91~*s., -C0.NH.CH-) , k.6k (1H, q. , J = 6 Hz., irr.
8.71-* s., -CH-CH,), ^.91 (1H , d., J = 9 Hz., irr. 2.86-*s.,
—  5
-CH-NH), 5.3-6.0 (5H, br., m. , -C0.CHN-, -NH.C0-), 6.31 (*+H,
br., ra. , irr. 8.25"* sharpens, -CH^-N) , 8.25 (1^ +H, br., m. ,
irr. 6.31-> sharpens, -CH^-), 8.71 (9H, m., irr. k.6 V* sharpens,
irr. 5 . 5 ^  sharpens , C-CH ) .—
NMR.. (100 Mc/s.) 'V 5% TFA/CDC1-,: 1.75 (1H, d. , J = 9 Hz., irr.j
5.*f — > s., -CH = N.C0-) , 2.2 (2H, m. , 0-H of Ar.CO-), 2.5 
(3H, m., m-, £- H of Ar.CO-), 2.7 (1H, d., J = 9 Hz., 
exchanged with D^O, -NH-CH-) , ^-.62 (1H, q., J - 6 Hz.,
-CH-CH7) , 4.91 (1H, d., J = 9 Hz.,— s. on exchange with 
D20, -CH-NH-) , 5.2-6.0 (6tl, m.,), 6 .3 (*fH, br., m. , -CH2-N) , 
8.25. (l*fH, br., m., -CH^-) , 8.71 (9H, m. , C-CH^).
MS. (see text p. 65)
Acid hydrolysis of brevigellin (208)
(a) Brevigellin (8.03 mg«) was .refluxed in 2.5N hydrochloric acid 
(1 ml.) for 6 hr., the cooled solution neutralised with aqueous 
ammonium hydroxide and evaporated to dryness. The hydrolysis products 
were identified by comparison with samples of the appropriate amino 
acids by paper chromatography (Table :I ) .
Amino acid analysis R^: 86 rnin. (threonine, 2k%) , 116 min.
(proline, 25%), 150 min. (alanine, 25%), 202 min. (unidentified 
component, 20%).
Table f^:I Separation of brevigellin hydrolysis products by
paper chromatography
Component Rf .* Ninhydrin Isatin
Threonine 0.25 red-brown red-brown
Alanine 0.31 purple —
Proline 0.3^ yellow blue
P-aminobutyrate 0 .^2 lilac green
*Rf. values were standardised by comparison with glycine 
(0.23) and phenylalanine (O.60).
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(b) Brevigellin (1,02 mg.) in 6N hydrochloric acid (0.5 ml.) was 
heated at 120°C in a sealed tube for 12 hr. and the hydrolysis pr.oducts 
directly analysed.
Amino acid analysis, R^: 85 min. (threonine, 31%)» 118 min. 
(proline, J>h%) , 130 min. (alanine, 33%) •
Alkaline hydrolysis of brevigellin ( 208)
Brevigellin (3 mg.) was treated with 0.5N methanolic potassium 
hydroxide (1 ml.) for 6 hr. and the solution carefully neutralised 
with 0.5 N hydrochloric acid. Extraction with chloroform (3 ml.) 
and subsequent evaporation of the solvent afforded a colourless 
residue (2 mg.) which was dissolved in methanol (1 ml.) and treated 
with an excess of ethereal diazomethane for 3 min. Evaporation of 
the solvent gave the methyl ester (220, 1 mg.).
T.l.c.: 10% methanol/chloroform, Rf. 0.7, y. (12)* bn.,
(Ceif+).
MS. (see text p. 66 )•
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